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abs absolute 
acac acetylacetonate 
AIBN aza-isobutyronitrile 
Bn benzyl 
bp boiling point 
brine saturated NaCl solution 
brsm based on recovered starting 
material 
BTS bis(trimethylsilyl)sulfate 
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CAN cerium(IV) ammonium 
nitrate 
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conc concentrated 
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eq equivalent 
Et ethyl 
fl fluid 
h hour 
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correlation  
HPLC high-pressure liquid 
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HSQC heteronuclear single-
quantum correlation  
i iso 
m meta 
M molar 
Me methyl 
min minute 
mp melting point 
MS mass spectroscopy  
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NMR nuclear magnetic resonance 
NOE nuclear Overhauser effect 
OTf triflate 
p para 
PE hexanes 
PPTS pyridinium p-toluenesulfate 
Pr propyl 
p-TSA para-toluenesulfonic acid 
py pyridine 
ref reference 
r.t. room temperature 
t tert 
TBAF tetrabutylammonium fluoride 
TBDMS tert-butyldimethylsilyl 
TFA trifluoroacetic acid 
THF tetrahydrofuran 
TLC thin layer chromatography 
TMS trimethylsilyl 
Ts tosyl 
vol% volume % 
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A. Introduction 
 
Traditional herbal prescriptions attracted worldwide attention within the last years, 
due to their effectiveness against many afflictions and their low toxicity. In some 
instances they provide an even more effective way to heal diseases where western 
therapies failed or were insufficient to provide a palliative cure.1-4 
Natural products of herbal origin had an indisputable impact in modern medicinal 
chemistry and still break ground for new drugs. Peony root bark (chinese: 
“mu-dan-pi” or “dan-pi”) containing prescriptions like the multiherbal formula 
GuiZhiFuLing-Wan are employed in China, Japan and Korea to alleviate the 
syndromes of blood stasis and stiffness of abdominal muscles.5-7 Since Peony roots 
are under phytochemical investigation for many years, several new monoterpenoids 
could be isolated, characterized and pharmacologically analyzed (Figure 1):8-9  
 
 
Figure 1: Examples of natural products isolated from peony roots.  
 
For example, Paeonilactone C (3) suppresses both directly and indirectly stimulated 
muscle twitching of sciatic nerve-sartorius muscle preparations from frogs,10 while 
Paeoniflorigenone (4) has a blocking effect on the neuromuscular junction in phrenic 
nerve diaphragm preparations of mice.5  
The highly oxygenated monoterpenoid (+)-Paeonilide (+)-(5) was isolated from 
Paeonia delavayi in 2000 (Figure 2),11 which is endemic to the chinese provinces 
Likiang and Yunnan.12 1.13 kg of Paeonia delavayi roots were necessary to obtain 
8 mg of pure (+)-Paeonilide (+)-(5). Its new monoterpenoid skeleton could be 
confirmed by the combination of spectroscopic and crystallographic analyses.11 
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Figure 2: Structure of (-)-Paeonilide (5) and photo of Paeonia delavayi (photo by courtesy 
of Walter Good).13 
 
(+)-5 bears a sub-structural unit of the privileged class of ginkgolides 6 (Table 1), 
which themselves have very interesting properties. Ginkgolides 6 are diterpenoids 
derived from the dioecious “living fossil” Ginkgo biloba L., the last living member of a 
family of trees that appeared more than 250 million years ago.14 Due to the medicinal 
interest in the Ginkgo biloba extracts over 8000 tons of dried leaves are produced 
each year.15  
 
Table 1: Ginkgolide structure and photo of Ginkgo biloba L.; Paeonilide substructure 
marked in red (photo by courtesy of Armin Jagel, Bochumer Botanischer Verein).16 
 
 
Ginkgolide R1 R2 R3 
 
A H H OH 
B OH H OH 
C OH OH OH 
J H OH OH 
M OH OH H 
 
These extracts are used in the treatment of cardiac and cerebral vascular and 
peripheral circulatory disorders,17 diverse neurological disorders18 (e.g. 
cerebrovascular insufficiency with symptoms of vertigo, tinnitus, short term memory 
loss, headache, hearing loss and depression) and early senile dementia (Alzheimer´s 
disease).19 Ginkgolides are inhibiting the human platelet aggregation by inhibition of 
the binding of (3H)-PAF-acether to its membrane platelet receptor.  
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The pharmacological properties are, inter alia, antagonism on PAF induced 
thrombosis, lung anaphylaxis, cardiac anaphylaxis and inhibition of transplant 
rejection.20 
 
Due to the structural similarity between Ginkgolides and Paeonilide (+)-(5), it was 
tested in bioassays.11 The results showed a selective inhibition of the platelet 
aggregation induced by the phospholipide PAF (7) (platelet activating factor, 
1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) with an IC50 value of 25 M 
(8 g/mL), but no effect on the platelet aggregation induced by adenoside 
diphosphate (ADP) (8) or arachidonic acid (AA) (9) (Figure 3). 
 
 
Figure 3: Structure of PAF (7), AA (8) and ADP (9). 
 
The PAF receptor is a 7-transmembrane G protein receptor belonging to the 
rhodopsin family.21 A feature of this family is that critical residues, which are in 
charge of binding ligands, are located in the membrane spanning helices within the 
lipid double-layer and not exclusively on the surface. When PAF is binding to the 
PAF-receptor it starts a transduction cascade that facilitates the conformational 
change of glycoprotein (GP) IIb and IIIa (50000-80000 copies of this receptor on 
platelet surface), which is necessary to enable the binding of the receptor to 
fibrinogen (Figure 4). This is by far the most important ligand for GP IIb and IIIa. In 
this way fibrinogen cross-links two separate platelets which is critical for their 
aggregation.22 
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Figure 4: Pathway of platelet activation (the thickness of arrows indicates the 
strength of the activator).23  
 
So far, the bio-synthetic pathway of Paeonilide is still not clarified. It belongs to a 
group of irregular acyclic monoterpenoids which seems to descend from 
re-arrangements of isoprene units via cleavage of the cyclic monoterpenoid 
p-menthan (10). A subsequent ring formation between C1, C4 and C10 would give 
rise to the core structure of Paeonilide (Scheme 1). 
 
Scheme 1: Proposed biosynthetic route to Paeonilide rac-(5).11  
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Up to now three syntheses of Paeonilide are published, two delivering the racemic 
product24-25 and one diastereoselective.26 
The first total synthesis was accomplished by Zhang et al. in 2006, consisting of 16 
steps and an overall yield of 15%.24 The synthesis started from commercially 
available 2-hydroxy-4-methylacetophenone (13) (Scheme 2), benzyl protection and 
Rubottom oxidation27 lead to -hydroxy ketone 15. A further conversion of the 
intermediate via Wittig olefination, hydroboration of the resulting C-C double bond 
and a deprotection-protection step of the hydroxyl groups afforded the TBDMS 
protected acetal 20. 
 
Scheme 2: Zhang´s racemic synthesis of rac-5. 
 
Reagents and Conditions: a) K2CO3, KI, BnCl, MeCN, 95%; b) i. LDA, THF, TMSCl; ii. mCPBA, 
DCM, NaHCO3; iii. HCl, 95%; c) TBDMSCl, Imidazole, DMF, quant.; d) Ph3PCH3I, tBuOK, THF, 95%; 
e) i. BH3
.
THF; ii. H2O2, NaOH, 90%; f) i. Pd/C, H2; ii. DMP, PPTS; 94% over two steps based on 18; g) 
TBDMSCl, NEt3, DCM, quant; h) Li, NH3 (fl), THF/EtOH, 90%; i) H3BO3, TBAF, THF/H2O, 87%; 
j) OsO4, NMO, THF, tBuOH, H2O, 92%; k) IBX, EA, 94%; l) H5IO6, EA; m) BzCl, py, DCM, 46% over 
four steps based on 24. 
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Acetal 20 was subjected to a Birch reduction and the resulting enol ether 21 was 
hydrolyzed to ketone 22. The subsequent Osmium mediated syn-dihydroxylation of 
the remaining C-C double bond afforded selectively 23, since the six-membered 
acetal ring shielded the back side of 22. Afterwards the secondary alcohol was 
oxidized by IBX to 24, which was afterwards cleaved in an oxidative pathway to 
generate the intermediate 25. A subsequent intramolecular cyclization delivered the 
alcohol 26. Final benzoyl protection of the free hydroxyl group yielded racemic 
Paeonilide rac-(5). 
 
The first diastereoselective synthesis was also established by Zhang et al. starting 
from (R)-(-)-Carvone (27), which is readily available from the chiral pool, providing 
(+)-5 within 16 steps and 6.2% overall yield (Scheme 3).26  
 
Scheme 3: Part one of Zhang´s diastereoselective synthesis of (+)-Paeonilide 
(+)-(5).  
 
Reagents and Conditions: a) NBS, NaOAc, AcOH, DCM, 35%; b) AgOAc, acetone, 92%; c) NaBH4, 
CeCl3, MeOH, 95%; d) mCPBA, DCM, NaHCO3, 93%; e) LiBr (in situ), THF, AcOH, 97%; f) DMP, 
DCM, TsOH, 95%; g) BH3∙SMe2, THF, H2O2, NaOH, 89%; h) tBuOK, DMF, 95%. 
 
Carvone 27 was transformed to acetyl protected 29 by the allyl bromide intermediate 
28, which was further subjected to a Luche-reduction of the carbonyl group and an 
epoxidation by mCPBA. Since the hydroxyl group of 30 exhibits a directing effect, the 
epoxide is formed chemo- and stereoselectively. Therefore, the resulting oxirane ring 
is located on the same side as the hydroxyl group in 31. In situ generated LiBr 
opened the epoxide to the corresponding vicinal syn-diol 32, which was ketal 
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protected, hydroborated and treated with the strong base tBuOK to eliminate HBr and 
form the diol 35. The reaction with NBS lead to the formation of the cis-fused rings 36 
as a single diastereomer, which was subsequently benzoyl protected on the free 
hydroxyl group to afford 37, which was deprotected under acidic conditions to yield 
diol 38 (Scheme 4). The additional treatment with IBX created ketone 39, which was 
cleaved oxidatively to furan 40 and subsequent HBr elimination by DBU yielded the 
key intermediate 41. Finally 41 was submitted to an acidic furan opening, subsequent 
cyclization to the hemiacetal 43 and the formation of the lactone afforded 
(+)-Paeonilide (+)-(5) in a diastereoselective manner. 
 
Scheme 4: Part two of Zhang´s diastereoselective synthesis of (+)-Paeonilide (+)-(5). 
 
Reagents and conditions: a) NBS, THF, 95%; b) BzCl, py, DCM, 99%; c) HCl, MeOH, 92%; d) IBX, 
EA, 90%; e) H5IO6, EA, CH2N2, Et2O; f) DBU, benzene; g) HCl, EA, 40%.  
 
The latest and so far shortest synthesis of Paeonilide rac-(5) was published by Du 
et al. providing racemic rac-5 in five steps in an overall yield of 59% starting from 
commercially available tris(hydroxymethyl)methane (44) (Scheme 5). This triol 44 
was converted to the corresponding acetal 45 and submitted to an one-pot 
Swern-Wittig-reaction to furnish the desired (E)-olefin 46. Subsequently, 46 and 
aldehyde 47 were subjected to a benzoyl peroxide promoted radical addition to give 
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rise to the critical ketone-ester 48, which undergoes an in situ 
deprotection/hemiacetal-formation/lactonization cascade while treating it with HCl. 
This three-reaction-one-pot approach delivers 26 which is finally benzoyl protected to 
the desired racemic Paeonilide rac-(5). 
 
Scheme 5: Du´s racemic synthesis of Paeonilide rac-(5).  
 
Reagents and conditions: a) DMP, TsOH, THF; b) i. (COCl)2, DMSO, Et3N; ii. Ph3P=CHCO2Et, 
DCM, 84% over two steps based on 44; c) (BzO)2, benzene, 79%; d) HCl, EA, 91%; e) BzCl, py, 98%. 
 
In conclusion, both syntheses of Zhang et al. start from a monoterpene 
(diastereoselective synthesis) or a comparable carbon skeleton (racemic synthesis). 
This starting materials, 27 and 13, are both transferred over several steps virtually to 
almost the same aliphatic key intermediate (42 and 25), which undergo a hemiacetal-
formation/lactonization cascade to accomplish the final steps toward Paeonilide in 
one-pot. The most recently published synthesis by Du et al., employs again the furo-
lactone formation via the same aliphatic intermediate, but not starting from an 
(almost) monoterpenoide carbon body. In contrast to Zhang et al., the C-10 skeleton 
is constructed by the combination of a C-6 and a C-4 building block. 
Despite of these results no enantioselective total synthesis is known so far, neither 
for (+)- nor for (-)-Paeonilide. 
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Aim of this work 
 
This work seeks to explore a synthetic way to create the unnatural enantiomer of the 
wanted monoterpene in an enantioselective manner, without starting from the chiral 
pool. Since there are only studies of the biological activity of (+)-Paeonilide it is still of 
great interest to synthesize and investigate the potential of the opposite, unnatural 
enantiomer (-)-Paeonilide (5). 
 
Scheme 6: Transfer of an established method to a new substrate scope (similarities 
to Paeonilide structure are marked in red).  
 
 
The idea was to modify an already well established method for building a fused ring 
system, consisting of a 2-substituted furan and a -lactone,28 and utilizing this 
approach to get access to a ring system bearing a 3-substituted furan (Scheme 6).  
The retro synthetic analysis (Scheme 7) of the target compound 5 does not start from 
a chiral starting material in contrast to the published diastereoselective synthesis, but 
employs commercially available 3-furoic acid (59). The chiral information is 
introduced by a copper(I)-catalyzed cyclopropanation reaction using a chiral 
bis(oxazoline) ligand to yield the bi-cycle 58. The subsequent lactonization gives rise 
to the core skeleton 57 of the desired monoterpenoid. Key step of this synthesis is 
the so far literature unknown side chain introduction proceeding under substrate 
control concerning the stereochemistry and providing the functionalized furo-lactone 
56, which is finally transformed to the unnatural enantiomer (-)-Paeonilide (5)  
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Scheme 7: Retrosynthesis of (-)-Paeonilide (5).  
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B. Main Part 
 
Although cyclopropanes are a highly strained entity, they are found as a pivotal 
structural element in a wide range of natural products, including pheromones, 
unnatural amino acids, fatty acid metabolites and terpenes.29-33 This interesting 
moiety is also present in biologically active compounds, as natural and synthetic 
cyclopropanes are endowed with a large range of biological properties, such as 
enzyme inhibition, insecticidal, antifungal, herbicidal, antimicrobial, antibiotic, 
antibacterial, antitumor and antiviral activities.34 
The history of cyclopropanations of furans started already more than two decades 
ago. In 1988 Saltykova et al. reported the first racemic synthesis of cyclopropanated 
2-furoic ethyl ester 60, catalyzed by rhodium acetate dimer (Scheme 8, top).35 
 
Scheme 8: First reported syntheses of cyclopropanated furan esters.  
 
Reagents and conditions: a) N2CHCOOMe (1 eq), 60 (3 - 5 eq), Rh2(OAc)4 (0.5 - 10 mol%), r.t., 
18 - 22%; b) N2CHCOOEt (1 eq), Rh2(OAc)4 (0.3 mol%), r.t., 12 h, 55 %. 
 
Two years later, in 1990, Wenkert et al. published the racemic cyclopropanation of 
2-furoic methyl ester 62 with diazo glycine ethyl ester (63), also catalyzed by 
dirhodium acetate, but providing higher yields than Saltykova et al (Scheme 8, 
bottom).36 
As this scaffold is an interesting and very convenient gateway for natural product 
synthesis it was extensively utilized to enter a several natural product families 
(Scheme 9). 64 provided an access to the core nuclei of trans seven-membered 
sesquiterpenes 66 (Xanthanolides).37-38 Furthermore, the core structure of 5,6,5-
tricyclic (Eudesmanolides)37-38 and 5,7,5-tricyclic (Guaianolides)37 sesquiterpenes 67 
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and 68 became available. In 2007 Reiser et al. reported the enantioselective 
synthesis of Arglabin™ (65)39, a member of the guaianolide family. 65 is already 
successfully used for the treatment of breast, colon, ovarian and lung cancer in 
Kazakhstan. 64 was also used as starting material for the total synthesis of paraconic 
acids,40 i.e. roccellaric acid (69),41 nephrosteranic acid (70) and protopraesorediosic 
acid (71). Methylenolactocin (73) and protolichesterinic acid (72) were accessed in a 
formal total synthesis.40 The -lactone moiety in these natural products and natural 
product skeletons mentioned before, was synthesized via ozonolysis of 64 and 
subsequent retro-aldol reaction. Contrary to those lactones, the furo-lactones 76 and 
77 were built via a lactonization of the cyclopropane ring.28  
 
Scheme 9: 64 as versatile building block for natural product synthesis (E = ester). 
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1. Preparatory work for the asymmetric cyclopropanation 
 
By choosing commercially available 3-furoic acid (59) as starting material for the 
planned synthesis of (-)-Paeonilide (5) a protection of the free carboxylic acid by 
esterification proved to be necessary to avoid unwanted side reactions.42 The ester 
was formed under strongly acidic conditions, i.e. in the presence of sulfuric acid 
(Scheme 10). 
 
Scheme 10: Esterification of 3-furoic acid (59).43 
 
Reagents and conditions: a) MeOH, H2SO4, r.t., 24 h, 82 %. 
 
The tool that brings chirality in the copper(I) mediated cyclopropanation is a complex 
of a chiral ligand and a metal center. A plethora of these catalytic systems has been 
applied for the cyclopropanation of olefins, e.g. bis(oxazoline)-ligands. Alternative 
ligands and cyclopropanation shall be discussed later in this chapter. The 
bis(oxazoline)-ligands were already successfully applied in the transformation of 
2-furoic esters with diazo esters,40 but a few reactions concerning 3-furoic esters 
were published as well.40, 44 Therefore, a bis(oxazoline) system was chosen for the 
asymmetric reaction between 3-furoic ester 78 and a diazo compound. 
(4S,4'S)-2,2'-(propane-2,2-diyl)bis(4-isopropyl-4,5-dihydrooxazole) (82) was prepared 
starting from L-valinol (80) and 2,2-dimethylpropanedioyl dichloride (79) reacting 
under amide formation to intermediate 81, which was cyclized to afford ligand 82 
(Scheme 11).45 
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Scheme 11: Synthesis of (4S,4'S)-2,2'-(propane-2,2-diyl)bis(4-isopropyl-4,5-
dihydrooxazole) (82). 
 
Reagents and conditions: a) L-valinol (2.0 eq), NEt3 (2.5 eq), DCM 0 °C to r.t., 70 min, 84 %; 
b) DMAP (10 mol %), NEt3 (4.0 eq), TsCl (2.0 eq), DCM, r.t., 27 h, 83%. 
 
The second ligand used for cyclopropanation within this thesis was also a 
bis(oxazoline)-ligand, possessing a secondary binding site. It was synthesized from 
the amino alcohol (1S,2S)-2-amino-1-phenyl-1,3-propanediol (84), which is not 
derived from a natural amino acid. This amino alcohol 84 was converted with 
2,2-dimethylmalononitrile (83)46 in an one-pot reaction to ((4S,4'S,5S,5'S)-
2,2'-(propane-2,2-diyl) bis (5-phenyl-4,5-dihydrooxazole-4,2-diyl)) dimethanol (85), 
catalyzed by cadmium acetate (Scheme 12).44, 47 
 
Scheme 12: Synthesis of ((4S,4'S,5S,5'S)-2,2'-(propane-2,2-diyl)bis(5-phenyl-4,5-
dihydrooxazole-4,2-diyl))dimethanol (85).  
 
Reagents and conditions: a) amino alcohol 84 (2.5 eq), Cd(OAc)2
.
2H2O (5 mol%), chlorobenzene, 
reflux, 14 h, 39%.  
 
After substrate and ligand, the final compound, which needs to be prepared, is the 
diazo compound presenting the precursor for the reactive species in the 
cyclopropanation.  
The tert-butyl diazo compound 89 was synthesized according to literature precedents 
following a two-step protocol utilizing the Regitz diazo transfer48 from tosyl azide (87) 
to tert-butyl acetoacetate (88) under phase transfer conditions49 yielding tert-butyl 
diazo acetate (89) as a solution in n-pentane (Scheme 13). Since this solvent is not 
suitable for the subsequent reaction due to solubility problems of the 
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copper(I)-complex, it was inevitable to remove the solvent. The remaining yellow 
diazo ester 89 was then diluted with anhydrous DCM. This procedure exhibits the 
advantage of preparing a diazo ester-DCM solution which can be adjusted to a 
certain wt% by calculating the amount of DCM added. 
 
Scheme 13: Synthesis of tert-butyl diazo acetate (89). 
 
Reagents and conditions: a) NaN3 (1.1 eq), EtOH, r.t., 3 h, 76%; b) NaOH (2.8 eq), Bu4NBr 
(2 mol%), H2O, n-pentane, 0 °C to r.t., 20 h, 88%.  
 
The corresponding ethyl diazo ester 91 was prepared in an one-step procedure 
starting from glycine ethyl ester hydrochloride (90) (Scheme 14).50 This method does 
not provide the advantage of an adjustable wt%. It depends on the amount of DCM 
used for the reaction and work up. Typically, solutions of 10 - 15 wt% are obtained. 
 
Scheme 14: Synthesis of ethyl diazo acetate (91). 
 
Reagents and conditions: a) NaNO2 (1.3 eq), H2SO4 (cat), H2O/DCM, -20 °C to r.t., 1 h, 96%. 
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2. Cyclopropanation  
 
2.1 General information 
 
Although the history of transition metal catalyzed cyclopropanations started in 1906,51 
more than a century ago, there were only small developments until the late 1960s 
when the catalyst development became more interesting, not only for natural product 
synthesis.  
Besides the biological attributes, cyclopropanes are also of synthetic interest, since 
they can be used for the formation of highly functionalized cycloalkanes52-58 or acyclic 
compounds.59-62 The main reason for the broad interest in this special moiety is the 
reactivity of cyclopropanes, which is usually associated with electron-donating and/or 
electron-accepting substituents. 
 
 
Figure 5: Donor (Don) - Acceptor (Acc) substituted cyclopropanes; geminal (92), 
vicinal (93), 1,3-dipolar synthon (94).63 
 
The synthetic use of geminal donor-acceptor substituted cyclopropanes, which have 
no synergistic substituent effect, is only reported in a few publications. Vicinal 
substituted cyclopropanes are very attractive for organic synthesis, since they are 
utilized as 1,3-dipolar synthons in a plethora of organic transformation (Figure 5).64-65  
Among others, one way en route to donor-acceptor substituted cyclopropanes is the 
transition-metal catalyzed decomposition of a diazo compound, which results in 
extrusion of nitrogen and the formation of a transition-metal-carbene complex. 
Calculations66 and Hammett studies67 support the addition of a very reactive metal-
carbene intermediate in the early transition state to the substrate in a concerted, yet 
strongly asynchronous pathway with a cationic substrate character on one alkene 
carbon. This is represented by transition state A, rather than in the 
metallacyclobutane B (Scheme 15).  
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Scheme 15: Catalytic cycle of metal-catalyzed carbenoid cyclopropanation reaction 
with diazo compounds.68 
 
 
The use of copper, rhodium and, more recently, also ruthenium catalysts proved to 
be highly effective. Palladium catalysts have advantages in reactions with electron-
deficient alkenes, while other late transition metals like iron or osmium are only 
reported occasionally.68 Regarding copper, Kochi69 was the first to show that Cu(OTf) 
is a highly effective catalyst. Cu(II)-complexes are applicable as well, but need to be 
reduced in-situ since Cu(I) is the active species70 in carbene reactions. This can be 
achieved by treatment with DIBAL-H, substituted hydrazines, or the diazo agent itself.  
In order to perform the cyclopropanations in an enantioselective manner, a chiral 
environment is needed to transfer stereochemical information to the olefin substrate. 
This is achieved by using chiral ligands for complexing the metal ion. A short 
overview is provided in Figure 6. 
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Figure 6: Short overview of chiral ligands for asymmetric cyclopropanations.68 
 
The diazo compounds have a rather broad scope regarding tolerated functional 
groups and substitution patterns, both, mono- and disubstituted ones (Figure 7). The 
most exhaustively studied diazo reagents are the -diazo esters (101, Y = OR).  
 
 
Figure 7: Different -diazo compounds. 68 
 
Attempts to use diazo compounds containing chiral auxiliaries for asymmetric 
cyclopropanation of styrene resulted only in poor diastereoselectivity (Figure 8).71-73 
 
 
Figure 8: Diazo compounds bearing chiral auxiliaries.  
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2.2 Furan cyclopropanation  
 
The copper(I) catalyzed cyclopropanation of furan derivatives like 62 comes along 
with some features. It proceeds regioselectively, since the highly electrophilic copper-
carbene complex 111 (Figure 9, left) attacks only the less hindered and presumably 
more electron rich C-C double bond, as long as the diazo compound is not added in 
a huge excess. Furthermore, the reaction is diastereoselective, as the ester group at 
the introduced cyclopropanes is exclusively directed to the convex face of the fused 
ring system.41  
 
Scheme 16: Copper(I) catalyzed cyclopropanation of furan ester 62.  
 
Reagents and conditions: a) i. N2CHCOOEt (2.67 eq.), Cu(OTf)2 (0.66 mol%), (S,S)-iPr-BOX 
(0.84 mol%), PhNHNH2 (0.70 mol%), DCM, 0 °C, 54%, 85-90% ee; ii. recrystallization (DCM, 
n-pentane), >99% ee, 37%. 
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The stereochemical outcome can be explained by a model for the asymmetric 
cyclopropanation of olefins as suggested by Pfaltz74 and Andersson:75 
 
 
Figure 9: Reactive complex 111 (left) in the asymmetric cyclopropanation with 
(S,S)-iPr-BOX ligand 82, Cu(I), and ethyl diazo-acetate (91, E = COOEt); model for 
asymmetric cyclopropanation (center and right). 
 
The pathway in which 62 approaches from the left is favored over an approach from 
the right side of the complex 111 (Figure 9, center), since the latter bears a strong 
repulsive steric interaction between the approaching olefin and the iPr group of the 
ligand. This model indicates that the high enantioselectivity depends also on the 
structure of the olefin, since the COOMe substituent on the furan tends to be pointing 
away from the ligand framework which results in high enantioselectivity. As the iPr 
groups of the ligand block the upper left and lower right quadrant of the complex, the 
substrate attacks from the unhindered quadrants (Figure 9, right). With this complex 
being C2-symmetric, the approach via these unblocked quadrants leads to the same 
enantiomer of 110. 
 
The ligand and diazo ester screening for the asymmetric cyclopropanation of 62 
showed that the bis(oxazoline) ligands (Table 2, entry 1 - 6) are superior to the aza-
bis(oxazolines) (Table 2, entry 7 - 10) in terms of isolated yield and slightly superior in 
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terms of enantiomeric excess obtained.40 It turned out that ligand 99 bearing the 
bulky tBu groups delivered the best results. However, recrystallization of the product 
furnished the enantiomerically pure cyclopropanation product 112. Hence, 82 is the 
ligand of choice for economic reasons (readily available from L-valine in contrast to 
ligand 99, which is produced from the expensive unnatural amino acid tert-butyl 
leucine). The steric demand of the diazo ester is another issue. It turned out that 
exchanging the ethyl group with a tert-butyl group has a beneficial effect on the 
stereochemical outcome of the reaction (Table 2, entry 4 and 6).   
 
Table 2: Ligand and diazo acetate screening for the conversion of 2-furoic ester 62.40 
 
 
Entry Diazo acetate 
R 
Ligand 
L* 
Yield 
[%] 
Selectivity 
[%] ee 
1 Me 85 45 69 
2 Me 99 55 85 
3 Et 99 63 91[a] 
4 Et 82 35 81[a] 
5 Et ent-82 33 75[a] 
6 tBu 82 38 95[a] 
7 Me 113 23 94 
8 Me 100 36 91 
9 Me 114 18 91 
10 Me 115 31 85 
[a]: 99% ee after single recrystallization [isolated yield 53% (entry 3), 32% (entry 4), 29% (entry 5) and 
27% (entry 6)]. 
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In order to extend the scope of the asymmetric cyclopropanation of furan derivatives, 
the copper(I)-bis(oxazoline)-diazo-ester system was also examined with 3-furoic 
methyl ester (78) (Table 3). In contrast to the 2-substituted cyclopropanation product 
112, the 3-substituted 58 was formed in slightly lower yields but significantly lower 
enantiomeric excess.  
 
Table 3: Ligand and diazo acetate screening for the conversion of 3-furoic ester 78. 
 
 
Entry Diazo acetate 
R 
Ligand 
L* 
Yield 
[%] 
Selectivity 
[%] ee 
1[a] Et 85 27 74 
2 tBu 85 38 65 
3[b] Et 116 31 68 
4[b] Et 117 19 40 
5[a] Et 99 22 74 
6 Et 82 31 83 
7 tBu 82 38 83 
[a]: Ref. 
40
 ; [b]: Ref. 
76
. 
 
 
In the case of ligands 85, 116 and 117 (Table 3, entry 1 - 4) carrying secondary 
binding sites, this difference in selectivity can be explained via the substrate-complex 
coordination. Since the steric demand of the side chains is relatively low compared to 
an iPr or tBu group, the OH group of 85 (NH for 116 and 117, respectively) is 
suggested to act as a hydrogen bond donor (Figure 10, left).76 This fact explains the 
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higher enantiomeric excess of the 2-substituted cyclopropanated furan 112 over the 
3-substituted one 58. The latter is supposed to be unable of forming hydrogen bonds 
with the ligand-OH/NH group, as the distance between the ester and the OH/NH 
group is too long (Figure 10, right). Thus, the missing hydrogen bond cannot 
compensate the relatively low steric demand of the side chains, which results in lower 
ee values.  
 
 
Figure 10: Complex of 2-furoic ester 62 (left)76 and 3-furoic ester 78 (right) with 
ligand 85 bearing a secondary binding site (the same applies to ligand 116 and 117 
with the NH groups acting as hydrogen donor); E = ester.  
 
There is a different explanation for the comparable but mostly lower enantiomeric 
excess using ligands without secondary binding sites 99 and 82 (Table 3, entry 5 - 7). 
As mentioned above, the substrate approaches to the complex in a way that the 
furan-COOMe group points away from the bulky moieties (iPr or tBu) of the ligand. 
This fact, combined with the C2-symmetry of the complex, is responsible for the 
stereoselectivity (Figure 11, left column). The exchange of 2-furoic ester with 3-furoic 
ester should lead to a lower steric repulsion between the furan-COOMe group and 
the ligand residue, due to the lengthened distance. This steric difference can be 
responsible for an initially unfavored approach turning into a likely pathway (Figure 
11, right column). Although this hypothesis has yet to be proven, it gives an 
explanation for the lower enantioselectivity of this cyclopropanations and makes the 
way for further optimization. In order to increase the steric repulsion, more bulky ester 
groups could be introduced into the 3-furoic acid (59) to enable a screening process. 
If the hypothesis is accurate, the ee values should increase with the bulkiness of the 
ester (Me < Et < iPr < tBu). 
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Figure 11: Selectivity comparison of the cyclopropanation of two different substrates 
(E = ester). 
 
In contrast to the diazo compound screening for the conversion of the 2-furoic ester 
62, the exchange of ethyl diazo glycine (91) by tert-butyl diazo glycine (89) gave no 
advantage for the stereoselectivity when using 3-furoic ester 78 (Table 3, 
entry 6 and 7). 
Contrary to the 2-furoic-ester-pathway, the 3-furoic-ester pathway does not allow the 
purification of the desired enantiomer by crystallization. The ethyl ester derivative 119 
did not form a solid and stayed a sticky oil even during storage at -18 °C for several 
weeks. In contrast, the tert-butyl derivative 118 crystallizes already as a white solid, 
while being concentrated under reduced pressure after column chromatography. All 
attempts to recrystallize it in order to increase the enantiomeric excess, either in the 
established n-pentane/DCM mixture or other solvent mixtures, failed due to the high 
solubility in almost all common organic solvents (even in neat n-pentane at low 
temperatures). 
The stereochemistry of the tert-butyl substituted cyclopropanation product 118 was 
confirmed by X-ray crystallography (Figure 12). 
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Figure 12: X-ray structure of 118. 
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3. Toward the furo-lactone formation 
 
Due to the easier accessibility of the ethyl diazo glycine (91), even on multi gram 
scale, the further experiments toward the furo-lactone 121 were carried out with the 
ethyl ester derivative 119 of the cyclopropanated furan (Scheme 17). 
 
Scheme 17: From the cyclopropanated furan 119 to the furo-lactone moiety 121, the 
core structure of Paeonilide (5). 
 
A preliminary account was the straightforward direct lactonization of the cyclopropane 
119 to the furo-lactone 121 to yield the core skeleton of the desired target molecule. 
In order to achieve this reaction several literature known lactonization methods were 
carried out. 
 
Table 4: Direct lactonization attempts. 
 
 
Entry Reagents Conditions Yield [%] Observations 
1[a] 6 M HCl / dioxane 24 h, r.t. - saponification 
2[b] MeSO3H (3.3 eq), 
acetone 
24 h, r.t. - intractable mixture 
3[c] BTS (2 eq), DCM 14 h, 0 °C to r.t. 87 (127) formation of acyclic 
isomers 
[a]: Ref 
28
; [b]: Ref 
77
; [c]: Ref 
78
. 
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The acid mediated lactonization (Table 4, entry 1), already used in the synthesis of 
the core nuclei 76 and 77 of Macfarlandin C, Norrisolide and Cheloviolene A/B 
(Scheme 9), usually applied on saturated systems afforded in present case, e.g. an 
unsaturated substrate, only a mixture of partially and completely saponified starting 
material. The use of methane sulfonic acid, successfully employed in the one-pot ring 
expansion of cyclopropane rings by Theodorakis et al., resulted in the case of 119 in 
a complex mixture of components. Hiyama et al. reported the utilization of 
bis(trimethylsilyl) sulfate (128, BTS, synthesized according to reference 79) for the 
transformation of activated cyclopropane carboxylates into -butyrolactones.78 So far 
BTS - highly Lewis acidic and less nucleophilic - was limited to the silylation of active 
hydrogen compounds.80-81 According to Hiyama BTS was superior to other Lewis and 
Brønsted acids like H2SO4, TMS-OTf, TMS-I, BF3
.OEt2 or TiCl4, which gave 
unsaturated aliphatic byproducts in different quantities, depending on the acid used 
(Scheme 18, top). The treatment of X with BTS did not afford desired lactone but 
exclusively a mixture of unsaturated aliphatic isomers (Z/E-127 and E/E-127 1.7:1, 
Scheme 18, bottom). According to Reissig et al., this kind of transformation is one of 
the most frequently applied reactions in the class of small ring molecules.63 Although 
these reactions usually provide 1,4-dicarbonyl compounds, 119 delivers 
1,6-dicarbonyls due to its fused ring system.  
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Scheme 18: Lactonization by Hiyama et al., literature example (top) 78 and 
application of 119 (bottom).  
 
Reagents and conditions: a) Lewis or Brønsted acid (2 eq), DCM or DCE, reflux, 98% 124 
(for acid = BTS); b) BTS (2 eq), DCM, 0 °C to r.t., 14 h, 87% (Z/E-127 and E/E-127 1.7:1). 
 
Parallel to these efforts on the lactonization, the selective reduction of the 
furan-COOMe group was attempted, which probably would be advantageous for the 
later steps, since the COOMe group needs to be transformed into a hydroxyl group 
anyway.  
 
Scheme 19: Attempted selective methyl ester reduction.  
 
Reagents and conditions: a) LiAlH4 (0.6 eq), THF, 0 °C, 1 h, 87%; b) LiAlH4 (0.6 eq), THF, 0 °C, 1 h, 
34% 131 and 32% 132. 
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The reduction of the 2-substituted derivative 110 with LiAlH4 proceeded in a selective 
way, which can be explained via chelating of the oxygen atoms by a lithium ion, 
probably activating the methyl ester carbonyl (Scheme 19, top).82 Due to the 
3-position of the methyl ester in 119, it is not possible to chelate the oxygen atoms, 
which results in a mixture of both possible alcohols 131 and 132 (Scheme 19, 
bottom). Because of this selectivity problem, experiments concerning this route were 
ceased.  
 
To circumvent the problems occurring in the direct lactonization (Table 4) or the 
selective reduction pathway (Scheme 19), it was envisaged first to reduce the C-C 
double bond and then implement further modifications toward the furo-lactone core 
skeleton. In order to achieve this goal, standard methods for C-C double bond 
hydrogenation were applied (Table 5). 
Several attempts in different solvents showed the high dependency of this reactions 
to the applied solvent, e.g. methanol and ethyl acetate proved to be completely 
ineffective. Moreover, variation of the catalyst (e.g. palladium on charcoal, palladium 
hydroxide on charcoal, ruthenium on aluminum oxide) did not result in consumption 
of starting material (Table 5, entry 1 - 4). 
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Table 5: C-C double bond hydrogenation. 
 
Changing the catalytic system from heterogeneous to homogeneous, i.e. by 
application of Wilkinson´s catalyst,83 gave no conversion as well, even when 
hydrogen pressure was applied up to 30 bar in an autoclave. 
The use of aqueous ethanol together with palladium on charcoal finally resulted in 
conversion of 119. However, the reaction in EtOH/H2O with Pd/C provided not only 
the desired product 133, but also byproduct 134 from hydrogenation of one 
cyclopropane bond. The structure of 134 could be confirmed by 2D-NMR analysis. A 
similar byproduct was also observed when derivatives of the 2-substituted 
cyclopropanated furan 110 was submitted to hydrogenation conditions, albeit 
opening of the furan occurred next to addition to the cyclopropane ring.84 It could be 
shown that the presence of water promoted the reaction, since the conversion in 
anhydrous ethanol was negligible even after 3 days (according to TLC control). The 
addition of catalytic amounts of acetic acid accelerated the product formation but 
 
Entry Reagents[a] Conditions 
Yield [%] 
133     134 
Observation 
1 Pd/C, MeOH, H2 24 h, r.t. - 
- 
- 
- 
no reaction 
2 Pd(OH)2, MeOH, H2 24 h, r.t. no reaction 
3 Pd/C, EA, H2 24 h, r.t. no reaction 
4 Rh/AlOx, EA, H2 24 h, r.t. no reaction 
5 Pd/C, EtOH/H2O (95:5), H2 24 h, r.t. 25 8  
6 entry 5 + AcOH (cat) 12 h, r.t. 23 48  
7 Pd/C, EtOH (abs), H2 >3 d, r.t.   extremely slow 
8 Mg (1 eq), MeOH 0.5 h, 0 °C - 38 transesterification 
2x COOMe (135) 
9 RhCl(Ph3P)3,
[b] EtOH/THF 
(9:1), H2
[c] 
18 h, r.t.    
[a]: if not stated otherwise H2 applied via balloon; [b]: Wilkinson´s catalyst [c]: balloon 1 h (no reaction), 
autoclave 20 bar 2 h (no reaction), autoclave 30 bar 15 h (no reaction). 
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gave also an increase in ring opened 134. The same effect was observed when 
different acids like p-TSA, oxalylic acid or TFA were used. Product 133 was formed 
as expected, exhibiting the methyl ester group on the concave side of the fused ring 
system, since the hydrogenation takes place from the less hindered, convex side. 
The stereochemistry of 133 was confirmed by X-ray crystallography (Figure 13). 
 
 
 
 
Figure 13: X-ray structure of 133. 
 
A screening should give rise to the origin of the byproduct 134 (Scheme 20). To this 
end, olefin 119 was stirred in the presence of palladium on charcoal but without any 
hydrogen to determine whether the side reaction occurs on the catalyst surface itself, 
but only very slow decomposition could be observed (Scheme 20, top). The desired 
hydrogenation product 133 reacted fast under hydrogenation conditions to the 
opened cyclopropane 134 (Scheme 20, middle). Contrary to these results, treatment 
of 133 only with solvent and catalyst without hydrogen gave no new compounds on 
TLC, therefore it seems to be stable under these conditions (Scheme 20, bottom). 
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Scheme 20: Studies on byproduct formation. 
 
A final hydrogenation was attempted with in situ generated hydrogen by treating the 
starting material 119 with magnesium in methanol.85-86 According to literature 
precedents, this method was successfully applied on ,-unsaturated esters and 
tolerates several functional groups, e.g. esters, epoxides and ethers. The 
recommended 10 equivalents of magnesium caused a rapid formation of multiple 
compounds within a few minutes. Changing the conditions to 1 equivalent of 
magnesium and cooling to 0 °C gave rise to the opened cyclopropane 135, which is 
similar to 134, but transesterificated to a double methyl ester. In contrast to 134, 
which was formed as a single diastereomer, 135 was produced as a 1:1 mixture of 
two diastereomers, which could not be exactly identified yet.   
 
As the aforementioned lactonization directly after cyclopropanation was 
unsuccessful, the alternative approach of reducing the C-C double bond was further 
envisaged to be optimized, since a product formation was already observed. To 
circumvent these problems, saponification of the methyl ester was envisaged. In 
order to perform this reaction selectively, with respect to the COOMe group, very mild 
conditions were chosen. A small excess of lithium hydroxide in aqueous THF at 0 °C 
did not give the desired product but an inseparable 1:1 mixture of both possible 
mono-saponified products 136 and 137 (Scheme 21). 
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Scheme 21: Attempt of selective saponification. 
 
Reagents and conditions: a) LiOH (1.1 eq), H2O/THF 2:1, 0 °C, 6 h, 85% (136/137 = 1:1).  
 
Literature known procedures for a selective conversion of a methyl ester like the 
reaction of sodium cyanide in DMPU, did not furnish the desired product either, but 
only a complex mixture which could not be analyzed.87-88 
 
Due to the small difference in reactivity regarding the hydrolysis of the methyl and 
ethyl ester of 119, a change of these groups was needed. For this reason the initial 
cyclopropanation was performed with tert-butyl diazo glycine (89) to accomplish the 
cyclopropanated furan 118 (Scheme 22, X-ray structure Figure 12), now bearing a 
methyl and a tert-butyl ester (for a closer discussion of furan-cyclopropanation see 
chapter 2.2). All further reactions found on this molecule. 
 
Scheme 22: Asymmetric cyclopropanation with tert-butyl diazo glycine (89). 
 
Reagents and conditions: a) Cu(OTf)2 (1.12 mol%), (S,S)-iPr-BOX (82) (1.5 mol%), PhNHNH2 
(1.12 mol%), N2CHCOOtBu (1.3 eq), DCM, 0 °C, 38% (53% brsm), 83% ee. 
 
The subsequent hydrolysis of the methyl ester in the presence of the tert-butyl ester 
performed by the utilization of lithium hydroxide now worked as desired in a 
chemoselective way, delivering the carboxylic acid 138 in excellent yield         
(Scheme 23). The synthesis was even applicable on multi gram scale. The following 
C-C double bond hydrogenation was first tested with the so far best solvent-catalyst 
system according to the prior hydrogenation screening, palladium on charcoal in 
ethanol-water 95:5. Already the first reaction proceeded smoothly to the product 139     
(Scheme 23). Due to steric reasons the reduction should proceed from the less 
hindered, convex side of the fused ring system, which was confirmed later. 
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Scheme 23: Hydrogenation and hydrolysis to 139. 
 
Reagents and conditions: a) LiOH (1.1 eq), H2O/THF 3:1, r.t., 6 h, 85% (quant. brsm); b) Pd/C 
(10%), EtOH/H2O 95:5, H2 (balloon), r.t., 6 h, quant. 
 
Having 139 in hands, there were two alternative routes to proceed in the synthesis. 
Either reduction of the free carboxylic acid group to the corresponding alcohol, 
followed by the lactonization, or vice versa. Both ways were examined. The reduction 
of the acid group was performed in THF by the use of a borane-THF-complex, which 
selectively reduces carboxylic acids to the corresponding alcohol in the presence of 
esters if not added in too large excess.89 The reaction itself worked as desired but 
problems during the work up were encountered, since the product 140 seemed to be 
unstable under these conditions (Scheme 24). 
 
Scheme 24: Different lactonization pathways.  
 
Reagents and conditions: a) BH3
.
THF (1.2 eq), THF, 0 °C to r.t., 13 h, 22%; b) 6 M HCl, THF, r.t., 
6 h; c) BnOH, H2SO4 (2.8 eq), 0 °C to r.t., 14 h, 30%; d) i: MeSO3H (6 eq), DCM, -20 °C to r.t., 12 h, 
(143/144 = 1.4:1); ii: DBU (1.1 eq), DCM, H2O (cat), reflux, 2h, 70% (143/144 =  5:1); e) THF, Pd/C 
(10%), H2 (balloon), r.t., 2 h, 85%. 
 
 
B. Main Part 
35 
The obtained alcohol 140 was analyzed by X-ray crystallography (Figure 14). This 
structure proved the assumption that the reduction of the C-C double bond occurred 
in a way that led to the carboxylic acid 139 (Scheme 23) exhibiting the acid group on 
the concave side of the fused ring system. 
Figure 14: X-ray structure of 140. 
 
The ensuing lactonization attempt of 140, following the acid mediated lactonization 
protocol,28 resulted in a complex mixture of unidentified, highly polar compounds. 
Since this route seemed incapable of generating the desired fused ring system, the 
second route was examined.  
It is possible to form the bi-cyclic system either in an one-pot acid mediated or a 
two-step reaction. The latter was published by Theodorakis et al. for the total 
synthesis of the spongiane diterpene norrisolide and starts with an acidic opening of 
the cyclopropane moiety to form the acetal 142.90 Under these conditions all 
containing ester or carboxylic acid groups are transesterificated or esterificated 
respectively, depending on the used alcohol (in this case benzyl alcohol). The 
product was obtained in a diastereomeric mixture and isolated in an impure form by 
column chromatography. The subsequent lactone closure was accomplished by 
using methanesulfonic acid furnishing two different diastereomers 143 and 144 in a 
1.4:1 ratio. 
The formation of the two appearing diastereomers is illustrated in Scheme 25 and 
can be explained by a mechanism published by Reiser et al.28 The expected 
diastereomer is lactone 144, which is formed when the backward-directed 
CH2COOBn of 142 substitutes the OBn group on the furan. Under acidic conditions, 
which occur in the cyclopropane ring opening reaction, benzyl alcohol can be 
reversibly eliminated from compound 142 to yield the enol 150. This enol can 
undergo a re-addition of benzyl alcohol to the acetal 149, now possessing the 
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CH2COOBn group on the steric less hindered upper side of the furan ring. This 
thermodynamically more favored acetal is converted under benzyl alcohol elimination 
to the lactone 143, bearing the benzyl ester on the convex side of the bicycles. 
It could also be shown that treatment with DBU shifted the diastereomeric ratio from 
1.4:1 to 5:1. This can be explained by the base mediated lactone opening of 144 to 
the hemiacetal 146 and a subsequent water elimination to enol 147, followed by 
re-addition of water to form again a hemiacetal 148 (Scheme 25, dashed box). 
Possessing the two substituents in anti position 148 is thermodynamically more 
favored than 146. The final ring closure gives rise to the furo-lactone 143. 
 
Scheme 25: Acid mediated formation of lactone diastereomers 143 and 144 (boxes); 
base mediated lactone isomerization (dashed box). 
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Although the one-pot acid mediated lactonization was never applied to a 
cyclopropanated furan having the ester substituent in 3-position, like 139, it seemed 
worthwhile to adopt it for that substrate, since the two-step lactonization procedure 
lacks diastereoselectivity. First attempts with 6 M hydrochloric acid at ambient 
temperature afforded the lactone 145, but only as a part of a multi component 
mixture, which was inseparable due to the high polarity of the compounds.28 A slight 
modification of the conditions improved the outcome of this reaction (Scheme 26): 
using 2 M hydrochloric acid and cooling to 0 °C during the acid addition made the 
starting material 139 react smoothly to the desired product 145. Since the 
subsequent base mediated transformation to the other lactone diastereomer was 
already known from the two-step lactonization discussed before (Scheme 24), this 
methodology was applied as well. In contrast to the use of DBU, pyridine could be 
employed without refluxing the reaction mixture, thus avoiding the formation of 
byproducts to give rise to the core ring system of (-)-Paeonilide (5) as the substituent 
in 3-position was already on the convex side.  
 
Scheme 26: One-pot lactonization and subsequent isomerization. 
 
Reagents and conditions: a) 2 M HCl/THF 3:1, 0 °C to r.t., 12 h, not isolated; b) py, H2O, r.t., 2 h, 
75% over 2 steps. 
 
The absolute stereochemistry of both lactone isomers was confirmed by X-ray 
crystallography (Figure 15). It should be mentioned that 57 could only be crystallized 
by the following technique: dissolving 57 in a small amount of acetonitrile on a watch 
glass, addition of one equivalent of (R)-1-(4-chlorophenyl)ethylamine and slow 
evaporation of the solvent during storage in the refrigerator. 
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Figure 15: X-ray structures of lactone 145 and 57, the latter co-crystallized with 
(R)-1-(4-chlorophenyl)ethylamine. 
 
The following experiments were performed in parallel with both lactone 
diastereomers. In order to complete the final steps toward (-)-Paeonilide (5), except 
for the ketone side chain, the free carboxylic acid was reduced to the corresponding 
alcohol with the aid of borane.89 The best results were obtained when the reaction 
mixture was heated up to 40 °C once the addition of the reducing agent was finished. 
Using this procedure, both alcohols 141 and 152 could be obtained in good to 
excellent yield. The subsequent protection step of the alcohol to the final benzoyl 
ester was done following the literature reaction of the already published Paeonilide 
synthesis by Du et al.25 The measurement of the optical rotation of both products of 
the protection reactions gave the same  value, which indicated the isomerization of 
one of both alcohols, either 141 or 152. The absolute stereochemistry of the obtained 
isomer could be confirmed by X-ray crystallography (Scheme 27). 
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Scheme 27: Reduction and protection reaction; X-ray structure of 153. 
 
 
Reagents and conditions: a) BH3
.
THF (1 eq), THF, 0 °C to 40 °C, 3 h, 68%; b) BzCl (2 eq), py, r.t., 
3 h, 36%; c) BH3
.
THF (1 eq), THF, 0 °C to 40 °C, 3 h, 97%; d) BzCl (2 eq), py, r.t., 3 h, 39%. 
 
 
 
 
This means both protection reactions provide the same product 153. The 
isomerization is supposed to proceed in the same way as previously discussed, 
especially concerning the base mediated lactone-isomerization (Scheme 25, dashed 
box). Like in that case, the formation of the steric less hindered and therefore 
thermodynamically favored lactone 153 is privileged. 
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4. Side chain introduction by C-H insertion 
 
4.1 General information 
 
The final transformation to the target compound 5 was planned to be accomplished 
by the utilization of a metal catalyzed carbene C-H insertion in the acetal-like C-H 
bond (Scheme 28). 
 
Scheme 28: Planned C-H insertion in acetal-like position. 
 
 
Since its first observation more than 60 years ago91 and due to its novel chemistry at 
that time described as unusual reaction, C-H insertions became of great interest not 
only because of mechanistic implications but also in natural product synthesis. In the 
latter case, this kind of conversion exhibits huge benefits: Traditional reactions take 
advantage of functional groups which can hamper the synthesis due to the formation 
of unwanted byproducts. In contrast to functional group conversions, C-H insertions 
can be utilized to streamline reaction sequences and to diminish the generation of 
byproducts. Despite years of investigation in this area, the number of known catalytic 
processes for these transformations is still limited.92-94 Several reasons might account 
for this:95 
First, predominant investigations on “classic” C-H activations including the formation 
of an organometallic compound, and second, the big energy requirement for cleaving 
a C-H bond combined with the arising selectivity problems. 
Regarding the first point, most effort in this field was put in studies concerning 
“classic” C-H activation reaction including the formal insertion of a metal center into 
the C-H bond to form a -organyl derivative (Scheme 29, top). In this case, the 
relative stability of the newly formed carbon-metal and carbon-hydrogen bonds gave 
rise to an inert organometallic compound 156, which paralyzes subsequent 
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transformations. In contrast to this fact, the transient metallo-carbene 157 with a C-H 
bond would give rise to the formation of a new carbon-carbon bond 158 by a formal 
insertion of a carbene into a carbon-hydrogen bond (Scheme 29, middle). 
Simultaneously, the metal center is released and reused in the catalytic cycle by the 
in situ reaction of the metal complex 154 with an diazo compound 159 (Scheme 29, 
bottom).96-97 
 
Scheme 29: C-H activation: C-M bond formation (top), carbene insertion (middle), 
in situ formation of metallo-carbene intermediate (bottom).95 
 
 
This alternative route via the transient metal-carbene was first reported by Scott et al. 
using inorganic copper sulfate and chloride as catalyst for the insertion of an ethyl 
diazo glycine (91) derived carbene into a C-H bond of cyclohexane.98 The 
employment of Cu(acac)2, as published by Wulfmann et al. in 1976, gave similar 
results.99 Besides copper also rhodium complexes, like Rh2(TFA)4, were employed. 
Focusing on Rh containing catalysts, Teyssié, Noels and co-workers reported several 
articles, which showed superior yields compared to the copper catalyzed reaction 
mentioned before.100-104 Therefore, many related rhodium catalysts were applied 
within the following years, which might be considered as interesting from the 
mechanistic point of view, but with limited value for synthetic chemistry, at least at 
that time.105 
The second reason why C-H insertion chemistry had a rather small impact in recent 
years is regioselectivity. While established methods rely on selectivity control by 
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steric and electronic means, the biggest challenge within C-H insertions is to reach 
comparable level of selectivity as in functional-group based chemistry. This is 
especially true, because there are typically more than one C-H bond in a common 
organic substrate molecule. Additionally, the required energy for C-H bond cleavage 
is quite high. Studies showed that the C-H bond energy values are as follows:106  
 
carbon center: CH4 primary secondary tertiary 
C-H bond energy [kcal/mol]: 105 101 99 97 
 
For this reason, reactive reagents like the applied metal carbenes, generated by the 
decomposition of diazo compounds under nitrogen evolution by transition metals, are 
required. It is assumed that the newly formed carbon-carbon bond is generated by 
the interaction of the empty p-orbital of the metal-carbene complex and the filled 
-molecule orbital of the C-H bond (Scheme 30). 
 
Scheme 30: Interaction of metal-carbene complex with a C-H bond. 
 
 
The first transition metal carbene was reported by Greuter et al. in 1958 utilizing 
copper oxide.107 Although the origins of transition metal catalyzed C-H insertion 
chemistry started with the employment of copper,108 nowadays dirhodium complexes 
are the most utilized catalysts. This originates from the increased conversion attained 
by dirhodium complexes at mild reaction conditions compared to the copper 
counterparts.109  
Within the last years, there were a few reports on C-H insertions, dealing with furans 
or acetals as substrates, which are of great interest for the key step in the synthesis 
of (-)-Paeonilide (5), since it was necessary to find a C-H insertion reaction which can 
be applied to the acetal-like position in 153 (Scheme 28).  
In 2007, Mayoral and Fraile reported an enantioselective C-H insertion of methyl 
phenyldiazoacetate (161) in 2-position of THF (160) catalyzed by bis(oxazoline) 
ligand 163 immobilized on laponite clay (Scheme 31).110 It is worth to mention, that 
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the immobilized ligand was superior to the homogeneous counterpart, both, in terms 
of enantiomeric excess and diastereoselectivity. Due to the fact, that THF was used 
as solvent and as substrate, this methodology is not suitable for natural product 
synthesis and therefore it needs to be adjusted. 
 
Scheme 31: Copper catalyzed C-H insertion using an immobilized bis(oxazoline) 
ligand 163 by Fraile and Mayoral.110 
 
Reagents and conditions: a) THF excess, L* (2 mol%), diazo compound 161 (1 eq), reflux, 2 h,66 % 
based on 161, up to 88% ee (dr 75:25). 
 
The same reaction as described in Scheme 31 was also reported by Davies et al. 
using optimized conditions and a Rh2(S-DOSP)4 ligand, which provided the product 
162 in 67% yield and 97% ee (dr 2:1).111 
 
A second study came from Pérez et al. in 2002, utilizing a different class of ligand, 
employed on a broader substrate scope, albeit in racemic rections.112 The substrate 
scope could be even extended according to a related publication in 2003.95 They 
applied a homoscorpionate-copper(I) catalyst (164) to the successful functionalization 
of (mostly cyclic) aliphatic ethers and also of acetals by ethyl diazo glycine (91)   
(Table 6). In all cases, only the carbon center adjacent to the oxygen was 
functionalized, which is in agreement with the results of Adams et al., who reported 
the same observation using a rhodium catalyst more than ten years ago.113 The high 
reactivity of these -carbons is expounded by its bond energy, since methanol, 
bearing a comparable electronic environment, exhibits a value of 96 kcal/mol for the 
H-CH2OH bond, which is very close to the energy of the reactive tertiary, aliphatic 
C-H bonds (97 kcal/mol).106 The inert behavior of the -carbon center can be 
explained by the contribution of Nakatani, who showed the deactivation of the C-H 
bond in -position to a electron-withdrawing group.114 This fact might give an 
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explanation for the comparable low yield of the conversion of dioxane (Table 6, 
entry 6), since in this molecule each carbon center is in the activated -position as 
well as the deactivated -position. 
 
Table 6: Functionalization of ethers and acetals by using a homoscorpionate-
copper(I) catalyst 164. 
.Entry Substrate Product Yield [%][a] 
1[b] 
  
>99 
2[b] 
 
 
38 
 
62 
3[b] 
  
41 
4[b] 
 
--- no reaction 
5[c] 
  
84 
6[c] 
  
20 
7[b] 
  
>99 
8[b]  
 
>99 
[a]: Determined at the end of the reaction by GC after total consumption of N2CHCOOEt. Diethyl 
fumarate and maleate accounted for 100% of N2CHCOOEt [b]: Ref 
95
; [c]: Ref 
112
; [d]: Third pyrazole 
ring indicated by N-N for better lucidity. 
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4.2 Preparatory work for the C-H insertion reaction 
 
In order to find a model system for the C-H insertion an unsubstituted furo-lactone 
system was chosen, bearing the same acetal-like position as compound 153, but 
being easily producible, even on gram scale.115 The first step involved the formation 
of tin ester 166 by the neat reaction of hexabutyldistannoxane (165) with iodoacetic 
acid. The subsequent radical reaction with 2,3-dihydrofuran gave the desired, 
unsubstituted furo-lactone 167. As C-H insertion reactions in the acetal-like C-H of 
furo-lactones have not been published so far, a second model compound was 
prepared, exhibiting a “real” acetal C-H position. This was accomplished by the 
aforementioned method already employed for the two-step lactonization (Scheme 24) 
using benzyl alcohol under strongly acidic conditions to furnish 168 as a 
diastereomeric mixture. 
 
Scheme 32: Synthesis of model substrates. 
 
Reagents and conditions: a) ICH2COOH (2 eq), 130 °C, 30 min, quant; b) 2,3-dihydrofuran (3 eq), 
AIBN (5 mol%), benzene, reflux, 8 h, 68%; c) H2SO4 (3 eq), BnOH, r.t., 12 h,86 %. 
 
Besides the model substrates, also the homoscorpionate-copper(I) catalyst 164 was 
prepared as acetonitrile complex. According to literature procedures, 116 commercially 
available 1H-pyrazole (169) was converted to perbromo pyrazole 170, which was 
subsequently treated with a shortfall of NaBH4 at 260 °C by the help of a metal bath 
(Wood´s metal).117 Remaining 170 was removed by multiple sublimation from the 
caramel-like sodium boropyrazole (171, [TpBr3]Na). In order to exchange the sodium 
cation by Cu(I) yielding the catalytically active catalyst, 171 was stirred with CuI in 
degassed solvents.118 The final complex [TpBr3]Cu-NCCH3 (164), is very sensitive to 
moisture and oxygen, but can be stored under inert atmosphere at ambient 
temperature. 
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Scheme 33: Synthesis of homoscorpionate [TpBr3]Cu-NCCH3 (164). 
 
Reagents and conditions: a) NaOH (4 eq), Br2 (3 eq), H2O, r.t., 4 h, 76%; b) NaBH4 (0.25 eq), 
260 °C, 82%; c) CuI (1 eq), MeCN (degassed), r.t., 10 h, 75%. 
 
Although the C-H bond of substrate 167, which is the target of the planned 
functionalization, is an acetal-like moiety, there might arise several problems. Due to 
the fact that it is not a “real” acetal, since one of the oxygen atoms belongs to the 
lactone moiety, the electronic properties of this carbon center are different. There is 
so far no literature precedence for this kind of conversion, employing such an acetal-
like position for C-H insertion chemistry. Therefore, various metal salts were tested in 
the decomposition of diazo compounds, being the key step in the subsequent 
reactivity studies (Figure 16 and Table 7). For this reason each salt was treated with 
ethyl diazo glycine (91) and screened for the evolution of nitrogen gas. As a 
benchmark, established catalysts for this reaction, such as Sc(OTf)3, Cu(OTf)2, and 
Rh2(OAc)4 were tested. It is worth mentioning, that FeCl3 and SbCl5 showed the most 
violent nitrogen gas evolution among the tested metal salts. 
Besides transition metal salts, a handful of lanthanoide salts were also tested since 
they might have been interesting, due to their high oxophilic properties and large 
ionic radii, which would make them suitable for coordinating the oxygen atoms of the 
constrained substrates 167 (Scheme 28).119 However, from the tested lanthanoide 
salts, only Gd(OTf)3 catalyzed the decomposition of the diazo compound.  
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H                 He 
Li Be           B C N O F Ne 
Na Mg           Al Si P S Cl Ar 
K Ca Sc Ti V Cr Mn Fe Co Ni Cu Zn Ga Ge As Se Br Kr 
Rb Sr Y Zr Nb Mo Tc Ru Rh Pd Ag Cd In Sn Sb Te I Xe 
Cs Ba * Hf Ta W Re Os Ir Pt Au Hg Tl Pb Bi Po At Rn 
Fr Ra ** Rf Db Sg Bh Hs Mt Ds Rg Cn       
                  
  * La Ce Pr Nd Pm Sm Eu Gd Tb Dy Ho Er Tm Yb Lu 
  ** Ac Th Pa U Np Pu Am Cm Bk Cf Es Fm Md No Lr 
 
Figure 16: Periodic table of elements, salts of marked elements were employed for 
diazo compound decomposition screening. 
 
 
 
Table 7: Screened metal salts. 
no N2 gas evolution observed  N2 gas evolution observed 
LiBF4 NaBF4  NaSbF6 MgBr2
.OEt2 Sc(OTf)3 
K2PtCl4 CaCl2  Cp2TiCl2 CrCl2 MnCl2 
Ca(OiPr)2 CrCl3  FeCl3 (NH4)2Fe(SO4)2 Fe(BF4)2 
Fe(OAc)2 NH4Fe(citrate)2  Fe(acac)3 Ni(acac)2 Cu(OTf)2 
Co(OAc)2 NiCl2  CuI Cu(MeCN)4BF4 ZnBr2 
NbCl5 (NH4)6(Mo7O24)  YCl3 RuCl3 Rh2(OAc)4 
Sb2S3 LaCl3  PdBr2 AgClO4 SbCl5 
CeCl3 Eu(NO3)3  TaCl5 IrCl3 Gd(OTf)3 
EuCl3      
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4.3 C-H insertion experiments 
 
The first screening with the evaluated metal salts was performed by employing 
10 mol% of catalyst and 2 equivalents of ethyl diazo glycine (91) in dichloromethane 
at ambient temperatures as a standard procedure for the furo-lactone substrate    
(Table 8). According to TLC control, in most cases no conversion of the starting 
material could be observed, only the dimerization of 91 to diethyl maleate and diethyl 
fumarate was found. The two very strong Lewis acids FeCl3 and SbCl5 showed 
lactone opening reactions, very rapidly in the latter case. The only catalyst, which 
was somewhat active, was Fe(BF4)2
.6H2O. However, this reaction proceeded not in a 
clean way.  
 
Table 8: First reaction screening. 
 
Entry Catalyst Observations[a] 
1 FeCl3 lactone opening 
2 Fe(BF4)2
.6H2O slow conversion, complex mixture 
3 Cu(OTf)2 no reaction 
4 MgBr2
.OEt2 no reaction 
5 Sc(OTf)3 no reaction 
6 ZnBr2 no reaction 
7 Cp2TiCl2 no reaction 
8 PdBr2 no reaction 
9 TaCl5 no reaction 
10 AgOCl4 no reaction 
11 SbCl5 rapid lactone opening 
12 Rh2(OAc)4
[b]
 no reaction 
13 Gd(OTf)3 no reaction 
[a]: Plenty of dimerization products observed in all cases; [b]: 2 mol%. 
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To optimize this reaction, it was carried out at 0°C, which was envisaged to lead to 
the formation of less byproducts.  
 
Scheme 34: Lewis acid catalyzed lactone opening of 167 in the presence of ethyl 
diazo glycine (91). 
 
Reagents and Conditions: a) N2CHCOOEt (2 eq), Fe(BF4)2
.
6H2O (10 mol%), DCM, r.t., 6 h, 32% 
(combined yield). 
 
Although the reaction provided still many byproducts, two diastereomers of a lactone 
opening product could be isolated from the mixture (Scheme 34). The Lewis acidic 
iron(II) salt catalyzes the lactone opening by water, which is originating from the 
catalyst. The new hydroxyl group and the free carboxylic acid of 174 react with 91 to 
the corresponding esterified acetal 175, which was formed as a 1:1 mixture of 
diastereomers, possessing the two substituents in anti conformation to each other. 
As the iron catalyst showed some activity it was also tested on the second model 
compound 168 (Scheme 35). This reaction was carried out at ambient temperatures 
and at 0 °C, but in both cases TLC control showed massive byproduct formation and 
an incomplete conversion of the starting material 168. The 13C-NMR of the crude 
reaction mixture showed no indication for the presence of desired product, which was 
expected to give a signal at about 110 ppm for the newly formed quaternary acetal 
carbon center. Besides the iron catalyst, dirhodium was also tested, since rhodium 
complexes are the most used catalysts for C-H insertion reactions (see chapter 4.1).  
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Therefore, rhodium(II) acetate dimer was employed in the following reactions 
(Scheme 35). 
 
Scheme 35: Insertion test reaction.  
 
Reagents and conditions: a) N2CHCOOEt (2 eq), Fe(BF4)2
.
6H2O (10 mol%), DCM, r.t. and 0°C, 6 h; 
b) N2CHCOOEt (2 eq), Rh2(OAc)4 (2 mol%), DCM, r.t. 6 h; c) N2CHCOOEt (2 eq), Rh2(OAc)4 
(2  mol%), DCM, r.t., °C, 6 h; d) N2CHCOOEt (2 eq), Rh2(OAc)4 (2 mol%), DCM, 0 °C, 6 h, 
anti-176/syn-176 = 1:1, 38% (combined yield). 
 
The expected conversion of furo-lactone 167 did not proceed at all, except for the 
dimerization of ethyl diazo glycine (91). Using acetal-substrate 168 at room 
temperature, many spots occurred on TLC, although the starting material was not 
converted completely. The analysis of the crude NMRs showed that the main 
compound possesses an aldehyde, one ethyl ester and one benzyl group, but it 
could not be isolated from the other compounds. The same reaction at 0 °C gave 
less spots on TLC and a diastereomeric compound mixture could be isolated by 
column chromatography. It turned out, that the benzyl ether was cleaved within the 
reaction, followed by ether formation by the reaction with the diazo ester 91 yielding 
176 as a 1:1 mixture of diastereomers.  
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The literature known reaction conditions were screened as well. The reactions, 
utilizing the homoscorpionate-copper(I) complex 164 (Table 6), were performed in 
degassed dichloromethane, due to the instability of 164 against oxygen.95 The 
reaction with furo-lactone 167 afforded only the dimerization products of the diazo 
ester 91, as mentioned before in the dirhodium catalyzed reaction. When using the 
acetal substrate 168 a new compound was furnished and separated form few other 
byproducts. It turned out, that also in this case no desired acetal-insertion occurred. 
The insertion took place on the -position of the benzyl ester, which seems to be the 
most active site in this molecule. According to literature, the acetal-position of 168 
and the acetal-like position of 167 should be privileged for C-H insertion reactions, as 
they are tertiary centers with comparable low C-H bond energy (97 kcal/mol, 
see chapter 4.1).106 Additionally, they are in -position to the oxygen atoms, electron 
withdrawing groups, which should activate these C-H bonds even more.106 
Nonetheless, the most active site bears 168 on the -carbon of the benzyl ester, 
being the only site where an insertion reaction took place providing 177 as a 
diastereomeric mixture. In contrast, the -position of the lactone moiety of 167 was 
absolutely inactive.  
 
Scheme 36: Insertion attempts by employing homoscorpionate-copper(I) 
complex  164.95 
 
Reagents and conditions: a) N2CHCOOEt (2 eq), [TpBr3]Cu-NCCH3 (164) (5 mol%), DCM 
(degassed), r.t., 6 h; b) N2CHCOOEt (2 eq), [TpBr3]Cu-NCCH3 (164) (5 mol%), DCM (degassed) r.t., 
6 h, 27%. 
 
Finally, the C-H insertion conditions of Mayoral were applied to both test substrates. 
As in the original conditions THF was utilized as substrate and as solvent, the 
conditions needed to be adjusted for natural product synthesis. For this reason the 
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substrate was dissolved together with the catalyst in a small amount of 
dichloromethane, refluxed and dropwise treated with diazo ester 91. As Mayoral et al. 
mentioned in their publication, even Cu(OTf)2 itself was catalytically active in this 
insertion reaction, therefore both, the Cu(OTf)2 alone and the corresponding 
aza-bis(oxazoline)-complex were tested (Table 9). All experiments provided 
exclusively the dimerization products of the diazo compound 91 but no conversion of 
the starting material could be observed. As this might have been a result of the 
maximal applicable reaction temperature, dichloromethane was exchanged by 
chloroform, exhibiting almost the same boiling point as THF (Table 9, entry 3 and 6). 
However, the higher temperature provided again no conversion of the starting 
material. 
 
Table 9: C-H insertion screening applying Cu(OTf)2.
110 
 
Entry Substrate Reagents and conditions[a] Observation[b] 
1 167 Cu(OTf)2, DCM, reflux no reaction 
2 167 Cu(OTf)2, L*, DCM, reflux no reaction 
3 167 Cu(OTf)2, L*, CHCl3, reflux no reaction 
4 168 Cu(OTf)2, DCM, reflux no reaction 
5 168 Cu(OTf)2, L*, DCM, reflux no reaction 
6 168 Cu(OTf)2, L*, CHCl3, reflux no reaction 
[a]: All reactions carried out with 4 mol% of Cu(OTf)2, 4.4 mol% of ligand L*178 (if mentioned), and 
2 eq of N2CHCOOEt; [b]: formation of diazo ester dimerization products in all reactions. 
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5. Side chain introduction by established chemistry 
 
As the C-H activation turned out to give not the desired results for the side chain 
introduction, the attempts concerning this approach were ceased. The focus was put 
on the utilization of “traditional” chemistry for the transformation of furo-lactone 57 
into an intermediate that gives rise to the acetal-functionalized skeleton 179  
(Scheme 37). 
 
Scheme 37: Functionalization via an intermediate. 
 
 
Matsuda et al. reported in 2008 within their synthesis of a partially benzylated 
derivative of the anhydro-D-altro-heptulose the functionalization of -lactone using 
Grignard-reagents attacking the lactone carbonyl center (Scheme 38).120  
 
Scheme 38: Conversion of a hydrocarbon lactone derivative with allyl-MgBr. 
 
Reagents and conditions: a) allyl-MgBr (1.2 eq), THF, -78 °C, 1.5 h, 92%. 
 
According to this consideration, an acidic lactone opening under oxidative conditions 
should force the formation of a ,-substituted -lactone as synthon for 179. To reach 
this intermediate, the model substrate 167, already applied for the C-H insertion 
attempts, was treated with 2.5 M Jones-reagent in acetone (Scheme 39). The applied 
conditions opened the lactone moiety, setting free a hemiacetal which was further on 
oxidized to the corresponding lactone 183 by Cr(VI) oxide in excellent yield. 
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Scheme 39: Conversion of model substrate 167 to lactone 183 by Jones-reagent. 
 
Reagents and conditions: a) Jones-reagent (3.5 eq), acetone, 0 °C to r.t., 3 h, 94%. 
 
This -substituted lactone 183 was subsequently treated with a Grignard-reagent that 
was envisaged to preferentially attack the lactone carbonyl in presence of the 
carboxylate. As the free carboxylic acid consumes one equivalent of the 
Grignard-reagent, at least two equivalents are needed to be employed for the 
planned conversion. Already the first test reactions provided the desired, 
functionalized furo-lactone 185, using 2.5 equivalents of Me-MgBr at -78 °C      
(Scheme 40). It should be noted that the final product 185 was formed during the 
acidic quenching of the residual Grignard-reagent, by the addition of 2 M hydrochloric 
acid. Since the nucleophilic attack of Me-MgBr at the lactone carbonyl center delivers 
a hemiacetal as intermediate, the proton source is needed to enable the lactone 
closure.  
 
Scheme 40: Side chain introduction by utilizing the methyl Grignard-reagent. 
 
Reagents and conditions: a) Me-MgBr (2.5 eq), THF, -78 °C to 0 °C, 2 h, 19%. 
 
The isolated product showed the characteristic quaternary carbon peak at 117 ppm in 
the 13C-NMR. Although the yield was relatively low, this sequence was tested on the 
actual furo-lactone 57. As described before, it was necessary to open the lactone 
moiety first under oxidative conditions, which was again accomplished by employing 
Jones-reagent to lactone 57, deriving the desired ,-substituted -lactone 186 in 
excellent yield.  
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Scheme 41: Oxidative lactone opening. 
 
Reagents and conditions: a) Jones-reagent (2.5 eq), acetone, 0 °C to r.t., 6h, 88%.  
 
Having this precursor in hands, it was essential to find an appropriate 
Grignard-reagent that introduces a side chain being convertible to the final 
keto-group. For that reason allyl-MgBr was chosen to introduce the allyl side chain 
which should be oxidizable to the necessary methyl ketone moiety. First attempts 
were carried out by employing 3.2 equivalents of the reagent, since theoretically 
2 equivalents are decomposed by the two free carboxylic acid functions, affording the 
allylated product 187 in 68% yield (Table 10). Further tests proved, that 
2.5 equivalents are the optimal amount for this conversion giving an enhanced yield 
of 73% for 187.  
 
Table 10: Allyl side chain introduction and reaction optimization. 
 
Reagents and conditions: a) allyl-MgBr, THF, -78 °C to 0 °C, 2 h. 
 
Entry Allyl-MgBr (eq) Yield [%] 
1 2 53 
2 2.5 73 
3 3.2 68 
   
 
[a]: pKB values calculated from corresponding pKA values of methane and propene in DMSO; Ref 
121
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The increased yield of the allyl-Grignard reaction (Table 10) compared to the 
Me-MgBr one (Scheme 40) might be ascribed to the stronger basicity of the 
methyl-anion and therefore the resulting higher reactivity (Table 10, bottom). This fact 
is in compliance with the TLC monitoring of the reactions: the Me-MgBr reaction 
showed much more byproduct formation than the reaction using allyl-MgBr. 
 
According to literature, there is no precedence of a furo-lactone functionalized on the 
acetal-like center. To the best of knowledge, this is a new methodology, using 
well-established chemistry for this kind of side chain introduction. 
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6. Final steps toward (-)-Paeonilide 
 
The final section of the synthesis of (-)-Paeonilide (5) was envisaged to start with a 
selective reduction of the carboxylic acid in presence of the lactone moiety and the 
terminal olefin. For this reason a procedure of Fludzinski et al.,122 who reported the 
reduction of a carboxylic acid in the presence of a C-C double bond by utilizing a 
borane-THF complex at low temperatures, was applied. Moreover, this borane-THF 
complex was already successfully applied on the reduction of the carboxylic acid in 
the presence of a lactone moiety, as discussed earlier (Scheme 27). Employing 
Fludzinski´s conditions to carboxylic acid 187 afforded besides some byproducts the 
desired alcohol 188 (Table 11, entry 1). After quenching and aqueous workup the 
amount of byproducts increased drastically. However, column chromatography 
yielded only traces of the impure product 188, which turned out to be not stable 
under purification conditions. Furthermore, a modified protocol, using lower 
temperatures, achieved a relatively clean reaction (according to TLC monitoring) 
(Table 11, entry 2). In order to avoid too long contact time of the product with water 
during the workup, the reaction was quenched by the addition of slightly wet silica 
gel. Furthermore, the solvent was removed under reduced pressure to provide 
directly a dry-load for column chromatography. Nevertheless, only impure traces of 
the target compound 188 were isolated again. 
 
Table 11: Envisaged reduction by BH3
.THF. 
 
 
Entry Reagents and conditions Yield [%] 
1[a] BH3
.THF (1 eq), THF, -10°C to r.t., 6 h traces 
2 BH3
.THF (1 eq), THF, -30°C to r.t., 8 h traces 
3[b] Zn(BH4)2 (1 eq), ClCOOEt (1 eq), 
NEt3 (1 eq) THF, 0 °C to r.t., 1 h 
traces 
[a]: Ref 
122
; [b]: Ref 
123
. 
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A third method was the application of zinc borohydride to accomplish the reaction, 
which was prepared following a literature protocol.124 This reagent was already 
successfully used for the reduction of a carboxylic acid in the presence of a lactone 
by Helmchen et al., although the acid group was in situ converted to a mixed 
anhydride before Zn(BH4)2 was added.
123 Additionally, this borohydride reagent was 
used by Crimmins et al. for ketone reduction on a molecule bearing a terminal olefin, 
without harming the latter.125 Although the reaction looked promising according to 
TLC monitoring, 188 proved to be unstable during workup.  
 
Therefore, one additional reaction step was crucial in the sequence toward 
(-)-Paeonilide (5) (Scheme 42). The allyl chain was planned to be oxidized using 
Wacker-chemistry, followed by a reduction to the corresponding diol 190. This 
compound allows two ways to the target molecule 5: either selective oxidation of a 
secondary alcohol, followed by a benzyl protection, or selective protection of the 
primary alcohol followed by oxidation of the secondary alcohol.  
 
Scheme 42: Final reaction sequence incorporating diol 190. 
 
 
The conversion of the olefin was envisaged to be accomplished by the 
Wacker-oxidation to give rise to the keto-moiety (Table 12). This reaction is one of 
the best studied palladium promoted reactions and has important applications in 
industry126-128 as well as in academia.129-130  
Common Wacker-oxidation protocols apply PdCl2 or Pd(OAc)2 as catalyst together 
with a stoichiometric co-catalyst (e.g. CuCl), under one atmosphere of oxygen gas in 
a DMF/water- or DMA/water-mixture. 
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The first tests were carried out according to these conditions, following a procedure 
by Lowary et al., who employed the Wacker-oxidation for the total synthesis of 
Buergerinin F and G (Table 12, entry 1).131 It turned out, that his protocol afforded 
only low conversion of the starting material 187, although additional catalyst and 
co-catalyst were added after five hours. Rising the temperature did not give any 
advantage either. The isolated product showed impurities of the corresponding 
aldehyde, which was inseparable from the desired product by column 
chromatography. This lack of product selectivity was also described by Lowary et al. 
Additionally, the product mixture contained small amounts of DMA, exhibiting almost 
the same Rf value like 189.  
 
Table 12: Olefin oxidation. 
 
Entry Reagents and conditions[a] Yield [%] 
1[b] PdCl2 (10 mol%), CuCl (1 eq) O2, DMF/H2O 3:1, 
r.t. to 70 °C, 10 h  
19%[c][d] 
2[e] PdCl2 (10 mol%), O2, DMA/H2O 15:1, 70 °C, 6 h  62%
[d] 
3[f] Jones-reagent (2.5 eq), Hg(OAc)2 (0.25 eq), 
acetone/H2O 4:1, 0 °C to r.t., 15 h 
79% 
[a]: O2 applied via balloon; [b]: Ref 
131
 [c]: mixture of ketone and aldehyde; [d]: containing 
inseparable solvent residues; [e]: Ref 
132
; [f]: Ref 
133
. 
 
A second approach, following the procedure of Kaneda et al., where the copper 
co-catalyst was abandoned, which is usually used to facilitate the re-oxidation of the 
Pd(0) by oxygen and to prevent the formation of palladium black.132 Kaneda et al. 
showed the beneficial effect of using DMA instead of DMF for this reaction, which 
provides the advantage of faster catalyst regeneration. Their proposed catalytic cycle 
(Scheme 43) illustrates the competition between the rate determining step of catalyst 
recycling (kcat) and catalyst decomposition, which forms inactive Pd(0) metal (kdec). It 
was demonstrated that kcat/kdec in DMA was almost 2.3 times higher than observed in 
DMF.  
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These data showed the ability of DMA to promote the re-oxidation of Pd(0) to the 
active catalyst and to suppress the competing Pd(0) aggregation. 
 
Scheme 43: Proposed catalytic cycle by Kaneda et al. (kcat = rate of the re-oxidation, 
kdec = rate of the decomposition).
132 
 
 
The application of this protocol to substrate 189 afforded the desired product in 
significantly higher yield compared to the procedure before, delivering only the 
desired ketone 189 without formation of the corresponding aldehyde (Table 12, 
entry 2). However, the problem of inseparable DMA contamination in the isolated 
product after column chromatography arose once more.  
Another method, also delivering the desired Wacker-product, utilizes a Hg(OAc)2 
mediated oxymercuration combined with subsequent oxidation by Jones-reagent.134 
As Hg(II) resembles Pd(II) in its ability to activate a C-C double bond for nucleophilic 
attack, it is an interesting candidate for catalytic oxidation.135  
 
Scheme 44: Catalytic cycle of Hg(II).134 
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The reaction is driven in the direction of the thermodynamically less stable hydrated 
form 191, by trapping this intermediate with the help of the oxidation to the 
corresponding ketone 192.  
The actual experiment, using 187 as starting material, was carried out following the 
procedure of Zou et al., who used this methodology for the oxidation of an allyl group 
connected to carbohydrate derivatives.133, 136 Already the first tests showed a cleaner 
reaction compared to the Wacker-oxidations applied before (Table 12, entry 3). There 
was also no problem during the isolation of the product concerning solvent residues 
after column chromatography, as occurred when using DMF or DMA, respectively. In 
this way the desired ketone 189 was obtained in good yields. 
 
Having ketone 189 in hands, both, the free carboxylic acid and the ketone needed to 
be reduced to the diol 190, as a selective reduction of the COOH group in presence 
of the ketone moiety was not possible, due to the higher reactivity of the latter. The 
reduction was again achieved by using the BH3
.THF-complex at lower temperatures 
(Scheme 45). 
 
Scheme 45: Reduction of ketone 189 to diol 190. 
 
Reagents and conditions: a) BH3
.
THF (2.1 eq), THF, -15 °C to r.t., 4 h, 16%. 
 
Unfortunately, this diol 190 proved to be unstable against the purification procedures 
like the alcohol 188 mentioned before (Table 11), although the reaction itself 
proceeded smoothly to the desired product (according to TLC monitoring). 
Nevertheless, a small amount of 190 could be isolated in an impure manner, but was 
tried to be converted in a selective oxidation of the secondary OH group in presence 
of the primary OH. For this reason, several oxidation procedures were implemented 
(Table 13). First attempts employed cerium(IV) catalysis, applicable for selective 
oxidation of secondary alcohols in the presence of primary ones.137 Either cerium(IV) 
sulfate (Table 13,entry 1) or cerium(IV) ammonium nitrate (CAN) (Table 13, entry 2) 
was used as catalyst and sodium bromate as co-catalyst.  
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This method was also applied by Meinwald et al., who used cerium sulfate for the 
synthesis of (±)-Palasonin.138 However, in the case of the diol 190 both reagents did 
not give success. While cerium sulfate showed only traces in the NMR of the crude 
mixture, CAN gave no conversion at all. Applying more equivalents of oxidation 
reagent and longer reaction times, afforded a mixture of highly polar components in 
both cases. 
 
Table 13: Attempts for the selective oxidation of the secondary alcohol group. 
 
Entry Reagents and conditions Yield [%] 
1[a][b] Ce(SO4)2
.H2SO4 (10 mo%), NaBrO3 (1 eq), 
MeCN/H2O 7:3, 80 °C, 3 h 
traces 
2[a] CAN (10 mol%), NaBrO3 (1 eq), MeCN/H2O 7:3, 
80 °C, 6 h  
no reaction 
3[c] NaOCl (1 eq), HOAc, 0 °C to r.t., 1.5 h slow decomposition 
4[d] NBS (1.5 eq), DME/H2O 9:1, 0 °C to r.t., 1 h complex mixture 
[a]: Ref 
137
; [b]: Ref 
138
; [c]: Ref 
139
; [d]: Ref 
140
.  
 
The utilization of a sodium hypochlorite solution in acetic acid, a common mixture for 
selective oxidation of secondary alcohols, resulted in slow decomposition of the 
starting material 190 (Table 13, entry 3).139, 141 The last applied protocol was the use 
of N-bromosuccinimide in aqueous DME generating a complex mixture of 
compounds in short time (Table 13, entry 4).140  
 
As the approach of a selective oxidation of the secondary OH group of diol 190 did 
not deliver the desired results, a selective protection of the primary alcohol moiety of 
190 as a benzoyl ester was planned, as this group is finally required in 
(-)-Paeonilide 5. A subsequent oxidation of the remaining OH group would then give 
rise to the target monoterpenoid 5. An advantage of this procedure is the possibility 
to use a bigger variety of oxidative agents, since the primary OH would already be 
converted to the final OBz group. To reach this goal, the following steps were carried 
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out in an one-pot manner, without purification of the intermediates by column 
chromatography, as the alcohol 188 and the diol 190 proved to give problems during 
their purification. 
 
Scheme 46: The endgame. 
 
Reagents and conditions: a) BH3
.
THF (2.1 eq), THF, -15 °C to r.t., 4 h; b) BzCl (1.05 eq), NEt3 
(6 eq), DMAP (0.1 eq), DCM, -40 °C to -10 °C, 1.5 d; c) DMP (1 eq), DCM, 0 °C, 3 h, 44% over 
3 steps, based on 189.  
 
The final steps started again with a simultaneous reduction of the ketone and the 
carboxylic acid of 189 by BH3
.THF-complex, which smoothly provided diol 190 
(Scheme 46). After removing the solvent under reduced pressure, the crude mixture 
was dissolved in DCM and treated with a small excess of benzoyl chloride in the 
presence of an excess of triethylamine and catalytic amounts of DMAP. This 
procedure of selectively protecting a primary OH followed the protocol of 
Schlessinger et al., who applied this methodology to the racemic synthesis of 
Senepoxide.142 These conditions afforded one new compound with negligible 
byproduct formation, according to TLC monitoring. In order to remove the amines, the 
crude mixture was washed with an ammonium chloride solution, to give rise to crude 
194, which was again dissolved in dichloromethane and finally treated with 
Dess-Martin periodinane for the oxidation of the secondary alcohol.143 The oxidation 
reaction was purified by column chromatography and subsequent crystallization from 
methanol.11 This reaction sequence gave rise to the target monoterpenoid 
(-)-Paeonilide 5 in an overall yield of 44% over the last 3 steps, based in 189 
correlating with an average yield of 76% for each of the last 3 reactions. 
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The complete synthesis, starting from commercially available 3-furoic acid (59) 
afforded (-)-Paeonilide (5) in a 12 step, straightforward synthesis with an overall yield 
of 4.4% (7.7% brsm). 
 
In comparison to the so far published syntheses (see chapter A. Introduction), the 
most significant difference of this work is the way of introducing enantioselectivity. 
Starting from an achiral substrate and implementing the chiral information in a later 
step, instead of applying an already chiral starting material and maintaining its 
stereoinformation throughout the complete synthetic route. Another important 
distinction is the introduction of a new way for the construction of the bi-cyclic system 
to the Paeonilide-chemistry. This new strategy ceases ring formation, which applies a 
reaction sequence used in all of the so far published Paeonilide-syntheses. Last but 
not least, the installation of the keto-side chain is performed in a novel way, instead 
of using a starting material, which already contains the required functional groups.  
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7. Characterization and biological evaluation of (-)-Paeonilide 
 
(-)-Paeonilide (5) was obtained as thin, colorless needles. The 1H- and 13C-NMR 
spectroscopic data are in accordance with the published data as well as the 
HMBC-correlations (Scheme 47, left). The assignment of the NOE signals were 
complicated by the overlap of the signals of the protons Ha and Hb by other proton 
signals. But there is an unambiguous NOE signal between the two side chains of the 
furo-lactone core skeleton (Scheme 47, right), which indicates the position of those 
two arms on the same side of the bi-cycle. Nevertheless, the absolute 
stereochemistry was confirmed by X-ray crystallography. 
 
Scheme 47: Significant C-H correlations by HMBC (indicated by arrows, left); NOE 
signal (indicated by arrow, right); X-ray structure of (-)-Paeonilide (5). 
 
 
 
 
 
The measured optical rotation of the obtained sample of (-)-Paeonilide (5) showed a 
    
   value of -42.0° (CHCl3, c = 0.14) which differs from the measured value of the 
originally isolated (+)-Paeonilide (     
   = +54.3°; CHCl3, c = 0.44), published by 
Liu et al., concerning the absolute value.11 This observation is in accordance with the 
fact, that the copper(I)-catalyzed asymmetric cyclopropanation delivered the 
cyclopropane 118 with an ee value of 83%. Furthermore, the enantiomeric excess 
could not be enriched during the synthesis, as (re)crystallization of the respective 
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compounds was either not possible or resulted in the same optical rotation values as 
before.  
Attempts to measure the enantiomeric excess of one of the final compounds via 
chiral HPLC were not successful, since all applied columns and conditions did not 
provide a separation of the two enantiomers.  
Anyway, if the ee value of the obtained (-)-Paeonilide (5) is calculated from the 
measured optical rotation, which is of course only a rule of thumb and not accurate 
for all chiral compounds,144 one expects an ee of approximately 85%, which would be 
in accordance with the enantiomeric excess, achieved from the cyclopropanation.  
 
So far, only the natural enantiomer (+)-Paeonilide (+)-(5) was applied for investigating 
the biological activities (see chapter A. Introduction). As (+)-5 shows structural 
similarities to the ginkgolide family, it was tested against the PAF induced 
thrombocyte-aggregation and provided an IC50 value of 8 g/mL (25 M). Having the 
enantiomerically enriched (-)-Paeonilide (5) in hands, it was submitted for biological 
assays in order to compare the behavior of both Paeonilide enantiomers (Table 14).  
 
Table 14: Obtained data from rabbit-thrombocyte-aggregation assay 
(kindly measured by Schwabe GmbH & Co. KG, Karlsruhe, Germany).  
Entry Concentration  
of 5 [g/mL] 
Inhibited aggregation [%] 
experiment 1      experiment 2 
Average value of 
inhibition [%] 
1 1 5.9 8.6 7.3 
2 3 -12.5 24.9 6.2 
3 10 -10.4 20.2 4.9 
4 30 26.8 13.2 20 
 
The thrombocyte aggregation was inhibited by 20% at a concentration of 30 g/mL 
(94 M) of 5, hence (-)-Paeonolide (5) seems to be much less active than the 
eutomeric (+)-5 (IC50 = 8 g/mL, 25 M respectively). Presumably, the antagonism is 
caused by the impurity of the eutomeric (+)-5 in the investigated sample. These 
results imply that the unnatural distomer of Paeonilide is not active against the PAF 
receptor, at least not up to concentrations of 30 g/mL.  
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C. Summary & Schematic Overview 
 
1. Summary 
 
A plethora of new interesting compounds was discovered in the realm of plants. One 
of them was the monoterpenoid (+)-Paeonilide (+)-(5), which was isolated, 
characterized and submitted to biological assays. The target of this thesis was the 
development of an enantioselective synthesis of the monoterpenoid (-)-Paeonilide (5) 
(Figure 17) based on commercially available 3-furoic acid (59). This goal was 
envisaged to be achieved by the application of an asymmetric copper(l)-catalyzed 
cyclopropanation introducing the stereochemical information into the achiral 
precursor. 
 
 
Figure 17: Structure of (-)-Paeonilide (5). 
 
The cyclopropanation utilizing diazo glycine ethyl ester (91) and the corresponding 
tert-butyl ester 89 in the presence of different bis(oxazoline)-ligands 82 or 85 
provided the cyclopropanated product 58. It was possible to improve the achieved 
yields and ee-values within this screening, compared to literature precedents    
(Table 15). 
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Table 15: Ligand and diazo ester screening. 
 
 
Entry Diazo acetate 
R 
Ligand 
L* 
Yield 
[%] 
Selectivity 
[%] ee 
1[a] Et 85 27 74 
2 tBu 85 38 65 
3 Et 82 31 83 
4 tBu 82 38 83 
[a]: Ref. 
40
. 
 
 
Using the ethyl substituted cyclopropane derivative 119, the straightforward synthesis 
via C-C double bond hydrogenation and subsequent lactonization failed due to 
byproduct formation during the hydrogenation and inappropriate lactonization 
conditions (Scheme 48).  
 
Scheme 48: Employment of the ethyl substituted cyclopropane 119. 
 
 
Changing the used diazo ester to the tBu-substituted 89 provided a straightforward 
synthesis toward the lactone 145, which could be converted into lactone 57, applying 
a base (Scheme 49). 
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The further steps included an oxidative lactone opening giving rise to the 
disubstituted lactone 186. A subsequent treatment with a Grignard-reagent afforded 
the allyl-substituted furo-lactone 187. Having the substituted lactone 187 in hands, 
oxymercuration-oxidation chemistry provided the ketone 189, which was converted in 
a three-step-one-pot manner to the final compound, since the intermediates proved 
to be unstable when purified (Scheme 50). 
 
Scheme 49: Synthetic route employing tBu-substituted cyclopropane 118. 
 
 
Ketone 189 was reduced to the corresponding diol, which was selectively protected 
on the primary hydroxyl group and finally the secondary alcohol was re-oxidized to 
the ketone, to yield the target monoterpenoid (-)-Paeonilide (5). 
 
Scheme 50: Completion of the synthesis of (-)-Paeonilide (5). 
 
 
This synthetic route presents a straightforward access to the synthesis of the 
unnatural (-)-Paeonilide (5) within 12 steps and an overall yield of 4.4% (7.7% brsm). 
Although this synthesis did not provided absolutely enantiomerically pure 
(-)-Paeonilide (obtained     
   = of -42.0° (CHCl3, c = 0.14); literature value 
    
   = +54.3° (CHCl3, c = 0.44)), it was submitted for biological assays in order to 
get an inkling of the activity of the unnatural enantiomer. The target compound 5 
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showed activity against the thrombocyte aggregation although the inhibition was 
much less than found for the natural enantiomer (+)-5. Presumably, this small 
measured effect is caused by the impurity of the eutomeric (+)-5 in the measured 
sample. These results imply that the unnatural distomer of Paeonilide is not active 
against the PAF receptor, at least not in the tested range of concentrations. 
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2. Schematic overview of synthesized compounds 
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D. Experimental 
1. General comments 
 
All reactions were carried out in oven dried glassware under atmospheric conditions 
unless otherwise stated. Commercially available chemicals were used as received, 
without any further purification. 
The following solvents and reagents were purified prior to use: 
Dichloromethane (CH2Cl2) was distilled from SICAPENT
®. Ethanol (EtOH) and 
methanol (MeOH) were distilled from magnesium and stored over molecular sieves 
(3 Å). Tetrahydrofuran (THF) was distilled from sodium wire. Toluene was dried with 
CaH2, distilled and stored over sodium wire. Ethyl acetate (EA) and hexanes (PE) for 
chromatographic separations were distilled prior to use. Benzoyl chloride was distilled 
prior to use. Triethylamine and pyridine were distilled from KOH.  
Analytical thin layer chromatography was performed on Merck TLC aluminium sheets 
silica gel 60 F 254. Visualization was accomplished with UV light (254 nm). For 
staining vaniline or permanganate solutions followed by heating were used. Liquid 
chromatography was performed using Merck flash silica gel 60 (0.040-0.063 mm). 
 
1H- and 13C-NMR: 
NMR-spectra were recorded on FT-NMR-spectrometers of the type Bruker Avance 
300 (300 MHz for 1H, 75 MHz for 13C), Avance 400 (400 MHz for 1H, 101 MHz for 
13C) or Avance III 600 (600 MHz for 1H, 151 MHz for 13C) at ambient temperature. 
Data are as follows: Chemical shift in ppm from internal CHCl3 (7.26 ppm) as 
standard on the δ scale, multiplicity (s = singlet, bs = broad singlet, d = doublet, t = 
triplet, q = quartet, dd = doublet of doublet, ddd = doublet of doublet of doublet, dddd 
= doublet of doublet of doublet of doublet, dt = doublet of triplet, td = triplet of doublet, 
tt = triplet of triplet, tdd = triplet of doublet of doublet, tdt = triplet of doublet of triplet, 
ddt = doublet of doublet of triplet, dtd = doublet of triplet of doublet, dq = doublet of 
quartet, qd = quartet of doublet and m = multiplet), integration and coupling constant 
(Hz). 13C chemical shifts are reported in ppm from internal CHCl3 (77 ppm) as 
standard on the δ scale. The 13C signals were assigned with the help of DEPT 90, 
DEPT 135 or HSQC techniques ((+) = CH or CH3, (-) = CH2, (Cq) = quaternary 
carbon). 
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X-ray analysis: 
All X-ray measurements were performed by the crystallographic department of the 
University of Regensburg. 
 
Melting points:  
The melting points were measured on a Büchi SMP-20 apparatus in a silicon oil bath 
or on a SRS MPA 100 OptiMelt. Values thus obtained were not corrected. 
 
Mass spectrometry: 
Mass spectrometry was performed using Varian MAT 311A, Finnigan MAT 95, 
Thermoquest Finnigan TSQ 7000 or Agilent Technologies 6540 UHD Accurate-Mass 
Q-TOF LC/MS at the Central Analytical Laboratory (University of Regensburg).The 
percentage set in brackets gives the peak intensity related to the basic peak 
(I = 100%). High resolution mass spectrometry (HRMS): The molecular formula was 
proven by the calculated precise mass.  
 
Elemental analysis: 
Elemental analysis was measured on a Vario EL III or Mikro-Rapid CHN (Heraeus) 
(micro analytic section of the University of Regensburg). 
 
IR spectroscopy:  
ATR-IR spectroscopy was carried out on a Biorad Excalibur FTS 3000 spectrometer, 
equipped with a Specac Golden Gate Diamond Single Reflection ATR-System. 
 
Optical rotation: 
The optical rotation was determined in a Perkin Elmer 241 polarimeter at 589 nm 
wavelength (sodium-d-line) in a 1.0 dm measuring cell of ca. 2 mL volume. 
 
HPLC: 
High performance liquid chromatography was carried out using Varian 920-LC with 
DAD. 
Phenomenex Lux Cellulose-2 or Chiralcel OD-H served as chiral stationary phase. 
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2. Synthesis of literature-known compounds and reagents 
 
2,2-dimethylmalonyl dichloride (79),145 (S)-2-amino-3-methylbutan-1-ol (80),145 
N1,N3-bis((S)-1-hydroxy-3-methylbutan-2-yl)-2,2-dimethylmalonamide (81),45 
(4S, 4'S)-2,2'-(propane-2,2-diyl)bis(4-isopropyl-4,5-dihydrooxazole) (82),45 2,2-
dimethyl-malononitrile (83),46 ethyl 2-diazoacetate (91),50 bis(trimethylsilyl) sulfate 
(BTS, 128),79 3,4,5-tribromo-1H-pyrazole (170),117 (S)-4-isopropyl-N-((S)-4-isopropyl-
4,5-dihydrooxazol-2-yl)-N-methyl-4,5-dihydrooxazol-2-amine (178),146 Jones-
reagent,147 Zn(BH4)2.
124 
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3. Syntheses 
 
((4S,4'S,5S,5'S)-2,2'-(propane-2,2-diyl)bis(5-phenyl-4,5-dihydrooxazole-4,2-
diyl))dimethanol (85) 
 
 
 
Dinitrile 83 (791 mg, 8.41 mmol, 1 eq), (1S,2S)-2-amino-1-phenyl-1,3-propanediol 
(84) (3.52 g, 21.03 mmol, 2.5 eq) and Cd(OAc)2
.2H2O (112 mg, 0.42 mmol, 5 mol%) 
were put together with 40 mL chlorobenzene. While refluxing it for 14 h it became a 
clear solution. The solvent was removed under reduced pressure and the remaining 
residue was dissolved in 20 mL DCM and washed with water (3 x 15 mL). The 
combined aqueous layers were washed with 20 mL DCM. The combined organic 
layers were dried over Na2SO4, filtered and concentrated under reduced pressure. 
The crude product was purified by silica column chromatography 
(DCM/MeOH = 95:5) to afford the product as yellow solid which was re-crystallized 
from EA to obtain the clean 85 as white crystals (1.29 g, 3.28 mmol, 39%). 
 
Rf (EA/MeOH = 10:1) = 0.23. -     
    = -84.5 (DCM, c = 1). 
1H NMR (300 MHz, CDCl3): δ = 7.42 - 7.22 (m, 10H), 5.52 (d, J = 6.3 Hz, 2H), 4.32 
(d, J = 5.8 Hz, 2H), 4.11 (dt, J = 6.3, 3.1 Hz, 2H), 3.93 (d, J = 11.8 Hz, 2H), 
3.74 - 3.61 (m, 2H), 1.68 (s, 6H). - 13C NMR (75 MHz, CDCl3): δ = 171.1(Cq), 
140.4(Cq), 128.8(+), 128.4(+), 125.6(+), 83.3(+), 75.7(+), 63.7(-), 39.7(Cq), 
23.8(+). - IR (neat): ṽ = 3335, 3288, 2923, 2821, 1650, 1459, 1333, 1270, 1150, 
1117, 1088, 972, 935, 762, 695, 635 cm-1. - mp: 153 °C.  
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methyl furan-3-carboxylate (78) 
 
 
 
Furan-3-carboxylic acid (25 g, 223.3 mmol) was dissolved in 120 mL MeOH. After 
cooling to 0 °C, 25 mL conc. H2SO4 were added dropwise. The reaction was stirred 
for 1 d at room temperature, 50 mL distilled water were added and transferred in a 
separation funnel. The mixture was extracted with 3 potions of 100 mL Et2O. The 
combined organic layers were washed with a saturated NaHCO3 solution, dried over 
Na2SO4 and concentrated under reduced pressure. The crude product was distilled 
at 15 mbar, 85 °C oil bath and 55 - 60 °C boiling point to yield the ester in 82% as 
colorless oil, which crystallized while storing at -18 °C. 
 
Rf (PE/EA = 3:1): 0.69. 
1H NMR (300 MHz, CDCl3): δ = 8.05 - 7.97 (m, 1H), 7.42 (t, J = 1.7 Hz, 1H), 
6.78 - 6.70 (m, 1H), 3.84 (s, 3H). - 13C NMR (75 MHz, CDCl3): δ = 163.4 (Cq), 
147.6(+), 143.7(+), 119.2(Cq), 109.7(+), 51.4(+). - IR (neat):   = 3153, 3000, 2954, 
1725, 1579, 1508, 1440, 1310, 1194, 1156, 1075, 984, 874, 793, 760, 601 cm-1.  
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(1S,5R,6S)-6-ethyl 4-methyl 2-oxabicyclo[3.1.0]hex-3-ene-4,6-dicarboxylate 
(119) 
 
 
A flame dried flask under nitrogen atmosphere was charged with 1 mL of dry DCM 
and Cu(OTf)2 (32 mg, 0.089 mmol, 0.56 mol%). To this suspension (S,S)-iPr-
bis(oxazoline)-ligand (82) (31.7 mg, 0.12 mmol, 0.75 mol%) was added, which 
caused the suspension to turn into a blue solution, which was stirred for 1 h. This 
solution was transferred using a syringe filter to another flame dried flask under 
nitrogen atmosphere, equipped with a mineral oil bubbler and containing 78 (2 g, 
15.07 mmol) dissolved in 1 mL dry DCM at 0 °C. Penylhydrazine (8.5 L, 0.089 
mmol, 0.56 mol%) was added dropwise turning the solution to a dark red-brown 
color. After 15 min the dropwise addition of ethyl diazo glycine (20.2 g solution of 
11.6 wt%, 20.6 mmol, 1.3 eq) in DCM was started (one drop every 10 sec). During 
the addition of diazo-compound at 0 °C nitrogen was evolved. After completion of the 
reaction, the mixture was allowed to warm to room temperature and was filtered 
through a plug of basic alumina followed by 50 mL of DCM. The organic layers were 
concentrated under reduced pressure to afford a yellow-brown oil. The residue was 
purified by fractioned distillation under reduced pressure (p = 15 mbar, bp = 55 - 66 
°C) in order to recover the starting material (607 mg, 4.8 mmol, 32%). The brown 
residue was purified by column chromatography (PE/EA = 10:1) to yield the desired 
product as a slightly yellow solid (990 mg, 4.67 mmol, 31%, brsm: 45%, 83% ee). 
Rf (PE/EA = 3:1) = 0.47. -     
    = -21.8 (DCM, c = 1). 
1H NMR (300 MHz, CDCl3): δ = 7.18 (s, 1H), 4.99 (d, J = 5.7 Hz, 1H), 4.12 (q, J = 7.1 
Hz, 2H), 3.73 (s, 3H), 3.06 (dd, J = 5.6, 2.9 Hz, 1H), 1.24 (t, J = 7.1 Hz, 3H), 1.11 (d, 
J = 2.7 Hz, 1H). - 13C NMR (75 MHz, CDCl3): δ = 171.5(Cq), 164.0(Cq), 156.4(+), 
115.7(Cq), 68.9(+), 61.0(-), 51.5(+), 29.5(+), 21.5(+), 14.1(+). - IR (neat): ṽ = 3104, 
2984, 2956, 2912, 1708, 1602, 1440, 1375, 1320, 1263, 1171, 1096, 1030, 1008, 
961, 933, 896, 834, 791, 764, 729 cm-1. - MS (EI-MS, 70 eV): m/z (%) = 212 (M+·, 
10), 139 (100), 108 (15), 107 (24), 95 (12), 79 (13), 52 (10), 51 (17). - HRMS (EI-MS, 
m/z): 212.0684 (C10H19O5, calc. 212.0685 [M
+·]). - HPLC analysis (Chiralcel OD-H, 
n-heptane/iPrOH 95:5, 1.0 mL/min, 254 nm): tr = 6.07, tr = 7.26; 83% ee. 
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(2Z,4E)-6-ethyl 1-methyl 2-formylhexa-2,4-dienedioate (Z/E-127) and (2E,4E)-6-
ethyl 1-methyl 2-formylhexa-2,4-dienedioate (E/E-127) 
 
 
 
In a flame dried flask under nitrogen atmosphere 119 (300 mg, 1.41 mmol) was 
dissolved in 5 mL of dry DCM and 10 pieces of 3 Å molecular sieves were added. 
The solution was cooled to 0 °C and BTS (128) (686 mg, 2.82 mmol, 2 eq) dissolved 
in 2 mL of dry DCM was added dropwise. The reaction was allowed to warm to room 
temperature and stirred for 14 h. The mixture was transferred to a separation funnel 
and diluted with 20 mL of DCM and washed with a saturated NaHCO3 solution 
(2 x 5 mL). The organic layer was dried over Na2SO4, filtered and concentrated under 
reduced pressure. The crude product was purified by silica column chromatograph 
(PE/EA = 10:1) to afford a 1.7:1 (Z/E-127 / E/E-127) mixture of isomers (260 mg, 
1.22 mmol, 87%). 
 
Rf (PE/EA = 3:1) = 0.43. 
1H NMR (600 MHz, CDCl3): δ = 10.12 (d, J = 2.7 Hz, 1H, minor), 9.84 (s, 1.7H, 
major), 8.25 (dd, J = 15.5, 12.0 Hz, 1H, minor), 8.00 (dd, J = 15.4, 12.0 
Hz, 1.7H, major), 7.51 (ddd, J = 12.0, 2.7, 0.8 Hz, 1H, minor), 7.37 (dd, J = 12.0, 0.7 
Hz, 1.7H, major), 6.42 (dd, J = 15.4, 0.8 Hz, 1.7H, major), 6.38 (dd, J = 15.5, 0.8 Hz, 
1H, minor), 4.21 (dq, J = 2.8, 7.1 Hz, 5.4H, major+minor), 3.89 (s, 5.1H, major), 3.85 
(s, 3H, minor), 1.27 (dt, J = 1.1, 7.1 Hz, 8.1H, major+minor). - 13C NMR (151 MHz, 
CDCl3): δ = 190.1(Cq, minor), 188.9(Cq, major), 165.3(Cq, minor), 165.0(Cq, minor), 
165.0(Cq, major), 164.2(Cq, major), 145.9(+, minor), 145.4(+, major), 137.0(+, major), 
136.8(+, minor), 136.0(+, minor), 135.2(+, major), 132.7(Cq, major), 129.7(Cq, minor), 
61.1(-, major),61.1(-, minor), 52.4(+, minor), 52.3(+, major), 14.0(+). - IR (neat): 
ṽ = 3411, 2982, 1711, 1583, 1438, 1369, 1303, 1267, 1235, 1196, 1148, 1103, 1029, 
984, 858, 734 cm-1. - MS (CI-MS, NH3): m/z (%) = 230 (MNH
4+, 100), 213 (MH+, 10). 
- HRMS (EI-MS, m/z): 212.0684 (C10H12O5, calc. 212.0685 [M
+·]).   
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(1S,5R,6S)-ethyl 4-(hydroxymethyl)-2-oxabicyclo[3.1.0]hex-3-ene-6-carboxylate 
(131) 
 
 
 
In a flame dried flask under an atmosphere of nitrogen 119 (300 mg, 1.45 mmol, 1 
eq) was dissolved in dry THF (5.7 mL) and cooled to 0 °C. LiAlH4 (32 mg, 0.85 mmol, 
0.6 eq) was added carefully, which caused hydrogen evolution. After 1 h the reaction 
was quenched by the addition on 1 mL water, transferred to a separation funnel and 
5 mL Et2O were added. It was washed with a saturated Rochelle salt solution 
(3 x 2 mL). The organic layer was dried over Na2SO4, filtered and concentrated under 
reduced pressure. The purification by silica column chromatography (PE/EA = 1:1) 
afforded alcohol 131 as colorless solid (90 mg, 0.49 mmol 34%)  
 
Rf (PE/EA = 1:1) = 0.39. -     
    = -59.1 (DCM, c = 1). 
1H NMR (300 MHz, CDCl3): δ = 6.37 (s, 3H), 4.87 (dt, J = 5.5, 0.8 Hz, 3H), 4.30 (s, 
6H), 4.13 (q, J = 7.1 Hz, 7H), 2.84 (dd, J = 5.6, 2.7 Hz, 3H), 1.63 (s, 2H), 1.26 (t, 
J = 7.1 Hz, 11H), 1.08 (d, J = 2.6 Hz, 3H). - 13C NMR (75 MHz, CDCl3): δ = 
172.6(Cq), 143.8(+), 121.2(Cq), 67.6(+), 60.8(-), 57.3(-), 32.0(+), 22.0(+), 14.2(+). - 
IR (neat): ṽ = 3412, 2952, 2879, 1703, 1600, 1442, 1378, 1312, 1173, 1105, 1034, 
976, 784, 760, 722 cm-1. - MS (EI-MS, 70 eV): m/z (%) = 184 (M+·, 17), 166 (15), 127 
(11), 111 (100), 81 (14), 55 (12), 53 (13), 39 (12). - HRMS (PI-EIMS, m/z): 184.0738 
(C9H12O4, calc. 184.0736 [M
+·]). - mp: 66 °C. 
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(1S,5R,6R)-methyl 6-(hydroxymethyl)-2-oxabicyclo[3.1.0]hex-3-ene-4-carboxy-
late (132) 
 
 
 
In a flame dried flask under nitrogen atmosphere, 119 (300 mg, 1.45 mmol, 1 eq) was 
dissolved in dry THF (5.7 mL) and cooled to 0 °C. LiAlH4 (32 mg, 0.85 mmol, 0.6 eq) 
was added carefully, which caused hydrogen evolution. After 1 h the reaction was 
quenched by the addition on 1 mL water, transferred to a separation funnel and 5 mL 
Et2O were added. It was washed with a saturated Rochelle salt solution (3 x 2 mL). 
The organic layer was dried over Na2SO4, filtered and concentrated under reduced 
pressure. The purification by silica column chromatography (PE/EA = 1:1) afforded 
alcohol 132 as colorless oil (79 mg, 0.46 mmol, 32%)  
 
Rf (PE/EA = 1:1) = 0.27. -     
    = +15.2 (DCM, c = 1). 
1H NMR (300 MHz, CDCl3): δ = 7.11 (s, 1H), 4.62 (d, J = 6.8 Hz, 1H), 3.73 (s, 3H), 
3.53 (dd, J = 7.1, 1.6 Hz, 2H), 2.56 (s, 1H), 2.44 (dd, J = 5.9, 3.1 Hz, 1H), 0.75 (tdd, 
J = 7.1, 3.1, 1.0 Hz, 1H). - 13C NMR (75 MHz, CDCl3): δ = 165.2(Cq), 155.9(+), 
115.6(Cq), 66.7(+), 61.6(-), 51.4(+), 23.7(+), 22.0(+). - IR (neat): ṽ = 3401, 3106, 
3003, 2952, 2883, 1688, 1599, 1441, 1377, 1313, 1172, 1100, 1031, 974, 783, 760, 
724 cm-1. - MS (EI-MS, 70 eV): m/z (%) = 169 (M-·H, 1), 152 ((M-H2O)
 +·, 2), 139 
((M-·CH2OH)
+, 100), 53 (12). - HRMS (PI-EIMS, m/z): 170.0577 (C8H10O4, 
calc. 170.0579 [M+·]). 
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(1S,4S,5S,6S)-6-ethyl 4-methyl 2-oxabicyclo[3.1.0]hexane-4,6-dicarboxylate 
(133) 
 
 
 
119 (200 mg, 0.94 mmol, 1 eq) was dissolved in 4 mL of a EtOH/water mixture (95:5) 
and 20 g Pd/C (10%) were added. The reaction mixture was stirred at room 
temperature for 24 h under an atmosphere of hydrogen applied via a balloon. After 
filtration the solution was concentrated under reduced pressure. The purification by 
silica column chromatography (PE/EA = 5:1) afforded the product as colorless 
crystals (50 mg, 0.24 mmol, 25%). 
 
Rf (PE/EA = 3:1) = 0.52. -     
   = +58.3 (DCM, c = 0.6). 
1H NMR (300 MHz, CDCl3): δ = 4.24 (dd, J = 5.4, 1.2 Hz, 1H), 4.20 - 4.05 (m, 3H), 
3.75 (s, 3H), 3.73 (dd, J = 21.3, 11.4 Hz, 1H), 3.40 (td, J = 9.5, 5.3 Hz, 1H), 2.42 (td, 
J = 5.3, 3.8 Hz, 1H), 2.27 (dd, J = 3.8, 0.9 Hz, 1H), 1.24 (t, J = 7.1 Hz, 
3H). - 13C NMR (75 MHz, CDCl3): δ = 171.8(Cq), 170.6(Cq), 67.9(-), 65.8(+), 60.7(-), 
52.3(+), 44.2(+), 27.9(+), 21.7(+), 14.1(+). - IR (neat): ṽ = 3063, 3002, 2170, 1732, 
1707, 1440, 1407, 1381, 1312, 1261, 1207, 1180, 1119, 1078, 1029, 988, 922, 865, 
780, 694 cm-1. - MS (EI-MS, 70 eV): m/z (%) = 214 (M+·, 1), 182 (23), 169 (18), 168 
(70), 155 (11), 154 (32), 141 (67), 140 (34), 126 (16), 125 (15), 111 (24), 109 (37), 10 
(32), 100 (21), 99 (43), 97 (17), 82 (29), 81 (100), 69 (28), 59 (37), 55 (75), 53 (58), 
45 (68). - HRMS (PI-EIMS, m/z): 214.0835 (C10H14O5, calc. 214.0841 [M
+·]); - 
mp: 68 °C. 
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(3S,5S)-methyl 5-(2-ethoxy-2-oxoethyl)tetrahydrofuran-3-carboxylate (134) 
 
 
 
119 (250 mg, 1.18 mmol, 1 eq) was dissolved in 5 mL of a EtOH/water mixture (95:5) 
and 25 mg Pd/C (10%) were added. The mixture was stirred for 72 h at room 
temperature under an atmosphere of hydrogen applied via a balloon. After filtration 
and the solution was concentrated under reduced pressure and purified by silica 
column chromatography (PE/EA = 5:1) to afford the product as colorless oil (255 mg, 
1.18 mmol, quant.). 
 
Rf (PE/EA = 3:1) = 0.31. -     
   = -10.4 (CHCl3, c = 1). 
1H NMR (600 MHz, CDCl3): δ = 4.26 (dq, J = 8.4, 6.3 Hz, 3H), 4.13 (q, J = 7.1 Hz, 
7H), 4.04 (dd, J = 8.9, 6.0 Hz, 3H), 3.92 (t, J = 8.5 Hz, 3H), 3.68 (s, 10H), 3.13 (qd, 
J = 8.2, 6.0 Hz, 3H), 2.67 (dd, J = 15.7, 7.2 Hz, 3H), 2.53 (dd, J = 15.7, 6.0 Hz, 3H), 
2.36 (ddd, J = 12.7, 8.8, 6.3 Hz, 3H), 1.89 (dt, J = 12.7, 8.2 Hz, 3H), 1.24 (t, 
J = 7.2 Hz, 11H). - 13C NMR (151 MHz, CDCl3): δ = 173.8(Cq), 170.9(Cq), 75.9(+), 
69.8(-), 60.5(-), 52.0(+), 44.0(+), 40.0(-), 34.8(-), 14.1(+). - IR (neat): ṽ = 2983, 1729, 
1438, 1370, 1155, 1064, 1201, 936, 850, 673 cm-1. - MS (CI-MS, NH3): m/z (%) = 
235 (21), 234 (MNH4
+, 100), 217 (MH+, 35). - HRMS (ESI, m/z): 217.1069 (C10H17O5, 
calc. 217.1071 [MH+]). 
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(3S,5S)-methyl 5-(2-methoxy-2-oxoethyl)tetrahydrofuran-3-carboxylate (135) 
 
 
 
In a flame dried flask under nitrogen atmosphere 119 (50 mg, 0.236 mmol) was 
dissolved in 2.5 mL MeOH. The flask was cooled to 0 °C and Mg turnings (5.7 mg, 
0.236 mmol, 1 eq) were added. When the reaction started hydrogen was evolved 
(mineral oil bubbler) and white precipitate occurred. After 30 min the precipitate and 
the remaining Mg were filtered off. The solution was concentrated under reduced 
pressure. The crude mixture was purified by silica column chromatography 
(PE/EA = 3:1) to afford the product as 1:1 mixture of diastereomers (18 mg, 0.089 
mmol, 38%).    
 
Rf (PE/EA = 3:1) = 0.39. -     
   = +17.6 (DCM, c = 1). 
1H NMR (600 MHz, CDCl3): δ = 4.40 - 4.34 (m, 1H, diast. 1), 4.29 (tt, J = 7.2, 6.2 Hz, 
1H, diast. 2), 4.16 - 4.11 (m, 1H, diast. 1), 4.07 (dd, J = 8.9, 6.0 Hz, 1H, diast. 2), 
3.94 (t, J = 8.5 Hz, 1H, diast. 2), 3.87 (dd, J = 8.9, 6.7 Hz, 1H, diast. 1), 3.70 (s, 6H), 
3.69 (s, 6H), 3.19 - 3.11 (m, 2H), 2.70 (dd, J = 15.7, 7.4 Hz, 1H, diast. 2), 2.61 (dd, J 
= 15.3, 7.3 Hz, 1H, diast. 1), 2.57 (dd, J = 15.7, 5.8 Hz, 1H, diast. 2), 2.52 (dd, 
J = 15.3, 5.8 Hz, 1H, diast. 1), 2.46 - 2.40 (m, 1H, diast. 1), 2.38 (ddd, J = 12.7, 8.8, 
6.4 Hz, 1H, diast. 2), 1.91 (dt, J = 12.7, 8.2 Hz, 1H, diast. 2), 1.83 (ddd, J = 12.8, 9.5, 
7.7 Hz, 1H, diast. 1). - 13C NMR (151 MHz, CDCl3): δ = 173.8(Cq), 171.4(Cq, diast. 2), 
171.2(Cq, diast. 1), 75.9(+,diast. 2), 75.4(+, diast. 1), 70.1(-,diast. 1), 69.9(-,diast. 2), 
52.1(+), 52.1(+), 51.8(+), 51.7(+), 44.1(-,diast. 2), 43.6(-,diast. 1), 39.9(-,diast. 1), 
39.9(-,diast. 2), 34.9(-,diast. 2), 34.7(-,diast. 1). IR (neat): ṽ = 2989, 2955, 1731, 
1437, 1371, 1263, 1197, 1171, 1062, 1016, 936, 847 cm-1. - MS (EI-MS, 70 eV): 
m/z (%) = 203 (MH+, 1), 171 (41), 170 (16), 142 (62), 129 (92), 116 (54), 102 (12), 
101 (61), 97 (13), 87 (18), 83 (11), 82 (14), 81 (14), 74 (18), 69 (100), 59 (53), 55 
(23), 45 (13), 43 (22). 
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4-methylbenzenesulfonyl azide (87) 
 
 
 
A 2 L flask was charged with sodium azide (71.5 g, 1.1 mol, 1.1 eq) and 400 mL of 
90% aqueous EtOH. In an additional 2 L flask tosyl chloride (190.5 g, 1 mol, 1 eq) 
was dissolved in 1 L of EtOH (it was warmed up to 50 °C for complete dissolving if 
necessary) and was added to the azide solution. After 3 h the formed NaCl was 
filtered off. The solvent was removed under reduced pressure (bath temperature 
35 °C, minimum applied pressure 110 mbar). The crude product was transferred to a 
separation funnel, 1 L water was added (without shaking) to induce phase 
separation. The product phase (lower one) was separated and washed with water 
(2 x 100 mL), dried over Na2SO4 and filtered to afford the desired product as an oil, 
which crystallized while storing at -18 °C (150 g, 0.76 mol, 76%). 
 
1H NMR (300 MHz, CDCl3): δ = 7.83 (d, J = 8.3 Hz, 2H), 7.40 (d, J = 8.3 Hz, 2H), 
2.47 (s, 3H). - 13C NMR (75 MHz, CDCl3): δ = 146.3(Cq), 135.4(Cq), 130.0(+), 
127.5(+), 21.7(+). - IR (neat): ṽ = 2121, 1595, 1366, 1161, 1084, 813, 743, 655 cm-1. 
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tert-butyl 2-diazoacetate (89) 
 
 
 
A three-necked 2 L flask, equipped with an internal thermometer, a mineral oil 
bubbler and a stopper was charged with 900 mL n-pentane and cooled to 0 °C. At 
that temperature tosyl azide (87) (62.6 g, 318 mmol, 1 eq), tert-butyl acetoacetate 
(88) (52.8 mL, 318 mmol, 1 eq) and Bu4NBr (2.05 g, 6.36 mmol, 2 mol%) were 
added. The resulting mixture was treated with a cold sodium hydroxide solution (36 g, 
0.9 mol, 2.8 eq, dissolved in 300 mL water), which was added in portions over a 
period of 15 min. When the addition was finished, the ice bath was removed, the flask 
was equipped with a mineral oil bubbler and stirring was continued for 20 h. The 
resulting white solid was removed via suction by the help of Celite, and the pad was 
washed with 100 mL n-pentane. The filtrate was transferred to a separation funnel, 
the phases were separated and the aqueous phase was washed with n-pentane 
(3 x 100 mL). The combined organic layers were washed with water (2 x 200 mL) and 
brine (1 x 200 mL) and dried over MgSO4. After filtration the solvent was removed 
under reduced pressure (water bath 15 °C, minimum pressure 110 mbar) to afford 
pure product 89 as yellow liquid (39.6 g, 279 mmol, 88%). This liquid was diluted in 
the necessary amount of DCM to adjust the required wt% in DCM for the further 
reaction. 
 
1H NMR (300 MHz, CDCl3): δ = 4.55 (s, 1H), 1.40 (s, 9H). 
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(1S,5R,6S)-6-tert-butyl 4-methyl 2-oxabicyclo[3.1.0]hex-3-ene-4,6-dicarboxylate 
(118) 
 
 
A flame dried flask under nitrogen atmosphere was charged with 3 mL of dry DCM 
and Cu(OTf)2 (884 mg, 2.28 mmol, 1.12 mol%). To this suspension (S,S)-iPr-
bis(oxazoline)-ligand (813 mg, 3.05 mmol, 1.5 mol%) was added, which caused the 
suspension to turn into a blue solution, which was stirred for 1 h. This solution was 
transferred using a syringe filter to another flame dried flask under nitrogen 
atmosphere, equipped with a mineral oil bubbler and containing 78 (25.64 g, 
203.5 mmol) dissolved in 10 mL DCM at 0 °C. Penylhydrazine (225 mL, 2.28 mmol, 
1.12 mol%) was added dropwise turning the solution to a dark red-brown color. After 
15 min the dropwise addition of tert-butyl diazo glycine (561.5 g solution of 6.7 wt%, 
264.6 mmol, 1.3 eq) in DCM was started (one drop every 10 sec). During the addition 
of diazo-compound at 0 °C nitrogen is evolved. After completion, the mixture was 
allowed to warm to room temperature and was filtered through a plug of basic 
alumina followed by 500 mL of DCM. The organic layers were concentrated under 
reduced pressure to afford a yellow-brown oil. The residue was purified by fractioned 
distillation under reduced pressure (p = 15 mbar, bp = 55 - 66 °C) to recover starting 
material (7.26 g, 77.3 mmol, 38%). The brown residue was purified by column 
chromatography (PE/EA = 15:1) to yield the desired product as a slightly yellow solid 
(18.56 g, 77.3 mmol, 38%, brsm: 53%, 83% ee). 
Rf (PE/EA = 5:1) = 0.61. -     
   = - 20.5 (DCM, c = 1). 
1H NMR (300 MHz, CDCl3): δ = 7.15 (s, 1H), 4.91 (dt, J = 5.6, 0.8 Hz, 1H), 3.72 (s, 
3H), 2.99 (dd, J = 5.6, 2.9 Hz, 1H), 1.42 (d, J = 9.0 Hz, 9H), 1.05 - 0.97 (m, 
1H). - 13C NMR (75 MHz, CDCl3): δ = 170.7(Cq), 164.1(Cq), 156.3(+), 115.7(Cq), 
81.3(Cq), 68.8(+), 51.4(+), 29.0(+), 28.0(+), 22.4(+). - IR (neat): ṽ = 3109, 3071, 2977, 
1699, 1599, 1444, 1367, 1271, 1157, 1097, 1045, 975, 830, 792, 760, 720 cm-1. - MS 
(EI-MS, 70 eV): m/z (%) = 240 (M+·, 1), 184 (78), 176 (30), 166 (14), 155 (12), 152 
(17),  139 (100), 108 (19), 107 (19), 57 (91). - HRMS (PI-EIMS, m/z): 240.0999 
(C12H16O5, calc. 240.0998 [M
+·]). - mp: 72 °C. - HPLC analysis (Phenomenex Lux 
Cellulose-2, nheptane/iPrOH 99:1, 1.0 mL/min, 254 nm): tr = 13.17, tr = 17.81; 
83% ee. 
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(1S,5R,6S)-6-(tert-butoxycarbonyl)-2-oxabicyclo[3.1.0]hex-3-ene-4-carboxylic 
acid (138) 
 
 
 
118 (12.31 g, 51.3 mmol) was dissolved in 400 mL of a 3:1 water-THF mixture. To 
the resulting turbid solution LiOH (1.35 g, 56.4 mmol, 1.1 eq) was slowly added, 
which turns the color to yellow. After 6 h of stirring, the reaction mixture was 
transferred to a separation funnel and washed with Et2O (2 x 150 mL) to recover 
remaining starting material (15%). The aqueous layer was acidified with HCl (2M) to 
a pH of about 2 and extracted with Et2O (3 x 150 mL). The combined organic layers 
were dried over Na2SO4, filtered and concentrated under reduced pressure to afford 
the desired product as a colorless solid (9.85 g, 43.6 mmol, 85%, brsm: 100%).  
 
Rf (PE/EA = 1:1) = 0.26. -     
    = -23.8 (MeOH, c = 1). 
1H NMR (300 MHz, Acetone): δ = 10.23 (s, 1H), 7.36 (s, 1H), 5.03 (d, J = 5.6 Hz, 
1H), 2.92 (dd, J = 5.6, 2.8 Hz, 1H), 1.44 (s, 10H), 1.05 (d, J = 2.6 Hz, 1H). - 13C NMR 
(75 MHz, Acetone): δ = 171.2(Cq), 164.8(Cq), 157.5(+), 116.6(Cq), 81.5(Cq), 69.2(+), 
29.7(+), 28.2(+), 22.9(+). - IR (neat): ṽ = 3038, 2976, 1711, 1655, 1602, 1447, 1385, 
1365, 1275, 1159, 1107, 975, 897, 836, 760, 717 cm-1. - MS (EI-MS, 70 eV): 
m/z (%) = 226 (M+·, 1), 170 (45), 153 (24), 152 (15), 125 (58), 107 (10), 57 (100), 51 
(11), 41 (32), 39 (10). - HRMS (EI-MS, m/z): 226.0841 (C11H14O5, calc. 226.0841 
[M+·]). - mp: 142 °C.  
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(1S,4S,5S,6S)-6-(tert-butoxycarbonyl)-2-oxabicyclo[3.1.0]hexane-4-carboxylic 
acid (139) 
 
 
 
138 (9.3 g, 41.2 mmol) was dissolved in 200 mL of an EtOH/water mixture (95:5) and 
900 mg Pd/C (10%) were added. After two times vacuum-hydrogen-spilling hydrogen 
was applied via a balloon. When the starting material was consumed (about 4 h), the 
mixture was filtered through celite and washed with 100 mL EtOH, twice. The organic 
layer was concentrated under reduced pressure to afford the desired product as 
colorless oil (9.4 g, 41.2 mmol, 100%) which crystallizes at ambient temperature after 
some days. 
 
Rf (PE/EA = 1:1) = 0.2. -     
   = +62.4 (MeOH, c = 1). 
1H NMR (300 MHz, CDCl3): δ = 8.77 (s, 1H), 4.23 - 4.11 (m, 2H), 3.69 (t, J = 9.8 Hz, 
1H), 3.42 (td, J = 9.5, 5.4 Hz, 1H), 2.41 (td, J = 5.4, 3.8 Hz, 1H), 2.21 (dd, J = 3.7, 0.8 
Hz, 1H), 1.42 (s, 9H). - 13C NMR (75 MHz, CDCl3): δ = 176.9(Cq), 169.8(Cq), 
81.2(Cq), 67.7(-), 65.7(+), 44.2(+), 28.0(+), 27.4(+), 22.7(+). - IR (neat): ṽ = 3192, 
2984, 1703, 1401, 1366, 1320, 1197, 1152, 1116, 1073, 981, 952, 870, 841, 779, 
725, 674 cm-1. - MS (ESI-MS): m/z (%) = 456 (19), 455 ((2M-H)-,82), 274 (14), 273 
(M+HCOO-,100), 227 ((M-H)-,3). - HRMS (ESI-MS, m/z): 227.0927 (C11H15O5, 
calc. 227.0925 [(M-H)-]). - mp: 92 °C.  
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(1S,4R,5S,6S)-tert-butyl-4-(hydroxymethyl)-2-oxabicyclo[3.1.0]hexane-6-
carboxylate (140) 
 
 
 
In a flame dried flask under nitrogen atmosphere 139 (377 mg, 1.65 mmol) was 
dissolved in 30 mL of dry THF and cooled to 0°C. BH3
.THF (2 mL of 1 M solution in 
THF, 1.2 eq) was added dropwise, which caused hydrogen evolution. The reaction 
was stirred for 1 h at 0 °C, warmed to room temperature and stirred for additional 
12 h. The reaction was quenched by the addition of 1 mL of water. It was transferred 
to a separation funnel, mixed with 2 mL of a saturated NH4Cl solution and extracted 
with EA (3 x 40 mL). The combined organic layers were dried over Na2SO4, filtered 
and concentrated under reduced pressure. The crude product was purified by silica 
column chromatography (PE/EA = 3:1) to afford the product as colorless crystals (78 
mg, 0.363 mmol, 22%). 
 
Rf (PE/EA = 1:1) = 0.40. -     
    = +54.8 (MeOH, c = 1). 
1H NMR (300 MHz, CDCl3): δ = 4.16 (d, J = 5.5 Hz, 1H), 4.07 (t, J = 9.1 Hz, 1H), 3.77 
(dd, J = 10.6, 6.9 Hz, 1H), 3.64 (dd, J = 10.6, 6.9 Hz, 1H), 3.14 (t, J = 9.8 Hz, 1H), 
2.88 - 2.73 (m, 1H), 2.13 (dd, J = 9.3, 5.2 Hz, 1H), 1.97 (s, 1H), 1.93 (d, J = 3.9 Hz, 
1H), 1.41 (s, 9H). - 13C NMR (75 MHz, CDCl3): δ = 170.3(Cq), 80.7(Cq), 69.1(-), 
65.6(+), 62.9(-), 42.3(+), 28.1(+), 26.8(+), 21.8(+). - IR (neat): ṽ = 3503, 3389, 3314, 
2977, 2823, 1705, 1691, 1398, 1368, 1314, 1261, 1153, 1106, 1064, 1038, 981, 947, 
924, 883, 837, 719, 694, 658 cm-1. - MS (CI-MS, NH3): m/z (%) = 232 (MNH4
+, 100), 
215 (MH+, 14), 176 (45). - HRMS (LSI-MS, m/z): 215.1278 (C11H19O4, calc. 215.1283 
[MH+]). - mp: 55-70 °C. 
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(3S,4R)-benzyl-5-(benzyloxy)-4-(2-(benzyloxy)-2-oxoethyl)tetrahydrofuran-3-
carboxylate (142) 
 
 
 
139 (500 mg, 2.19 mmol) was dissolved in 25 mL BnOH cooled to 0 °C and conc. 
H2SO4 (0.33 mL, 6.19 mmol, 2.8 eq) was added by an addition funnel over 15 min. 
The mixture was allowed to warm to room temperature and stirred over night. NEt3 
(1.72 mL, 12.4 mmol, 2 eq based on H2SO4) was added dropwise and the solvent 
was removed by distillation under reduced pressure. The set of diastereomers was 
separated from by-products by silica column chromatography (PE/EA = 15:1) to 
afford 142 (303 mg, 0.66 mmol, 30%) as yellow oil, which was used in the next 
reaction without further separation. 
 
Rf (PE/EA = 10:1) = 0.25 - 0.14.  
1H NMR (300 MHz, CDCl3): δ = 7.40 - 7.21 (m, 15H), 5.30 - 4.95 (m, 5H), 4.68 (dd, 
J = 11.9, 5.4 Hz, 1H), 4.42 (dd, J = 20.8, 11.9 Hz, 1H), 4.25 - 4.09 (m, 2H), 3.70 - 
3.51 (m, 1H), 3.13 - 2.92 (m, 1H), 2.77 - 2.31 (m, 2H). - 13C NMR (75 MHz, CDCl3): 
δ = 172.9(Cq), 171.8(Cq), 171.5(Cq), 171.5(Cq), 137.9(Cq), 137.8(Cq), 135.7(Cq), 
135.5(Cq), 128.6(+), 128.6(+), 128.6(+), 128.4(+), 128.4(+), 128.4, 128.3(+), 128.3(+), 
128.2(+), 127.7(+), 127.7(+), 127.6(+), 106.8(+), 103.3(+), 69.2(-), 68.9(-), 68.5(-), 
67.8(-), 66.9(-), 66.7(-), 66.5(-), 66.4(-), 46.9(+), 45.2(+), 44.0(+), 43.9(+), 33.2(-), 
32.2(-). - IR (neat): ṽ = 3033, 2944, 2898, 1731, 1497, 1455, 1388, 1347, 1245, 1166, 
1098, 1055, 1006, 948, 913, 734, 695 cm-1. - MS (ESI-MS, m/z): 943 (18), 939 (37), 
938 (2MNH4
+, 45), 479 (11), 478 (MNH4
+,58), 354 (27), 353 (MNH4
+-BnOH, 100).  
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(3S,3aR,6aR)-5-oxohexahydrofuro[2,3-b]furan-3-carboxylic acid (145) 
 
 
 
139 (2.64 g, 11.6 mmol) was dissolved in 30 mL THF and cooled to 0 °C. To the 
cooled solution 90 mL HCl (2 M) were added dropwise within 1 h. The resulting 
mixture was allowed to warm to room temperature and stirred for 12 h. The solvent 
was evaporated under reduced pressure to afford the crude product as brownish 
solid which was used without further purification. For analytic reasons the crude 
product can be purified by silica column chromatography (toluene/ethyl 
formate/formic acid = 5:4:1). 
 
Rf (PE/EA = 1:1) = 0.09. -     
   = -52.2 (MeOH, c = 1). 
1H NMR (600 MHz, DMSO): δ = 12.85 (s, 2H), 6.07 (d, J = 5.4 Hz, 2H), 4.11 (dd, 
J = 9.0, 7.6 Hz, 2H), 3.86 (dd, J = 10.9, 9.1 Hz, 2H), 3.40 (ddd, J = 15.4, 10.3, 5.0 Hz, 
2H), 3.29 (ddd, J = 10.9, 9.0, 7.6 Hz, 3H), 2.80 (dd, J = 18.8, 10.6 Hz, 2H), 2.36 (dd, 
J = 18.8, 4.7 Hz, 2H). - 13C NMR (151 MHz, DMSO): δ = 175.1(Cq), 171.4(Cq), 
107.7(+), 67.3(-), 46.2(+), 39.8(+), 29.9(-). - IR (neat) ṽ = 3086, 3008, 2904, 1773, 
1711, 1416, 1367, 1295, 1244, 1182, 1132, 1103, 966, 843, 802, 735, 664 cm-1. -
 MS (EI-MS, 70 eV): m/z (%) = 173 (MH+,1), 98 (15), 86 (16), 85 (27), 83 (76), 82 
(100), 81 (12), 73 (10), 69 (10), 68 (16), 55 (50), 54 (10). - HRMS (EI-MS, m/z): 
173.0454 (C7H9O5, calc. 173.0450 [MH
+]). - mp = 170 °C.  
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(3S,3aS,6aS)-5-oxohexahydrofuro[2,3-b]furan-3-carboxylic acid (57) 
 
 
 
Crude 145 (2 g, 11.6 mmol) was dissolved in 10 mL pyridine together with 10 drops 
of water and was stirred for 2 h at room temperature. Pyridine was removed by 
co-distillation with toluene (3 x 5 mL) under reduced pressure. The crude mixture was 
purified by silica column chromatography (toluene/ethylformate/formic acid = 5:4:1) to 
afford the desired product as slightly yellow solid (1.49 g, 8.66 mmol, 75% based 
on 139). 
 
Rf (PE/EA = 1:1) = 0.09. -     
   = - 19.2 (MeOH, c = 1). 
1H NMR (400 MHz, MeOD): δ = 6.09 (d, J = 5.5 Hz, 1H), 4.30 (dd, J = 9.5, 2.5 Hz, 
1H), 4.11 (dd, J = 9.5, 6.5 Hz, 1H), 3.60 - 3.49 (m, 1H), 3.02 (dt, J = 6.4, 2.5 Hz, 1H), 
2.97 (dd, J = 18.8, 10.6 Hz, 1H), 2.60 (dd, J = 18.8, 3.7 Hz, 1H). - 
13C NMR (101 MHz, MeOD): δ = 177.5(Cq), 175.3(Cq), 110.1(+), 70.6(-), 51.2(+), 
43.1(+), 34.7(-). - IR (neat): ṽ = 2994, 1771, 1695, 1416, 1358, 1295, 1178, 1103, 
966, 929, 885, 855, 803, 670, 614 cm-1. - MS (ESI-MS): m/z (%) = 515 ((3M-H+)-, 10), 
344 (17), 343 ((2M-H+)-, 100), 217 (M-HCOO-, 17), 137 (12). - HRMS (ESI-MS, m/z): 
171.0298 (C7H7O5, calc. 171.0299 [(M-H)
-]). - mp: 143 °C. 
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(3aR,4R,6aR)-4-(hydroxymethyl)tetrahydrofuro[2,3-b]furan-2(6aH)-one (141) 
 
 
 
In a flame dried flask under nitrogen atmosphere 145 (1 g, 5.81 mmol) was dissolved 
in 20 mL of dry THF and cooled to 0 °C. BH3
.THF (5.81 mL of a 1 M solution in THF, 
5.81 mmol, 1 eq) was added dropwise. After the addition was finished, the reaction 
was allowed to warm to room temperature and was then slowly heated up to 40 °C. 
After 3 h at that temperature, it was cooled to room temperature and 5 g of a slightly 
wet silica slurry were added to quench the reaction. The solvent was removed under 
reduced pressure in order to produce the dry-load for silica column chromatography 
(EA), which afforded the desired product as colorless oil (617 mg, 3.91 mmol, 68%).  
 
Rf (EA) = 0.26. -     
   = -2.2 (MeOH, c = 1). 
1H NMR (300 MHz, MeOD): δ = 6.08 (d, J = 4.7 Hz, 1H), 3.96 (ddd, J = 12.0, 9.5, 4.2 
Hz, 2H), 3.47 (dd, J = 7.4, 1.1 Hz, 2H), 3.06 - 2.88 (m, 2H), 2.65 - 2.49 (m, 1H), 2.31 
- 2.17 (m, 1H). - 13C NMR (75 MHz, MeOD): δ = 178.3(Cq), 110.5(+), 70.2(-), 63.5(-), 
49.2(+), 49.0(+), 42.5(+), 35.3(-). - IR (neat) ṽ = 3335, 2910, 1744, 1641, 1410, 1316, 
1199, 1107, 1035, 968, 928, 819, 744 cm-1. - HRMS (ESI-MS, m/z): 159.0653 
(C7H11O4, calc. 159.0652 [MH
+]). 
 
  
D. Experimental 
96 
(3aS,4R,6aS)-4-(hydroxymethyl)tetrahydrofuro[2,3-b]furan-2(6aH)-one (152) 
 
.  
 
In a flame dried flask under nitrogen atmosphere 57 (250 mg, 1.45 mmol) was 
dissolved in 5 mL of dry THF and cooled to 0 °C. BH3
.THF (1.45 mL of a 1 M solution 
in THF, 1.45 mmol, 1 eq) was added dropwise. After the addition was finished, the 
reaction was allowed to warm to room temperature and was then slowly heated up to 
40 °C. After 3 h at that temperature, it was cooled to room temperature and 1.3 g of a 
slightly wet silica slurry were added to quench the reaction. The solvent was removed 
under reduced pressure to produce the dry-load for silica column chromatography 
(EA), which afforded the desired product 152 as colorless oil (222 mg, 1.41 mmol, 
97%).  
 
Rf (EA) = 0.26. -     
   = -9.0 (MeOH, c = 1). 
1H NMR (300 MHz, MeOD): δ = 6.06 (d, J = 4.6 Hz, 1H), 3.97 (ddd, J = 11.9, 9.4, 
4.2 Hz, 2H), 3.46 (d, J = 7.4 Hz, 2H), 3.02 - 2.87 (m, 2H), 2.55 (ddd, J = 15.8, 11.6, 
7.7 Hz, 1H), 2.28 - 2.16 (m, 1H). - 13C NMR (75 MHz, MeOD): δ = 178.0(Cq), 
110.5(+), 70.3(-), 63.7(-), 49.5(+), 42.7(+), 35.4(-). - IR (neat) ṽ = 3331, 2960, 2884, 
1772, 1392, 1353, 1191, 1132, 1101, 1046, 1025, 977, 930, 896 cm-1. -
 HRMS (ESI-MS, m/z): 159.0651 (C7H11O4, calc. 159.0652 [MH
+]). 
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((3S,3aS,6aS)-5-oxohexahydrofuro[2,3-b]furan-3-yl)methyl benzoate (153) 
 
 
 
In a flame dried flask under nitrogen atmosphere 152 (158 mg, 0.69 mmol) was 
dissolved in 10 mL of dry pyridine and benzoyl chloride (160 L, 1.38 mmol, 2 eq) 
was added dropwise. After 3 h the solvent was removed under reduced pressure by 
co-distillation with toluene (3 x 10 mL). The residue was purified by silica column 
chromatography (PE/EA = 1:1) to afford 153 as yellow oil (72 mg, 0.27 mmol, 39%).  
 
Rf (PE/EA = 1:1) = 0.57. -     
   = -15 (DCM, c = 1). 
1H NMR (300 MHz, CDCl3): δ = 8.06 - 7.97 (m, 2H), 7.65 - 7.54 (m, 1H), 7.52 - 7.41 
(m, 2H), 6.15 (d, J = 5.1 Hz, 1H), 4.29 (qd, J = 11.1, 7.3 Hz, 2H), 4.10 (ddd, J = 12.2, 
9.8, 4.1 Hz, 2H), 3.08 - 2.90 (m, 2H), 2.62 - 2.52 (m, 2H). - 13C NMR (75 MHz, 
CDCl3): δ = 174.4(Cq), 166.3(Cq), 133.4(+), 129.6(+), 129.4(Cq), 128.5(+), 108.0(+), 
69.2(-), 64.8(-), 45.3(+), 41.8(+), 34.5(-). - IR (neat) ṽ = 2970, 2898, 1780, 1717, 
1451, 1355, 1315, 1274, 1176, 1112, 1071, 981, 937, 897, 712 cm-1. - 
HRMS (ESI-MS, m/z): 285.0734 (C14H14NaO5, calc. 285.0733 [(M+Na)
+]).  
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tributylstannyl 2-iodoacetate (166) 
 
 
 
Iodoacetic acid (11.15 g, 60 mmol, 2 eq) was heated together with bis(tributyltin) 
oxide (165) (17.88 g, 30 mmol, 1 eq) at 130 °C for 30 min. During that time a clear 
solution was formed, containing some drops of water. After cooling to room 
temperature the mixture was transferred with hot PE to a separation funnel where the 
water was separated. The solvent was removed under reduced pressure to afford the 
clean product as a white solid (26.25 g, 55.14 mmol, 92% based on iodoacetic acid). 
 
1H NMR (300 MHz, CDCl3): δ = 3.70 (s, 2H), 1.78 - 1.45 (m, 7H), 1.42 - 1.16 
(m, 13H), 0.91 (t, J = 7.3 Hz, 10H). - 13C NMR (75 MHz, CDCl3): δ = 175.7(Cq), 
30.0(-), 29.3(-), 18.9(+), 15.9(-). - IR (neat): ṽ = 2954, 2922, 2855, 1571, 1428, 1380, 
1290, 1159, 1078, 869, 769, 670, 603 cm-1. 
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tetrahydrofuro[2,3-b]furan-2(6aH)-one (167) 
 
 
 
Tin ester 166 (51.18 g, 107.5 mmol, 1 eq), 2,3-dihydrofuran (24.4 mL, 322.5 mmol, 
3 eq) and AIBN (984 mg, 6 mmol, 5 mol%) were refluxed in 120 mL benzene for 8 h. 
The reaction mixture was transferred to a separation funnel and partitioned between 
acetonitrile (100 mL) and PE (100 mL). The acetonitrile phase was washed with PE 
(3 x 100 mL) and concentrated under reduced pressure. The crude product was 
purified by silica column chromatography (PE:EA = 2:1) to afford the desired product 
X as yellowish oil (9.35 g, 73.1 mmol, 68%). 
 
Rf (PE/EA = 1:1) = 0.31. 
1H NMR (300 MHz, CDCl3): δ = 6.04 (d, J = 5.4 Hz, 1H), 4.10 - 4.00 (m, 1H), 3.96 - 
3.84 (m, 1H), 3.11 (dddd, J = 12.1, 9.0, 5.9, 3.2 Hz, 1H), 2.83 (dd, J = 18.6, 10.2 Hz, 
1H), 2.39 (dd, J = 18.6, 3.6 Hz, 1H), 2.16 (dddd, J = 12.8, 10.3, 9.2, 8.2 Hz, 1H), 1.73 
(ddt, J = 12.8, 5.7, 2.7 Hz, 1H). - 13C NMR (75 MHz, CDCl3): δ = 175.3(Cq), 108.2(+), 
67.3(-), 38.3(+), 34.7(-), 32.2(-). - IR (neat): ṽ = 2982, 2882, 1770, 1356, 1298, 1250, 
1170, 1106, 1003, 963, 935, 869, 832, 648 cm-1.  
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benzyl 2-(2-(benzyloxy)tetrahydrofuran-3-yl)acetate (168) 
 
 
 
167 (1.5 g, 11.7 mmol) was dissolved in 50 mL BnOH at 0 °C and conc. H2SO4 
(2 mL, 37.5 mmol, 3.2 eq) were added by an addition funnel over 15 min. The mixture 
was allowed to warm to room temperature and was stirred over night. NEt3 (15.5 mL, 
112 mmol, 3 eq based on H2SO4) was added dropwise and the solvent was removed 
by distillation under reduced pressure. The sticky residue was purified by silica 
column chromatography (PE/EA = 8:1) to afford the product as 1:1.3 mixture of 
diastereomers (3.1 g, 9.51 mmol, 82%). 
 
Rf (PE/EA = 5:1) = 0.36. 
1H NMR (600 MHz, CDCl3): δ = 7.39 - 7.26 (m, 23H), 5.14 (d, J = 4.4 Hz, 1.3H, 
major), 5.13 - 5.09 (m, 4H), 4.95 (d, J = 1.2 Hz, 1H, minor), 4.73 - 4.69 (m, 2.3H), 
4.44 (dd, J = 28.1, 12.0 Hz, 2H), 4.02 (td, J = 8.8, 3.6 Hz, 1.3H, major), 3.99 - 3.95 
(m, 2H, minor), 3.90 (dd, J = 16.2, 8.2 Hz, 1.4H, major), 2.77 - 2.68 (m, 2.3H), 2.61 - 
2.53 (m, 2.3H), 2.51 (dd, J = 15.7, 7.3 Hz, 1H, minor), 2.34 (dd, J = 15.7, 8.2 Hz, 1H, 
minor), 2.29 (dtd, J = 13.6, 7.8, 6.0 Hz, 1H, minor), 2.13 - 2.06 (m, 1.3H, major), 1.78 
(ddd, J = 22.4, 11.2, 9.1 Hz, 1.3H, major), 1.63 - 1.57 (m, 1H, minor). - 13C NMR 
(151 MHz, CDCl3): δ = 172.6(Cq,major), 171.8(Cq, minor), 138.4(Cq), 138.1(Cq), 
135.9(Cq), 135.8(Cq), 128.5(+), 128.5(+), 128.3(+), 128.3(+), 128.2(+), 128.2(+), 
128.2(+), 127.8(+), 127.5(+), 127.5(+), 127.4(+), 106.8(+, minor), 102.6(+, major), 
68.9(-, minor), 68.6(-, major), 66.6(-, major), 66.5(-, minor), 66.4(-, minor), 66.2(-, 
major), 41.8(+, minor), 39.9(+, major), 37.1(-, minor), 33.7(-, major), 29.8(-, minor), 
29.0(-, major). - IR (neat): ṽ = 2942, 2892, 1732, 1497, 1454, 1347, 1263, 1212, 
1162, 1022, 916, 734, 695, 613 cm-1. - MS (EI-MS, 70 eV): m/z (%) = 235 ((M-C7H7)
+, 
1), 219 ((M-·OC7H7)
+, 24), 129 (18), 91 (C7H7
+, 100). - Elemental analysis calcd. (%) 
for C20H22O4 (326.15): C 73.60, H 6.79, found C 73.55, H 6.69.  
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copper(I) tris(3,4,5-tribromo-1H-pyrazole-1-yl)hydroborate acetonitrile complex 
(164) (third pyrazole ring indicated by N-N for better lucidity) 
 
 
 
Perbromo pyrazole 170 (4.41 g, 14.6 mmol, 4 eq) and NaBH4 (138 mg, 3.65 mmol, 
1 eq) are molten in a sublimation apparatus under nitrogen atmosphere at 265 °C 
(metal bath) until cessation of hydrogen evolution. After cooling to room temperature 
the resulting solid was crushed. The remaining perbromo pyrazole (170) was 
removed by sublimation under reduced pressure (100 °C, 15 mbar).The crushing-
sublimation procedure was done thrice. This provided the crude [TpBr3]Na (171) 
(3,31 g, 3.50 mmol, 96%), which was used without further purification. For the 
following procedure all solvents were degassed thrice via pump-freeze-method and 
all steps were one under nitrogen atmosphere. In a flame dried flask under nitrogen 
atmosphere [TpBr3]Na (171) (946 mg, 1 mmol) and CuI (190 mg, 1 mmol, 1 eq) were 
dissolved in 60 mL dry MeCN and stirred over night at room temperature. After 
removing the solvent under reduced pressure the remaining solid was dissolved in 40 
mL dry DCM and filtered to remove NaI. The solvent was removed under reduced 
pressure until an thick oil was remaining. To this residue 5 mL of PE were added and 
white crystals (750 mg, 0.73 mmol, 73%) were formed while storing at -18 °C. The 
complex was stable at room temperature when stored under exclusion of moister and 
oxygen. 
 
1H NMR (300 MHz, CD2Cl2): δ = 10.87 (s, 1H), 2.18 (s, 2H). - 
13C NMR 
(75 MHz, CD2Cl2): δ = 129.7(Cq), 122.8(Cq), 116.1(Cq), 100.1(Cq), 3.0(+). - IR (neat): 
ṽ = 3094, 3011, 2855, 2771, 1527, 1479, 1389, 1349, 1323, 1178, 1123, 1003, 969, 
730 cm-1. 
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ethyl 2-(2-(2-(2-ethoxy-2-oxoethoxy)-5-oxotetrahydrofuran-3-yl)ethoxy)acetate 
(175) 
 
 
 
In a flame dried flask under nitrogen atmosphere 167 (250 mg, 1.95 mmol) was 
dissolved in 2 mL of dry DCM and Fe(BF4)2
.6H2O (66 mg, 0.195 mmol, 0.1 eq) was 
added at 0 °C. The mixture was treated with ethyl diazo glycine (1.96 g of a solution 
in DCM with 12.7 wt%, 2 eq) by the help of a syringe pump (0.25 mL/h). During the 
reaction nitrogen was evolved (mineral oil bubbler). After about 6 h, at the end of the 
addition, the solvent was removed under reduced pressure and the crude mixture 
was purified by silica column chromatography (PE/EA = 5:1) to afford 175 (two 
diastereomers) as yellow oil (197 mg, 0.62 mmol, 32% combined yield). 
 
Isomer 1 (92 mg, 0.29 mmol, 15%): Rf (PE/EA = 3:1) = 0.16. 
 
1H NMR (600 MHz, CDCl3): δ = 4.97 (d, J = 1.1 Hz, 1H), 4.61 (s, 2H), 4.21 (q, J = 7.1 
Hz, 4H), 4.13 (d, J = 2.3 Hz, 2H), 3.95 (t, J = 7.1 Hz, 2H), 2.86 – 2.71 (m, 1H), 2.61 
(dd, J = 15.8, 6.8 Hz, 1H), 2.39 (dd, J = 15.8, 8.6 Hz, 1H), 2.33 (ddd, J = 14.6, 12.6, 
7.1 Hz, 1H), 1.65 (dtd, J = 12.5, 7.3, 4.2 Hz, 1H), 1.27 (t, J = 7.1 Hz, 3H), 1.27 (t, 
J = 7.1 Hz, 3H). - 13C NMR (151 MHz, CDCl3): δ = 171.2(Cq), 170.4(Cq), 167.6(Cq), 
107.3(+), 66.9(-), 64.0(-), 61.4(-), 60.7(-), 41.6(+), 36.3(-), 29.4(-), 14.1(+), 14.0(+). - 
IR (neat): ṽ = 2980, 2939, 2909, 1741, 1424, 1382, 1277, 1198, 1155, 1119, 1054, 
1028, 957, 924 cm-1. - MS (ESI-MS): m/z (%) = 654 (2MNH4
+, 28), 336 (MNH4
+, 100). 
- HRMS (ESI-MS, m/z): 341.1205 (C14H22NaO8, calc. 341.1207 [(M+Na)
+]). 
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Isomer 2 (105 mg, 0.33 mmol, 17%): Rf (PE/EA = 3:1) = 0.27. 
 
1H NMR (600 MHz, CDCl3): δ = 5.09 (d, J = 4.4 Hz, 1H), 4.61 (dd, J = 50.2, 15.9 Hz, 
2H), 4.20 (q, J = 7.2 Hz, 2H), 4.16 (dd, J = 7.2, 1.5 Hz, 2H), 4.10 (dd, J = 38.4, 16.5 
Hz, 2H), 4.00 (ddd, J = 9.3, 8.5, 3.2 Hz, 1H), 3.86 (dd, J = 16.4, 8.2 Hz, 1H), 2.83 (dd, 
J = 16.6, 7.1 Hz, 1H), 2.62 (dd, J = 16.6, 7.7 Hz, 1H), 2.59 - 2.50 (m, 1H), 2.16 - 2.09 
(m, 1H), 1.81 (tt, J = 11.4, 9.1 Hz, 1H), 1.27 (t, 7.3 Hz, 3H), 1.25 (t, 7.6 Hz, 3H). - 
13C NMR (151 MHz, CDCl3): δ = 172.1(Cq), 170.4(Cq), 167.7(Cq), 103.3(+), 67.1(-), 
63.9(-), 61.3(-), 60.6(-), 60.6(-), 40.0(+), 32.9(-), 28.6(-), 14.1(+), 14.0(+). - IR (neat): 
ṽ = 2983, 2949, 2902, 1742, 1423, 1381, 1279, 1198, 1158, 1125, 1092, 1027, 984, 
900 cm-1. - MS (ESI-MS): m/z (%) = 341 (MNa+, 26), 336 (MNH4
+, 
100). - HRMS (ESI-MS, m/z): 341.1205 (C14H22NaO8, calc. 341.1207 [(M+Na)
+]). 
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benzyl 2-(2-(2-ethoxy-2-oxoethoxy)tetrahydrofuran-3-yl)acetate (176) 
 
 
 
In a flame dried flask under nitrogen 168 (200 mg, 0.613 mmol) was mixed with 1 mL 
of dry DCM and Rh2(OAc)4 (5.4 mg, 0.012 mmol, 2 mol%). The mixture was cooled 
to 0 °C and treated with ethyl diazo glycine (1.2 g of a solution in DCM with 12 wt%, 
2 eq) by the help of a syringe pump (0.25 mL/h). During the reaction nitrogen was 
evolved (mineral oil bubbler). At the end of the addition the solvent was removed 
under reduced pressure and the crude mixture was purified by silica column 
chromatography (1:1) to afford two diastereomers as yellow oil (75 mg, 0.23 mmol, 
38% combined yield). 
 
anti-isomer (176) (39 mg, 0.12 mmol, 20%): Rf (PE/EA = 1:1) = 0.60. 
 
1H NMR (300 MHz, CDCl3): δ = 7.43 - 7.27 (m, 4H), 5.37 (d, J = 2.5 Hz, 1H), 4.73 
(dd, J = 75.9, 11.6 Hz, 2H), 4.20 (q, J = 7.1 Hz, 2H), 4.00 (s, 2H), 3.64 - 3.48 (m, 2H), 
2.89 (dd, J = 17.7, 8.7 Hz, 1H), 2.69 - 2.54 (m, 1H), 2.29 (dd, J = 17.8, 4.6 Hz, 1H), 
1.87 (dtd, J = 12.3, 6.8, 5.6 Hz, 1H), 1.73 - 1.57 (m, 1H), 1.28 (t, J = 7.2 Hz, 3H). - 
13C NMR (75 MHz, CDCl3): δ = 175.8(Cq), 170.1(Cq), 136.4(Cq), 128.9(+), 128.5(+), 
128.1(+), 107.2(+), 71.2(-), 69.0(-), 68.2(-), 60.9(-), 39.1(+), 33.7(-), 31.7(-), 14.2(+). - 
IR (neat): ṽ = 2982, 2935, 1784, 1746, 1451, 1276, 1205, 1131, 1025, 938 cm-1. - 
MS (ESI-MS): m/z (%) = 345 (MNa+,26), 340 (MNH4
+, 100), 323 (MH+, 
73). - HRMS (ESI-MS, m/z): 345.1306 (C17H22NaO6, calc. 345.1309 [(M+Na)
+]. 
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syn-isomer (176) (36 mg, 0.11 mmol, 18%): Rf (PE/EA = 1:1) = 0.70. 
 
1H NMR (300 MHz, CDCl3): δ = 7.44 - 7.27 (m, 5H), 5.55 (d, J = 5.2 Hz, 1H), 4.71 
(dd, J = 78.2, 11.8 Hz, 2H), 4.19 (q, J = 7.1 Hz, 2H), 4.01 (s, 2H), 3.61 - 3.46 (m, 2H), 
2.84 - 2.70 (m, 1H), 2.60 (dd, J = 17.1, 8.2 Hz, 1H), 2.41 (dd, J = 17.1, 12.0 Hz, 1H), 
1.97 (dtd, J = 12.0, 6.9, 5.1 Hz, 1H), 1.90 - 1.76 (m, 1H), 1.27 (t, J = 7.1 Hz, 3H). - 
13C NMR (75 MHz, CDCl3): δ = 176.5(Cq), 170.3(Cq), 136.6(Cq), 128.9(+), 128.5(+), 
128.0(+), 103.3(+), 70.5(-), 69.4(-), 68.1(-), 60.8(-), 37.7(+), 32.6(-), 28.4(-), 14.2(+). - 
IR (neat): ṽ = 2925, 1786, 1748, 1455, 1358, 1205, 1175, 1139, 1024, 961, 926 cm-1. 
- MS (ESI-MS): m/z (%) = 345 (MNa+, 28), 340 (MNH4
+, 100), 323 (MH+, 
58). - HRMS (ESI-MS, m/z): 345.1305 (C17H22NaO6, calc. 345.1309 [(M+Na)
+]. 
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1-benzyl 4-ethyl 2-(2-(benzyloxy)tetrahydrofuran-3-yl)succinate (177) 
 
 
 
A flame dried flask under nitrogen atmosphere, was filled with 8 mL of dry DCM and 
168 (326 mg, 1 mmol). The resulting solution was degassed thrice by pump-freeze 
method and treated with [TpBr3]Cu-MeCN (164) (51 mg, 0.05 mmol, 5 mol%). Ethyl 
diazo glycine (770 mg of 14.8 wt% DCM solution, 1 mmol, 1 eq) was added by a 
syringe pump, 0.25 mL/h. During the reaction nitrogen gas was evolved (mineral oil 
bubbler). When the addition was finished the reaction was stirred for further 30 min, 
concentrated under reduced pressure. The residue was purified by silica column 
chromatography (PE/EA = 5:1) to afford a mixture of diastereomers (1:1) as colorless 
oil (111 mg, 0.27 mmol, 27%). 
 
Rf (PE/EA = 5:1) = 0.25. 
1H NMR (600 MHz, CDCl3): δ = 7.39 - 7.25 (m, 20H), 5.17 - 5.03 (m, 5H), 4.92 (s, 1H, 
isomer 2), 4.74 (d, J = 4.0 Hz, 1H), 4.72 (d, J = 4.3 Hz, 1H), 4.67 - 4.61 (m, 1H, 
isomer 1), 4.55 (ddd, J = 14.6, 8.1, 6.6 Hz, 1H, isomer 2), 4.42 (d, J = 11.6 Hz, 1H), 
4.37 (d, J = 11.9 Hz, 1H), 4.23 - 4.09 (m, 4H), 2.81 - 2.75 (m, 1H, isomer 2), 2.72 (dd, 
J = 7.8, 3.9 Hz, 1H), 2.71 - 2.68 (m, 2H), 2.67 (d, J = 7.8 Hz, 1H), 2.63 (ddd, J = 8.7, 
7.5, 4.7 Hz, 1H, isomer 1), 2.58 - 2.46 (m, 3H), 2.38 - 2.29 (m, 2H), 2.05 (dt, J = 12.9, 
7.6 Hz, 1H, isomer 1), 1.93 (ddd, J = 12.9, 7.1, 2.1 Hz, 1H, isomer 1), 1.55 (td, 
J = 12.0, 9.0 Hz, 1H, isomer 2), 1.27 (dt, J =  1.6, 7.1Hz, 8H). - 13C NMR (151 MHz, 
CDCl3): δ = 172.3(Cq), 171.6(Cq), 171.2(Cq), 171.1(Cq), 138.2(Cq), 137.8(Cq), 
135.8(Cq), 135.7(Cq), 128.5(+), 128.5(+), 128.3(+), 128.3(+), 128.2(+), 128.2(+), 
128.2(+), 128.2(+), 127.9(+), 127.6(+), 106.9(+, isomer 2), 102.8(+, isomer 1), 75.8(+, 
isomer 2), 75.6(+, isomer 1), 68.8(-), 68.6(-), 66.4(-), 66.2(-), 60.5(-), 60.4(-), 43.1(-), 
42.9(-), 42.2(+, isomer 2), 40.7(+, isomer 1), 36.4(-), 35.2(-, isomer 2), 34.8(-, isomer 
1), 33.5(-), 14.2(+).- IR (neat): ṽ = 2963, 2360, 2340, 1733, 1454, 1261, 1160, 1094, 
1024, 799, 736, 697 cm-1. - MS (ESI-MS): m/z (%) = 431 (27), 430 (MNH4
+, 100), 306 
(10), 305 (52). - HRMS (ESI-EIC-MS, m/z): 430.2223 (C24H32NO6, calc. 430.2224 
[(M+NH4)
+]). 
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2-(2-oxotetrahydrofuran-3-yl)acetic acid (183) 
 
 
 
167 (1 g, 7.8 mmol) was dissolved in 15 mL acetone and cooled in an ice bath. 2.5 M 
Jones reagent (11 mL, 27.5 mmol, 3.5 eq) was added by an addition funnel over a 
period of 1 h. When the addition was finished the reaction was stirred for further 2 h 
at room temperature. The green mixture was transferred to a separation funnel. After 
addition of 10 mL of water, the crude product was extracted with EA (4 x 10 mL). The 
combined organic layers were dried with Na2SO4, filtered and concentrated under 
reduced pressure. The product (1.06 g, 7.35 mmol, 94%) was used without further 
purification. 
 
Rf (PE/EA = 1:1) = 0.23. 
1H NMR (300 MHz, MeOD): δ = 4.39 (td, J = 8.9, 2.1 Hz, 1H), 4.25 (ddd, J = 10.2, 
8.9, 6.7 Hz, 1H), 3.04 - 2.90 (m, 1H), 2.77 (dd, J = 17.3, 4.3 Hz, 1H), 2.59 (dd, J = 
17.3, 7.7 Hz, 1H), 2.48 (dddd, J = 12.2, 8.9, 6.8, 2.1 Hz, 1H), 2.10 (dtd, J = 12.4, 
10.6, 9.0 Hz, 1H). - 13C NMR (75 MHz, MeOD): δ = 181.3(Cq), 174.7(Cq), 68.3(-), 
37.2(+), 34.9(-), 29.2(-). - IR (neat) ṽ = 3460, 3984, 2924, 1701, 1404, 1381, 1266, 
1158, 1020, 960, 897, 830, 782, 713, 668, 616 cm-1. - MS (EI-MS, 70 eV): m/z (%) = 
144 (M+·, 1), 100 (12), 82 (13), 58 (29), 57 (10), 56 (22), 55 (100), 54 (31), 45 (19), 43 
(24), 42 (19), 41 (46), 39 (26). - HRMS (ESI-MS, m/z): 145.0492 (C6H9O4, calc. 
145.0495 [MH+]). 
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6a-methyltetrahydrofuro[2,3-b]furan-2(6aH)-one (185) 
 
 
 
In a flame dried flask under nitrogen atmosphere 183 (100 mg, 0.69 mmol) was 
dissolved in 2 mL of dry THF and cooled to -78 °C. Me-MgBr (913 L of a 22 wt% 
solution in THF, 1.725 mmol, 2.5 eq) was added dropwise. After the turbid solution 
was kept at that temperature for 2 h, it was allowed to warm to 0 °C. Then it was 
transferred to a separation funnel and 1 mL of water was added. The mixture was 
acidified to a pH of 2 by HCl (2 M) and extracted with Et2O (4 x 5 mL). The combined 
organic layers were dried over Na2SO4, filtered and concentrated under reduced 
pressure. The crude product was purified by silica column chromatography 
(PE/EA = 1:1) to afford the desired product as colorless oil (18 mg, 0.13 mmol, 19%). 
 
Rf (PE/EA = 1:1) = 0.47. 
1H NMR (300 MHz, CDCl3): δ = 4.07 (td, J = 8.7, 2.5 Hz, 1H), 3.93 (td, J = 9.7, 6.2 
Hz, 1H), 2.94 (dd, J = 18.2, 9.8 Hz, 1H), 2.80 (tt, J = 9.6, 2.7 Hz, 1H), 2.50 (dd, 
J = 18.1, 2.6 Hz, 1H), 2.28 (ddd, J = 18.1, 12.9, 9.3 Hz, 1H), 1.83 - 1.70 (m, 1H), 1.65 
(s, 3H). - 13C NMR (75 MHz, CDCl3): δ = 174.6(Cq), 117.4(Cq), 67.4(-), 42.7(+), 36.5(-
), 33.1(-), 23.8(+). - IR (neat) ṽ = 2987, 2939, 2888, 1761, 1387, 1323, 1259, 1219, 
1129, 1084, 1014, 899, 832, 682, 606 cm-1. - MS (EI-MS, 70 eV): m/z (%) = 141 (M-
H·, 1), 127 (M-Me·, 5), 98 (38), 97 (16), 83 (12), 55 (31), 54 (14), 43 
(100). - HRMS (ESI-MS, m/z): 143.0702 (C7H11O3, calc. 143.0703 [(M+H)
+]).  
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(3S,4S)-4-(carboxymethyl)-5-oxotetrahydrofuran-3-carboxylic acid (186) 
 
 
 
57 (1.41 g, 8.2 mmol) was dissolved in 25 mL of acetone and cooled to 0 °C. Within 
30 min, 8.2 mL of Jones-reagent (2.5 M) were added. The mixture turned slowly from 
orange to green. After 6 h it was transferred to a separation funnel, 10 mL of water 
were added and it was washed with EA (4 x 25 mL). The combined organic layers 
were dried over Na2SO4, filtered and concentrated under reduced pressure. The 
crude mixture was purified by silica column chromatography (PE/EA = 1:2 + 1 vol% 
HOAc) to afford the desired product (1.36 g, 7.23 mmol, 88%). 
 
Rf (EA) = 0.27. -     
   = -29.5 (MeOH, c = 1). 
1H NMR (600 MHz, Acetone): δ = 4.57 (t, J = 9.0 Hz, 1H), 4.33 (t, J = 9.0 Hz, 1H), 
3.64 - 3.53 (m, 1H), 3.19 (dt, J = 10.3, 5.1 Hz, 1H), 2.86 (d, J = 5.2 Hz, 2H). - 
13C NMR (151 MHz, MeOD): δ = 179.2(Cq), 174.2(Cq), 174.0(Cq), 68.6(-), 45.5(+), 
40.3(+), 33.4(-). - IR (neat) ṽ =3506, 3321, 2977, 1721, 1699, 1408, 1380, 1259, 
1188, 1158, 1085, 1029, 861, 714, 692, 648 cm-1. - MS (ESI-MS): m/z (%) = 563 
((3M-H)-, 5), 375 ((2M-H)-, 100), 233 (M+HCOO-, 18), 187 ((M-H)-, 14). - HRMS 
(ESI-MS, m/z): 187.0247 (C7H7O6, calc. 187.0248 [(M-H)
-]).  
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(3S,3aS,6aS)-6a-allyl-5-oxohexahydrofuro[2,3-b]furan-3-carboxylic acid (187) 
 
 
 
In a flame dried flask under nitrogen atmosphere 186 (603 mg, 3.32 mmol) was 
dissolved in 50 mL of dry THF and cooled to -78 °C. Allyl-MgBr (8.02 mL of a 1 M 
solution in Et2O, 8.02 mmol, 2.5 eq) was added dropwise. After the turbid solution 
was kept at that temperature for 2 h, it was allowed to warm to 0 °C. Then it was 
transferred to a separation funnel, 20 mL of water were added. The mixture was 
acidified to a pH of 2 by HCl (2 M). It was extracted with Et2O (4 x 50 mL). The 
combined organic layers were dried over Na2SO4, filtered and concentrated under 
reduced pressure. The crude product was purified by silica column chromatography 
(toluene/ethyl formate/formic acid = 5:4:1) to afford the desired product as colorless 
oil (514 mg, 2.42 mmol, 73%). 
 
Rf (toluene/ethyl formate/formic acid = 5:4:1) = 0.35. -     
   = -16.2 (MeOH, c = 1). 
1H NMR (300 MHz, Acetone): δ = 5.81 (ddt, J = 17.3, 10.2, 7.1 Hz, 1H), 5.29 - 5.08 
(m, 2H), 4.32 (dd, J = 9.5, 2.2 Hz, 1H), 4.15 (dd, J = 9.5, 6.6 Hz, 1H), 3.38 (dt, 
J = 10.4, 2.7 Hz, 1H), 3.21 - 3.09 (m, 1H), 3.02 (dd, J = 18.7, 10.4 Hz, 1H), 2.73 - 
2.60 (m, 3H). - 13C NMR (75 MHz, Acetone): δ = 174.6(Cq), 173.6(Cq), 132.3(+), 
120.1(-), 118.6(Cq), 70.1(-), 51.6(+), 44.6(+), 41.9(-), 35.9(-). - IR (neat) ṽ = 3402, 
2930, 2848, 1716, 1648, 1414, 1263, 1208, 1089, 1017, 972, 924, 866 cm-1. - MS 
(ESI-MS): m/z (%) = 635 ((3M-H)-, 45), 423 ((2M-H)-, 100), 325 (M+F3CCOO
-, 24), 
257 (M+HCOO-, 52). - HRMS (ESI-MS, m/z): 211.0612 (C10H11O5, calc. 211.0612 
[(M-H)-]). 
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(3S,3aS,6aS)-5-oxo-6a-(2-oxopropyl)hexahydrofuro[2,3-b]furan-3-carboxylic 
acid (189) 
 
 
 
187 (100 mg, 0.47 mmol) was dissolved in 2 mL of acetone/water (4:1) and cooled to 
0°C. At that temperature Hg(OAc)2 (37.4 mg, 0.118 mmol, 0.25 eq) was added, which 
turned the solution yellow. After 15 min 470 L of Jones-reagent (2.5 M) were added 
dropwise. The mixture was allowed to warm to room temperature and was stirred for 
additional 15 h. After that time it was transferred to a separation funnel, mixed with 
1 mL of water and extracted with Et2O (4 x 3 ml). The crude product was purified by 
silica column chromatography (toluene/ethyl formate/formic acid = 5:4:1) to afford the 
desired product as yellow oil (85 mg, 0.37 mmol, 79%). 
 
Rf (toluene/ethyl formate/formic acid = 5:4:1) = 0.22. -     
   = -30.7 (MeCN, c = 1). 
1H NMR (600 MHz, CD3CN): δ = 4.22 (d, J = 9.7 Hz, 1H), 4.02 (dd, J = 9.8, 6.0 Hz, 
1H), 3.35 (dd, J = 21.5, 10.6 Hz, 2H), 3.15 (dd, J = 18.7, 10.9 Hz, 1H), 3.00 (dd, 
J = 27.8, 12.1 Hz, 2H), 2.54 (dd, J = 18.7, 3.6 Hz, 1H), 2.12 (s, 3H). -  13C NMR (151 
MHz, CD3CN): δ = 206.2(Cq), 175.8(Cq), 174.0(Cq), 116.1(Cq), 69.3(-), 51.8(+), 
49.9(-), 45.2(+), 36.3(-), 30.8(+).- IR (neat) ṽ = 3503, 2998, 2919, 1766, 1712, 1404, 
1373, 1275, 1205, 1173, 1112, 1036, 999, 949, 926, 862, 653, 609 cm-1. HRMS 
(ESI-MS, m/z): 227.0563 (C10H11O6, calc. 227.0561 [(M-H)
-]). 
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 ((3S,3aS,6aS)-5-oxo-6a-(2-oxopropyl)hexahydrofuro[2,3-b]furan-3-yl)methyl 
benzoate (5) 
 
 
 
In a flamed dried flask under nitrogen atmosphere 189 (18 mg, 0.079 mmol) was 
dissolved in 1 mL of dry THF and cooled to -15 °C. To this solution BH3
.THF (solution 
1 M in THF, 166 L, 0.166 mmol, 2.1 eq) was added dropwise. After 4 h at -15 °C it 
was allowed to warm to room temperature. The solvent was evaporated under 
reduced pressure. The obtained crude product was dissolved in 1.5 mL of dry DCM, 
cooled to -40 °C and treated with DMAP (1 mg, 0.008 mmol, 0.1 eq), triethylamine 
(66 L, 0.474 mmol, 6 eq) and benzoyl chloride (10 L, 0.083 mmol, 1.05 eq). The 
reaction was allowed to warm to -10 °C. After 1.5 d it was transferred to a separation 
funnel, treated with 1 mL of a half saturated NH4Cl solution and extracted with Et2O 
(3 x 2 mL). The combined organic layers were dried over Na2SO4, filtered and 
concentrated under reduced pressure. The crude product was again dissolved in 
2 mL of dry DCM, cooled to 0 °C and treated with solid DMP (33.5 mg, 0.079 mmol, 
1 eq). After 3 h at that temperature it was warmed to room temperature and 
transferred to a separation funnel. The mixture was washed with saturated NaHCO3 
solution (2 x 1 mL). The combined aqueous layers were extracted with DCM 
(2 x 1 mL). The combined organic layers were dried over Na2SO4, filtered and 
concentrated under reduced pressure. The crude product was purified by silica 
column chromatography (PE/EA = 2:1) to afford the clean 5 as white needles (11 mg, 
0.035 mmol, 44% based on 189). 
 
Rf (PE/EA = 1:1) = 0.50. -     
   = -42.0 (CHCl3, c = 0.17). 
1H NMR (600 MHz, CDCl3): δ = 8.02 (dd, J = 8.1, 1.0 Hz, 2H), 7.60 (tt, J = 7.2, 1.2 
Hz, 1H), 7.47 (t, J = 7.8 Hz, 2H), 4.29 (dd, J = 11.0, 7.3 Hz, 1H), 4.19 (dd, J = 11.0, 
8.0 Hz, 1H), 4.03 (qd, J = 9.9, 3.4 Hz, 2H), 3.40 (d, J = 17.7 Hz, 1H), 3.34 (dd, 
J = 18.6, 10.5 Hz, 1H), 2.99 - 2.93 (m, 2H), 2.58 - 2.51 (m, 2H), 2.20 (s, 3H).  
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13C NMR (75 MHz, CDCl3): δ = 204.5(Cq), 174.6(Cq), 166.5(Cq), 133.5(+), 129.7(+), 
129.6(Cq), 128.7(+), 115.1(Cq), 68.0(-), 65.0(-), 49.6(-), 46.8(+), 44.5(+), 36.7(-), 
31.0(+). - IR (neat): ṽ = 2984, 1703, 1401, 1366, 1320, 1197, 1152, 1116, 1074, 981, 
952, 927, 870, 841, 779, 725, 674 cm-1. - MS (ESI-MS, m/z): 456 (19), 455 ((2M-H)-, 
82), 274 (13), 273 (M+HCOO-, 100), 277 ((M-H)-, 3). - HRMS (ESI-MS, m/z): 
227.0927 (C11H15O5, calc. 227.0925 [(M-H)
-]). - mp: 152 °C.  
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E. Appendix 
 
1. NMR spectra 
 
1H-NMR spectra:     upper image 
 
13C-NMR spectra (DEPT 135 integrated): lower image 
 
 
Used solvent and MHz are stated at the actual spectra. 
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((4S,4'S,5S,5'S)-2,2'-(propane-2,2-diyl)bis(5-phenyl-4,5-dihydrooxazole-4,2-
diyl))dimethanol (85)                 (CDCl3, 300 MHz) 
 
             (CDCl3, 75 MHz)
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methyl furan-3-carboxylate (78) 
           (CDCl3, 300 MHz) 
 
             (CDCl3, 75 MHz) 
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(1S,5R,6S)-6-ethyl 4-methyl 2-oxabicyclo[3.1.0]hex-3-ene-4,6-dicarboxylate 
(119)          (CDCl3, 300 MHz) 
 
             (CDCl3, 75 MHz) 
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(2Z,4E)-6-ethyl 1-methyl 2-formylhexa-2,4-dienedioate (Z/E-127) and (2E,4E)-6-
ethyl 1-methyl 2-formylhexa-2,4-dienedioate (E/E-127)            (CDCl3, 600 MHz)  
 
           (CDCl3, 151 MHz) 
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(1S,5R,6S)-ethyl-4-(hydroxymethyl)-2-oxabicyclo[3.1.0]hex-3-ene-6-carboxylate 
(131)           (CDCl3, 300 MHz) 
 
             (CDCl3, 75 MHz) 
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(1S,5R,6R)-methyl-6-(hydroxymethyl)-2-oxabicyclo[3.1.0]hex-3-ene-4-
carboxylate (132)         (CDCl3, 300 MHz) 
 
             (CDCl3, 75 MHz) 
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(1S,4S,5S,6S)-6-ethyl 4-methyl 2-oxabicyclo[3.1.0]hexane-4,6-dicarboxylate 
(133)          (CDCl3, 300 MHz) 
 
             (CDCl3, 75 MHz) 
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(3S,5S)-methyl 5-(2-ethoxy-2-oxoethyl)tetrahydrofuran-3-carboxylate (134) 
           (CDCl3, 600 MHz) 
 
           (CDCl3, 151 MHz) 
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(5S)-methyl 5-(2-methoxy-2-oxoethyl)tetrahydrofuran-3-carboxylate (135) 
           (CDCl3, 600 MHz) 
 
           (CDCl3, 151 MHz) 
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4-methylbenzenesulfonyl azide (87) 
           (CDCl3, 300 MHz) 
 
             (CDCl3, 75 MHz) 
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tert-butyl 3-diazo-2-oxopropanoate (89) 
           (CDCl3, 300 MHz) 
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(1S,5R,6S)-6-tert-butyl 4-methyl 2-oxabicyclo[3.1.0]hex-3-ene-4,6-dicarboxylate 
(118)           (CDCl3, 300 MHz) 
 
             (CDCl3, 75 MHz) 
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(1S,5R,6S)-6-(tert-butoxycarbonyl)-2-oxabicyclo[3.1.0]hex-3-ene-4-carboxylic 
acid (138)           (acetone-d6, 300 MHz) 
 
               (acetone-d6, 75 MHz) 
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(1S,4S,5S,6S)-6-(tert-butoxycarbonyl)-2-oxabicyclo[3.1.0]hexane-4-carboxylic 
acid (139)          (CDCl3, 300 MHz) 
 
             (CDCl3, 75 MHz) 
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(1S,4R,5S,6S)-tert-butyl-4-(hydroxymethyl)-2-oxabicyclo[3.1.0]hexane-6-
carboxylate (140)         (CDCl3, 300 MHz) 
 
             (CDCl3, 75 MHz) 
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(3S,4R)-benzyl 5-(benzyloxy)-4-(2-(benzyloxy)-2-oxoethyl)tetrahydrofuran-3-
carboxylate (142)         (CDCl3, 300 MHz) 
 
             (CDCl3, 75 MHz) 
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(3S,3aR,6aR)-5-oxohexahydrofuro[2,3-b]furan-3-carboxylic acid (145) 
                (DMSO-d6, 600 MHz) 
 
                (DMSO-d6, 151 MHz) 
 
  
E. Appendix 
132 
(3S,3aS,6aS)-5-oxohexahydrofuro[2,3-b]furan-3-carboxylic acid (57) 
          (methanol-d4, 400 MHz) 
 
          (methanol-d4, 101 MHz) 
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(3aR,4R,6aR)-4-(hydroxymethyl)tetrahydrofuro[2,3-b]furan-2(6aH)-one (141) 
          (methanol-d4, 300 MHz) 
 
            (methanol-d4, 75 MHz) 
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(3aS,4R,6aS)-4-(hydroxymethyl)tetrahydrofuro[2,3-b]furan-2(6aH)-one (152) 
          (methanol-d4, 300 MHz) 
 
            (methanol-d4, 75 MHz) 
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((3S,3aS,6aS)-5-oxohexahydrofuro[2,3-b]furan-3-yl)methyl benzoate (153) 
           (CDCl3, 300 MHz) 
 
             (CDCl3, 75 MHz) 
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tributylstannyl 2-iodoacetate (166) 
           (CDCl3, 300 MHz) 
 
             (CDCl3, 75 MHz) 
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tetrahydrofuro[2,3-b]furan-2(6aH)-one (167) 
           (CDCl3, 300 MHz) 
 
             (CDCl3, 75 MHz) 
 
  
E. Appendix 
138 
benzyl 2-(2-(benzyloxy)tetrahydrofuran-3-yl)acetate (168) 
           (CDCl3, 600 MHz) 
 
           (CDCl3, 151 MHz) 
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copper(I) tris(3,4,5-tribromo-1H-pyrazole-1-yl)hydroborate acetonitrile complex 
(164) (third pyrazole ring indicated by N-N for better lucidity)          (CD2Cl2, 300 MHz) 
 
            (CD2Cl2, 75 MHz) 
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ethyl-2-(2-(2-(2-ethoxy-2-oxoethoxy)-5-oxotetrahydrofuran-3-yl)ethoxy)acetate 
(175) Isomer 1         (CDCl3, 600 MHz) 
 
           (CDCl3, 151 MHz) 
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ethyl-2-(2-(2-(2-ethoxy-2-oxoethoxy)-5-oxotetrahydrofuran-3-yl)ethoxy)acetate 
(175) Isomer 2        (CDCl3, 600 MHz) 
 
           (CDCl3, 151 MHz) 
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benzyl 2-(2-(2-ethoxy-2-oxoethoxy)tetrahydrofuran-3-yl)acetate (176) 
anti-isomer          (CDCl3, 300 MHz) 
 
             (CDCl3, 75 MHz) 
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benzyl 2-(2-(2-ethoxy-2-oxoethoxy)tetrahydrofuran-3-yl)acetate (176) 
syn-isomer          (CDCl3, 300 MHz) 
 
             (CDCl3, 75 MHz) 
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1-benzyl 4-ethyl 2-(2-(benzyloxy)tetrahydrofuran-3-yl)succinate (177) 
           (CDCl3, 600 MHz) 
 
           (CDCl3, 151 MHz) 
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2-(2-oxotetrahydrofuran-3-yl)acetic acid (183) 
          (methanol-d4, 300 MHz) 
 
            (methanol-d4, 75 MHz) 
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6a-methyltetrahydrofuro[2,3-b]furan-2(6aH)-one (185) 
           (CDCl3, 300 MHz) 
 
             (CDCl3, 75 MHz) 
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(3S,4S)-4-(carboxymethyl)-5-oxotetrahydrofuran-3-carboxylic acid (186) 
             (acetone-d6, 600 MHz) 
 
             (acetone-d6, 151 MHz) 
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(3S,3aS,6aS)-6a-allyl-5-oxohexahydrofuro[2,3-b]furan-3-carboxylic acid (187) 
             (acetone-d6, 300 MHz) 
 
               (acetone-d6, 75 MHz) 
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(3S,3aS,6aS)-5-oxo-6a-(2-oxopropyl)hexahydrofuro[2,3-b]furan-3-carboxylic 
acid (189)               (acetonitrile-d3, 600 MHz) 
 
                 (acetonitrile-d3, 151 MHz) 
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((3S,3aS,6aS)-5-oxo-6a-(2-oxopropyl)hexahydrofuro[2,3-b]furan-3-yl)methyl 
benzoate (5) (-)-Paeonilide       (CDCl3, 600 MHz) 
 
           (CDCl3, 151 MHz) 
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2. X-ray crystallography data 
 
(1S,4S,5S,6S)-6-ethyl 4-methyl 2-oxabicyclo[3.1.0]hexane-4,6-dicarboxylate 
(133) 
 
 
 
Table 1: Crystal data and structure refinement for 133. 
      Crystal Data    
Empirical formula  C10 H14 O5  
Formula weight  214.21  
Crystal size  0.1790 x 0.1140 x 0.1089 mm  
Crystal description  stick  
Crystal colour  colourless  
Crystal system Orthorhombic  
Space group  P 21 21 21  
Unit cell dimensions               a = 5.2775(1) A   alpha = 90 deg.  
                                         b = 7.4363(1) A    beta = 90 deg.  
                                         c = 26.0428(4) A   gamma = 90 deg.  
Volume  1022.05(3) A^3  
Z, Calculated density  4,  1.392 Mg/m^3  
Absorption coefficient  0.950 mm^-1  
F(000)  456 
   
       Data Collection    
Measurement device type  SuperNova, Single source at offset, Atlas  
Measurement method  \w scans  
Temperature  123 K  
Wavelength  1.54184 A  
Monochromator   graphite  
Theta range for data collection  3.39 to 76.43 deg.  
Index ranges  -6<=h<=6, -9<=k<=9, -31<=l<=32 
Reflections collected / unique  9985 / 2129 [R(int) = 0.0311]  
Reflections greater I>2\s(I) 2110 
Absorption correction  Analytical  
Max. and min. transmission  0.926 and 0.868  
   
 
 
E. Appendix 
152 
      Refinement    
Refinement method  Full-matrix least-squares on F^2  
Hydrogen treatment  :  
Data / restraints / parameters  2129 / 0 / 142  
Goodness-of-fit on F^2  1.077 
Final R indices [I>2sigma(I)]      R1 = 0.0431, wR2 = 0.1113  
R indices (all data)               R1 = 0.0434, wR2 = 0.1117  
Absolute structure parameter  -0.1(3)  
Largest diff. peak and hole  0.411 and -0.367 e.A^-3  
 
Table 2: Atomic coordinates (x 104) and equivalent isotropic displacement 
parameters (Å2 x 103) for 133. U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor. 
Atom x    y     z  U(eq)  
O(1) 1993(3) 9251(2) 2282(1) 30(1) 
O(2) 7794(3) 5360(2) 1483(1) 29(1) 
O(3) 4026(3) 4302(2) 1729(1) 32(1) 
O(4A) -292(4) 9433(2) 605(1) 41(1) 
O(5) 3268(3) 11057(2) 709(1) 40(1) 
C(1) 2890(4) 7415(3) 2307(1) 27(1) 
C(2) 5219(4) 7326(2) 1960(1) 23(1) 
C(3) 4753(4) 8817(2) 1571(1) 25(1) 
C(4) 2771(4) 9952(2) 1808(1) 26(1) 
C(5) 2129(4) 8841(2) 1327(1) 24(1) 
C(6) 5565(4) 5488(2) 1719(1) 22(1) 
C(7) 8349(5) 3631(3) 1252(1) 35(1) 
C(8) 1843(4) 9895(3) 851(1) 28(1) 
C(9A) -897(8) 10393(4) 134(1) 63(1) 
C(10) -392(14) 9278(8) -309(2) 48(1) 
C(9) -897(8) 10393(4) 134(1) 63(1) 
C(11) -1700(20) 9331(14) -267(3) 48(1) 
O(4) -292(4) 9433(2) 605(1) 41(1) 
 
Table 3: Bond lengths [Å] and angles [deg] for 133. 
O(1)-C(1) 1.447(3)  O(2)-C(6)-O(3) 123.73(16)  
O(1)-C(4) 1.403(2)  O(2)-C(6)-C(2) 111.22(15)  
O(2)-C(6) 1.331(3)  O(3)-C(6)-C(2) 125.04(19)  
O(2)-C(7) 1.450(3)  O(4A)-C(8)-C(5) 110.62(18)  
O(3)-C(6) 1.199(2)  O(5)-C(8)-C(5) 125.14(19)  
O(4)-C(8) 1.341(3)  O(4A)-C(8)-O(5) 124.19(18)  
O(4)-C(9) 1.455(3)  O(4)-C(8)-C(5) 110.62(18)  
O(4A)-C(8) 1.341(3)  O(4)-C(8)-O(5) 124.19(18)  
O(4A)-C(9A) 1.455(3)  O(4)-C(9)-C(11) 115.2(5)  
O(5)-C(8) 1.204(3)  O(4A)-C(9A)-C(10) 110.5(3)  
C(1)-C(2) 1.527(3)  O(1)-C(1)-H(1A) 110.00  
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C(2)-C(6) 1.514(2)  O(1)-C(1)-H(1B) 111.00  
C(2)-C(3) 1.521(2)  C(2)-C(1)-H(1A) 110.00  
C(3)-C(5) 1.523(3)  C(2)-C(1)-H(1B) 111.00  
C(3)-C(4) 1.479(3)  H(1A)-C(1)-H(1B) 109.00  
C(4)-C(5) 1.537(2)  C(1)-C(2)-H(2) 109.00  
C(5)-C(8) 1.475(3)  C(3)-C(2)-H(2) 109.00  
C(9)-C(11) 1.376(9)  C(6)-C(2)-H(2) 109.00  
C(9A)-C(10) 1.445(6)  C(2)-C(3)-H(3) 120.00  
C(1)-H(1A) 0.9900  C(4)-C(3)-H(3) 120.00  
C(1)-H(1B) 0.9900  C(5)-C(3)-H(3) 120.00  
C(2)-H(2) 10.000 O(1)-C(4)-H(4) 118.00  
C(3)-H(3) 10.000 C(3)-C(4)-H(4) 118.00  
C(4)-H(4) 10.000 C(5)-C(4)-H(4) 118.00  
C(5)-H(5) 10.000 C(3)-C(5)-H(5) 118.00  
C(7)-H(7A) 0.9800  C(4)-C(5)-H(5) 118.00  
C(7)-H(7B) 0.9800  C(8)-C(5)-H(5) 118.00  
C(7)-H(7C) 0.9800  O(2)-C(7)-H(7A) 109.00  
C(9)-H(9D) 0.9900  O(2)-C(7)-H(7B) 109.00  
C(9)-H(9C) 0.9900  O(2)-C(7)-H(7C) 109.00  
C(9A)-H(9B) 0.9900  H(7A)-C(7)-H(7B) 109.00  
C(9A)-H(9A) 0.9900  H(7A)-C(7)-H(7C) 109.00  
C(10)-H(10C) 0.9800  H(7B)-C(7)-H(7C) 110.00  
C(10)-H(10A) 0.9800  H(9C)-C(9)-H(9D) 107.00  
C(10)-H(10B) 0.9800  O(4)-C(9)-H(9C) 108.00  
C(11)-H(11A) 0.9800  O(4)-C(9)-H(9D) 108.00  
C(11)-H(11B) 0.9800  C(11)-C(9)-H(9C) 109.00  
C(11)-H(11C) 0.9800  C(11)-C(9)-H(9D) 108.00  
C(1)-O(1)-C(4) 107.11(13)  C(10)-C(9A)-H(9A) 109.00  
C(6)-O(2)-C(7) 115.70(16)  C(10)-C(9A)-H(9B) 110.00  
C(8)-O(4)-C(9) 117.5(2)  O(4A)-C(9A)-H(9B) 110.00  
C(8)-O(4A)-C(9A) 117.5(2)  O(4A)-C(9A)-H(9A) 110.00  
O(1)-C(1)-C(2) 106.14(15)  H(9A)-C(9A)-H(9B) 108.00  
C(1)-C(2)-C(6) 112.38(16)  H(10A)-C(10)-H(10C) 109.00  
C(3)-C(2)-C(6) 113.73(15)  H(10B)-C(10)-H(10C) 110.00  
C(1)-C(2)-C(3) 103.43(16)  C(9A)-C(10)-H(10A) 109.00  
C(2)-C(3)-C(5) 115.64(15)  C(9A)-C(10)-H(10B) 109.00  
C(4)-C(3)-C(5) 61.57(13)  C(9A)-C(10)-H(10C) 109.00  
C(2)-C(3)-C(4) 104.67(16)  H(10A)-C(10)-H(10B) 109.00  
O(1)-C(4)-C(5) 116.92(14)  C(9)-C(11)-H(11A) 110.00  
C(3)-C(4)-C(5) 60.65(13)  C(9)-C(11)-H(11B) 110.00  
O(1)-C(4)-C(3) 111.23(14)  C(9)-C(11)-H(11C) 110.00  
C(3)-C(5)-C(4) 57.78(12)  H(11A)-C(11)-H(11B) 110.00  
C(3)-C(5)-C(8) 116.72(17)  H(11A)-C(11)-H(11C) 109.00  
C(4)-C(5)-C(8) 114.92(14)  H(11B)-C(11)-H(11C) 109.00  
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Table 4: Anisotropic displacement parameters (A2 x 103) for 133. The anisotropic 
displacement factor exponent takes the form: -2 pi2 [ h2 a*2 U11 + .. + 2 h k a*b*U12]. 
Atom U11 U22 U33 U23 U13 U12 
O(1) 43(1) 25(1) 23(1) -4(1) -2(1) 9(1)  
O(2) 30(1) 23(1) 35(1) -3(1) 5(1) 0(1)  
O(3) 31(1) 21(1) 45(1) -4(1) 2(1) -4(1)  
O(4A) 59(1) 34(1) 30(1) 6(1) -18(1) -3(1)  
O(5) 46(1) 31(1) 42(1) 15(1) 4(1) 1(1)  
C(1) 36(1) 22(1) 23(1) 0(1) -2(1) 4(1)  
C(2) 26(1) 18(1) 26(1) -1(1) -4(1) 1(1)  
C(3) 27(1) 17(1) 32(1) 2(1) -1(1) -1(1)  
C(4) 33(1) 18(1) 26(1) -2(1) -5(1) 2(1)  
C(5) 29(1) 19(1) 25(1) -1(1) -2(1) 0(1)  
C(6) 26(1) 18(1) 23(1) 4(1) -4(1) 1(1)  
C(7) 38(1) 29(1) 39(1) -7(1) 5(1) 5(1)  
C(8) 38(1) 21(1) 25(1) -2(1) 1(1) 6(1)  
C(9A) 105(3) 50(2) 33(1) 10(1) -29(2) 8(2)  
C(10) 62(3) 53(2) 28(1) 8(1) -5(2) -7(3)  
C(9) 105(3) 50(2) 33(1) 10(1) -29(2) 8(2)  
C(11) 62(3) 53(2) 28(1) 8(1) -5(2) -7(3)  
O(4) 59(1) 34(1) 30(1) 6(1) -18(1) -3(1)  
 
Table 5: Hydrogen coordinates (x 104) and isotropic displacement parameters (A2 x 
103) for 133. 
Atom     x      y     z    U(eq)  
H(2) 6760 7627 2166 28 
H(3) 6215 9389 1390 30 
H(5) 1035 7755 1372 29 
H(7A) 7062 3353 993 53 
H(4) 2914 11286 1772 31 
H(7C) 10022 3674 1089 53 
H(9A) -2707 10742 136 76 
H(9B) 132 11504 113 76 
H(10A) 1438 9081 -340 72 
H(10B) -1019 9879 -619 72 
H(10C) -1251 8119 -268 72 
H(7B) 8339 2698 1518 53 
H(1A) 1566 6575 2184 32 
H(1B) 3345 7091 2664 32 
H(9C) -2235 11287 210 76 
H(9D) 627 11063 22 76 
H(11A) -649 8249 -286 72 
H(11B) -1564 10004 -590 72 
H(11C) -3475 8984 -212 72 
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Table 6: Torsion angles [deg] for 133. 
C(4)-O(1)-C(1)-C(2) 26.33(19)  C(3)-C(2)-C(6)-O(3) -106.2(2)  
C(1)-O(1)-C(4)-C(3) -15.5(2)  C(1)-C(2)-C(3)-C(4) 17.06(19)  
C(1)-O(1)-C(4)-C(5) 51.4(2)  C(4)-C(3)-C(5)-C(8) 103.91(17)  
C(7)-O(2)-C(6)-O(3) -3.1(3)  C(2)-C(3)-C(4)-O(1) -1.7(2)  
C(7)-O(2)-C(6)-C(2) 178.28(16)  C(2)-C(3)-C(4)-C(5) -111.52(15)  
C(8)-O(4A)-C(9A)-C(10) 104.8(4)  C(5)-C(3)-C(4)-O(1) 109.80(16)  
C(9A)-O(4A)-C(8)-O(5) 0.6(3)  C(2)-C(3)-C(5)-C(4) 93.41(17)  
C(9A)-O(4A)-C(8)-C(5) 178.1(2)  C(2)-C(3)-C(5)-C(8) -162.68(16)  
O(1)-C(1)-C(2)-C(3) -26.66(18)  O(1)-C(4)-C(5)-C(8) 152.56(17)  
O(1)-C(1)-C(2)-C(6) -149.74(15)  C(3)-C(4)-C(5)-C(8) -107.05(19)  
C(3)-C(2)-C(6)-O(2) 72.4(2)  O(1)-C(4)-C(5)-C(3) -100.39(18)  
C(1)-C(2)-C(3)-C(5) -48.08(19)  C(4)-C(5)-C(8)-O(4A) -131.63(19)  
C(6)-C(2)-C(3)-C(4) 139.25(17)  C(4)-C(5)-C(8)-O(5) 45.9(3)  
C(6)-C(2)-C(3)-C(5) 74.1(2)  C(3)-C(5)-C(8)-O(4A) 163.48(16)  
C(1)-C(2)-C(6)-O(2) -170.52(15)  C(3)-C(5)-C(8)-O(5) -19.0(3)  
C(1)-C(2)-C(6)-O(3) 10.9(3)  
   
Table 7: Hydrogen-bonds for 133 [Å and deg.]. 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA)  
 C(1)-H(1A)...O(3)  0.9900 24.400  2.826(3)  103.00  
 C(4)-H(4)...O(3)#1 10.000 23.200  3.308(2)  169.00  
 C(5)-H(5)...O(2)#2 10.000 24.900  3.478(2)  172.00  
 C(9A)-H(9B)...O(5)  0.9900 22.900  2.706(4)  104.00  
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(1S,5R,6S)-6-tert-butyl 4-methyl 2-oxabicyclo[3.1.0]hex-3-ene-4,6-dicarboxylate 
(118) 
 
 
 
Table 1: Crystal data and structure refinement for 118. 
      Crystal Data    
Empirical formula  C12 H16 O5  
Formula weight  240.25  
Crystal size  0.7024 x 0.0514 x 0.0399 mm  
Crystal description  stick  
Crystal colour  translucent colourless  
Crystal system Orthorhombic  
Space group  P 21 21 21  
Unit cell dimensions               a = 5.54365(8) A   alpha = 90 deg.  
                                         b = 23.9596(4) A    beta = 90 deg.  
                                         c = 28.0869(4) A   gamma = 90 deg.  
Volume  3730.61(10) A^3  
Z, Calculated density  12,  1.283 Mg/m^3  
Absorption coefficient  0.839 mm^-1  
F(000)  1536 
   
       Data Collection    
Measurement device type  SuperNova, Single source at offset, Atlas  
Measurement method  \w scans  
Temperature  123 K  
Wavelength  1.54184 A  
Monochromator   graphite  
Theta range for data collection  3.15 to 74.07 deg.  
Index ranges  -6<=h<=6, -29<=k<=24, -34<=l<=33 
Reflections collected / unique  26433 / 7472 [R(int) = 0.0277]  
Reflections greater I>2\s(I) 7005 
Absorption correction  Analytical  
Max. and min. transmission  0.974 and 0.785  
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     Refinement    
Refinement method  Full-matrix least-squares on F^2  
Hydrogen treatment  :  
Data / restraints / parameters  7472 / 0 / 472  
Goodness-of-fit on F^2  1.037 
Final R indices [I>2sigma(I)]      R1 = 0.0290, wR2 = 0.0760  
R indices (all data)               R1 = 0.0314, wR2 = 0.0778  
Absolute structure parameter  -0.03(8)  
Largest diff. peak and hole  0.151 and -0.165 e.A^-3  
 
Table 2: Atomic coordinates (x 104) and equivalent isotropic displacement 
parameters (Å2 x 103) for 118. U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor. 
Atom x y z U(eq) 
O(1) -4200(2) 2228(1) 6214(1) 33(1)  
O(2) -9861(2) 3336(1) 6638(1) 34(1)  
O(3) -6875(1) 3984(1) 6620(1) 24(1)  
O(4) -4295(2) 2115(1) 7856(1) 33(1)  
O(5) -1040(2) 1773(1) 7479(1) 26(1)  
C(1) -6253(2) 2528(1) 6383(1) 27(1)  
C(2) -6247(2) 2512(1) 6918(1) 23(1)  
C(3) -4014(2) 2192(1) 7019(1) 22(1)  
C(4) -2954(2) 2063(1) 6606(1) 28(1)  
C(5) -5743(2) 3058(1) 6652(1) 24(1)  
C(6) -7754(2) 3468(1) 6639(1) 24(1)  
C(7) -8468(2) 4479(1) 6600(1) 24(1)  
C(8) -9827(3) 4529(1) 7067(1) 36(1)  
C(9) -6669(2) 4951(1) 6537(1) 34(1)  
C(10) -10152(2) 4445(1) 6173(1) 29(1)  
C(11) -3175(2) 2033(1) 7493(1) 22(1)  
C(12) -166(2) 1565(1) 7929(1) 32(1)  
O(6) 469(2) 3156(1) 7831(1) 35(1)  
O(7) -5065(2) 4316(1) 8208(1) 36(1)  
O(8) -2026(1) 4946(1) 8259(1) 24(1)  
O(9) 615(2) 3154(1) 9477(1) 36(1)  
O(10) 3777(2) 2770(1) 9099(1) 31(1)  
C(13) -1543(2) 3470(1) 7996(1) 29(1)  
C(14) -1499(2) 3475(1) 8530(1) 25(1)  
C(15) 729(2) 3155(1) 8635(1) 26(1)  
C(16) 1746(2) 3003(1) 8223(1) 31(1)  
C(17) -988(2) 4012(1) 8245(1) 25(1)  
C(18) -2951(2) 4430(1) 8234(1) 26(1)  
C(19) -3595(2) 5442(1) 8281(1) 24(1)  
C(20) -5127(3) 5423(1) 8727(1) 35(1)  
C(21) -1764(2) 5912(1) 8310(1) 31(1)  
C(22) -5093(3) 5492(1) 7830(1) 33(1)  
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C(23) 1642(2) 3035(1) 9111(1) 25(1)  
C(24) 4771(3) 2613(1) 9556(1) 35(1)  
O(11) 5396(2) 4191(1) 9454(1) 32(1)  
O(12) -347(2) 5278(1) 9864(1) 37(1)  
O(13) 2595(1) 5924(1) 9974(1) 24(1)  
O(14) 5321(2) 4037(1) 11094(1) 36(1)  
O(15) 8658(2) 3750(1) 10716(1) 31(1)  
C(25) 3311(2) 4473(1) 9627(1) 27(1)  
C(26) 3304(2) 4437(1) 10160(1) 25(1)  
C(27) 5567(2) 4127(1) 10257(1) 25(1)  
C(28) 6653(2) 4019(1) 9841(1) 28(1)  
C(29) 3758(2) 5000(1) 9908(1) 23(1)  
C(30) 1752(2) 5405(1) 9910(1) 25(1)  
C(31) 944(2) 6406(1) 10010(1) 25(1)  
C(32) -754(2) 6334(1) 10429(1) 33(1)  
C(33) 2685(3) 6884(1) 10095(1) 40(1)  
C(34) -400(3) 6485(1) 9545(1) 33(1)  
C(35) 6443(2) 3973(1) 10730(1) 25(1)  
C(36) 9618(2) 3570(1) 11169(1) 34(1)  
 
Table 3: Bond lengths [Å] and angles [deg] for 118. 
O(1)-C(1) 1.4279(15)  C(2)-C(5)-H(5) 118.00  
O(1)-C(4) 1.3591(14)  C(7)-C(8)-H(8B) 110.00  
O(2)-C(6) 1.2095(14)  H(8A)-C(8)-H(8B) 109.00  
O(3)-C(6) 1.3318(14)  H(8A)-C(8)-H(8C) 109.00  
O(3)-C(7) 1.4789(14)  C(7)-C(8)-H(8A) 109.00  
O(4)-C(11) 1.2085(14)  H(8B)-C(8)-H(8C) 109.00  
O(5)-C(11) 1.3382(14)  C(7)-C(8)-H(8C) 109.00  
O(5)-C(12) 1.4443(14)  C(7)-C(9)-H(9C) 110.00  
O(6)-C(13) 1.4229(15)  C(7)-C(9)-H(9B) 109.00  
O(6)-C(16) 1.3593(16)  H(9A)-C(9)-H(9B) 110.00  
O(7)-C(18) 1.2057(14)  H(9A)-C(9)-H(9C) 109.00  
O(8)-C(19) 1.4736(14)  C(7)-C(9)-H(9A) 109.00  
O(8)-C(18) 1.3409(14)  H(9B)-C(9)-H(9C) 109.00  
O(9)-C(23) 1.2101(14)  H(10A)-C(10)-H(10B) 109.00  
O(10)-C(24) 1.4460(17)  H(10A)-C(10)-H(10C) 109.00  
O(10)-C(23) 1.3436(15)  C(7)-C(10)-H(10C) 109.00  
O(11)-C(28) 1.3557(14)  C(7)-C(10)-H(10A) 110.00  
O(11)-C(25) 1.4238(15)  H(10B)-C(10)-H(10C) 109.00  
O(12)-C(30) 1.2091(14)  C(7)-C(10)-H(10B) 110.00  
O(13)-C(30) 1.3400(14)  H(12A)-C(12)-H(12C) 109.00  
O(13)-C(31) 1.4784(14)  H(12B)-C(12)-H(12C) 110.00  
O(14)-C(35) 1.2082(14)  O(5)-C(12)-H(12A) 109.00  
O(15)-C(36) 1.4459(16)  O(5)-C(12)-H(12B) 109.00  
O(15)-C(35) 1.3397(14)  H(12A)-C(12)-H(12B) 110.00  
C(1)-C(5) 1.5048(17)  O(5)-C(12)-H(12C) 109.00  
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C(1)-C(2) 1.5015(16)  C(14)-C(13)-C(17) 61.67(8)  
C(2)-C(5) 1.5332(17)  O(6)-C(13)-C(14) 108.53(9)  
C(2)-C(3) 1.4837(16)  O(6)-C(13)-C(17) 116.55(9)  
C(3)-C(11) 1.4607(16)  C(13)-C(14)-C(15) 102.08(9)  
C(3)-C(4) 1.3373(16)  C(13)-C(14)-C(17) 59.45(8)  
C(5)-C(6) 1.4855(16)  C(15)-C(14)-C(17) 112.48(9)  
C(7)-C(9) 1.5177(16)  C(14)-C(15)-C(16) 108.56(10)  
C(7)-C(8) 1.5183(18)  C(14)-C(15)-C(23) 125.10(10)  
C(7)-C(10) 1.5202(16)  C(16)-C(15)-C(23) 126.34(11)  
C(1)-H(1) 10.000 O(6)-C(16)-C(15) 114.07(10)  
C(2)-H(2) 10.000 C(13)-C(17)-C(14) 58.89(8)  
C(4)-H(4) 0.9500  C(13)-C(17)-C(18) 115.08(9)  
C(5)-H(5) 10.000 C(14)-C(17)-C(18) 116.18(9)  
C(8)-H(8C) 0.9800  O(7)-C(18)-O(8) 125.82(11)  
C(8)-H(8A) 0.9800  O(8)-C(18)-C(17) 110.02(9)  
C(8)-H(8B) 0.9800  O(7)-C(18)-C(17) 124.16(11)  
C(9)-H(9C) 0.9800  O(8)-C(19)-C(22) 110.60(9)  
C(9)-H(9B) 0.9800  O(8)-C(19)-C(21) 101.86(8)  
C(9)-H(9A) 0.9800  C(21)-C(19)-C(22) 110.72(10)  
C(10)-H(10B) 0.9800  C(20)-C(19)-C(21) 110.60(10)  
C(10)-H(10A) 0.9800  C(20)-C(19)-C(22) 112.69(11)  
C(10)-H(10C) 0.9800  O(8)-C(19)-C(20) 109.86(10)  
C(12)-H(12A) 0.9800  O(10)-C(23)-C(15) 112.19(10)  
C(12)-H(12B) 0.9800  O(9)-C(23)-O(10) 123.16(11)  
C(12)-H(12C) 0.9800  O(9)-C(23)-C(15) 124.65(11)  
C(13)-C(17) 1.5069(17)  O(6)-C(13)-H(13) 119.00  
C(13)-C(14) 1.4981(16)  C(14)-C(13)-H(13) 119.00  
C(14)-C(17) 1.5402(17)  C(17)-C(13)-H(13) 119.00  
C(14)-C(15) 1.4839(16)  C(13)-C(14)-H(14) 122.00  
C(15)-C(23) 1.4568(16)  C(17)-C(14)-H(14) 122.00  
C(15)-C(16) 1.3384(18)  C(15)-C(14)-H(14) 122.00  
C(17)-C(18) 1.4798(16)  O(6)-C(16)-H(16) 123.00  
C(19)-C(20) 1.5155(19)  C(15)-C(16)-H(16) 123.00  
C(19)-C(22) 1.5181(19)  C(14)-C(17)-H(17) 118.00  
C(19)-C(21) 1.5185(16)  C(13)-C(17)-H(17) 118.00  
C(13)-H(13) 10.000 C(18)-C(17)-H(17) 118.00  
C(14)-H(14) 10.000 C(19)-C(20)-H(20A) 109.00  
C(16)-H(16) 0.9500  C(19)-C(20)-H(20B) 109.00  
C(17)-H(17) 10.000 H(20B)-C(20)-H(20C) 109.00  
C(20)-H(20A) 0.9800  C(19)-C(20)-H(20C) 110.00  
C(20)-H(20B) 0.9800  H(20A)-C(20)-H(20B) 110.00  
C(20)-H(20C) 0.9800  H(20A)-C(20)-H(20C) 109.00  
C(21)-H(21A) 0.9800  C(19)-C(21)-H(21A) 109.00  
C(21)-H(21C) 0.9800  C(19)-C(21)-H(21B) 109.00  
C(21)-H(21B) 0.9800  C(19)-C(21)-H(21C) 109.00  
C(22)-H(22B) 0.9800  H(21B)-C(21)-H(21C) 109.00  
C(22)-H(22C) 0.9800  H(21A)-C(21)-H(21B) 109.00  
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C(22)-H(22A) 0.9800  H(21A)-C(21)-H(21C) 109.00  
C(24)-H(24B) 0.9800  C(19)-C(22)-H(22B) 109.00  
C(24)-H(24C) 0.9800  H(22A)-C(22)-H(22C) 110.00  
C(24)-H(24A) 0.9800  C(19)-C(22)-H(22C) 109.00  
C(25)-C(26) 1.4984(16)  H(22A)-C(22)-H(22B) 109.00  
C(25)-C(29) 1.5097(17)  C(19)-C(22)-H(22A) 109.00  
C(26)-C(27) 1.4829(16)  H(22B)-C(22)-H(22C) 110.00  
C(26)-C(29) 1.5440(17)  O(10)-C(24)-H(24C) 110.00  
C(27)-C(28) 1.3403(16)  H(24A)-C(24)-H(24C) 109.00  
C(27)-C(35) 1.4607(16)  H(24B)-C(24)-H(24C) 109.00  
C(29)-C(30) 1.4754(16)  H(24A)-C(24)-H(24B) 110.00  
C(31)-C(32) 1.5170(16)  O(10)-C(24)-H(24A) 109.00  
C(31)-C(33) 1.5163(19)  O(10)-C(24)-H(24B) 109.00  
C(31)-C(34) 1.5171(18)  O(11)-C(25)-C(26) 108.39(9)  
C(25)-H(25) 10.000 O(11)-C(25)-C(29) 116.21(9)  
C(26)-H(26) 10.000 C(26)-C(25)-C(29) 61.76(8)  
C(28)-H(28) 0.9500  C(25)-C(26)-C(27) 102.18(9)  
C(29)-H(29) 10.000 C(25)-C(26)-C(29) 59.48(8)  
C(32)-H(32A) 0.9800  C(27)-C(26)-C(29) 112.57(9)  
C(32)-H(32B) 0.9800  C(26)-C(27)-C(28) 108.42(10)  
C(32)-H(32C) 0.9800  C(26)-C(27)-C(35) 125.13(10)  
C(33)-H(33A) 0.9800  C(28)-C(27)-C(35) 126.45(11)  
C(33)-H(33B) 0.9800  O(11)-C(28)-C(27) 114.15(10)  
C(33)-H(33C) 0.9800  C(25)-C(29)-C(26) 58.76(7)  
C(34)-H(34A) 0.9800  C(25)-C(29)-C(30) 115.34(10)  
C(34)-H(34B) 0.9800  C(26)-C(29)-C(30) 116.73(9)  
C(34)-H(34C) 0.9800  O(12)-C(30)-O(13) 125.58(11)  
C(36)-H(36A) 0.9800  O(12)-C(30)-C(29) 124.08(11)  
C(36)-H(36B) 0.9800  O(13)-C(30)-C(29) 110.34(9)  
C(36)-H(36C) 0.9800  O(13)-C(31)-C(32) 110.40(10)  
C(1)-O(1)-C(4) 106.31(9)  O(13)-C(31)-C(33) 101.99(9)  
C(6)-O(3)-C(7) 121.86(9)  O(13)-C(31)-C(34) 109.95(10)  
C(11)-O(5)-C(12) 115.47(9)  C(32)-C(31)-C(33) 111.12(11)  
C(13)-O(6)-C(16) 106.66(9)  C(32)-C(31)-C(34) 112.23(10)  
C(18)-O(8)-C(19) 121.32(9)  C(33)-C(31)-C(34) 110.69(11)  
C(23)-O(10)-C(24) 115.93(10)  O(14)-C(35)-O(15) 123.22(11)  
C(25)-O(11)-C(28) 106.75(9)  O(14)-C(35)-C(27) 124.51(11)  
C(30)-O(13)-C(31) 121.28(9)  O(15)-C(35)-C(27) 112.27(10)  
C(35)-O(15)-C(36) 115.50(9)  O(11)-C(25)-H(25) 119.00  
C(2)-C(1)-C(5) 61.33(8)  C(26)-C(25)-H(25) 119.00  
O(1)-C(1)-C(2) 108.60(9)  C(29)-C(25)-H(25) 119.00  
O(1)-C(1)-C(5) 116.26(9)  C(25)-C(26)-H(26) 122.00  
C(3)-C(2)-C(5) 112.51(9)  C(27)-C(26)-H(26) 122.00  
C(1)-C(2)-C(5) 59.44(8)  C(29)-C(26)-H(26) 122.00  
C(1)-C(2)-C(3) 101.96(9)  O(11)-C(28)-H(28) 123.00  
C(2)-C(3)-C(4) 108.61(10)  C(27)-C(28)-H(28) 123.00  
C(4)-C(3)-C(11) 126.23(11)  C(25)-C(29)-H(29) 118.00  
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C(2)-C(3)-C(11) 125.14(10)  C(26)-C(29)-H(29) 118.00  
O(1)-C(4)-C(3) 114.41(10)  C(30)-C(29)-H(29) 118.00  
C(2)-C(5)-C(6) 116.02(9)  C(31)-C(32)-H(32A) 109.00  
C(1)-C(5)-C(6) 113.91(9)  C(31)-C(32)-H(32B) 109.00  
C(1)-C(5)-C(2) 59.23(8)  C(31)-C(32)-H(32C) 109.00  
O(2)-C(6)-O(3) 126.52(11)  H(32A)-C(32)-H(32B) 109.00  
O(2)-C(6)-C(5) 123.57(11)  H(32A)-C(32)-H(32C) 110.00  
O(3)-C(6)-C(5) 109.90(9)  H(32B)-C(32)-H(32C) 109.00  
C(8)-C(7)-C(9) 111.53(11)  C(31)-C(33)-H(33A) 109.00  
C(8)-C(7)-C(10) 112.35(10)  C(31)-C(33)-H(33B) 110.00  
C(9)-C(7)-C(10) 110.65(10)  C(31)-C(33)-H(33C) 109.00  
O(3)-C(7)-C(10) 110.76(9)  H(33A)-C(33)-H(33B) 109.00  
O(3)-C(7)-C(9) 102.05(8)  H(33A)-C(33)-H(33C) 110.00  
O(3)-C(7)-C(8) 109.02(10)  H(33B)-C(33)-H(33C) 109.00  
O(4)-C(11)-C(3) 124.20(11)  C(31)-C(34)-H(34A) 109.00  
O(5)-C(11)-C(3) 112.03(10)  C(31)-C(34)-H(34B) 109.00  
O(4)-C(11)-O(5) 123.76(11)  C(31)-C(34)-H(34C) 109.00  
C(5)-C(1)-H(1) 119.00  H(34A)-C(34)-H(34B) 110.00  
C(2)-C(1)-H(1) 119.00  H(34A)-C(34)-H(34C) 109.00  
O(1)-C(1)-H(1) 119.00  H(34B)-C(34)-H(34C) 110.00  
C(1)-C(2)-H(2) 122.00  O(15)-C(36)-H(36A) 109.00  
C(5)-C(2)-H(2) 122.00  O(15)-C(36)-H(36B) 109.00  
C(3)-C(2)-H(2) 122.00  O(15)-C(36)-H(36C) 109.00  
C(3)-C(4)-H(4) 123.00  H(36A)-C(36)-H(36B) 110.00  
O(1)-C(4)-H(4) 123.00  H(36A)-C(36)-H(36C) 109.00  
C(1)-C(5)-H(5) 118.00  H(36B)-C(36)-H(36C) 110.00  
C(6)-C(5)-H(5) 118.00  
   
Table 4: Anisotropic displacement parameters (A2 x 103) for 118 The anisotropic 
displacement factor exponent takes the form: -2 pi2 [ h2 a*2 U11 + .. + 2 h k a*b*U12]. 
Atom U11 U22 U33 U23 U13 U12 
O(1) 41(1) 35(1) 22(1) -1(1) 1(1) 10(1)  
O(2) 20(1) 30(1) 51(1) 8(1) -3(1) -1(1)  
O(3) 20(1) 22(1) 31(1) 2(1) -2(1) 1(1)  
O(4) 33(1) 42(1) 25(1) 3(1) 7(1) 13(1)  
O(5) 24(1) 29(1) 25(1) 3(1) 1(1) 7(1)  
C(1) 30(1) 27(1) 26(1) 0(1) -1(1) 1(1)  
C(2) 22(1) 22(1) 26(1) 3(1) 0(1) -1(1)  
C(3) 23(1) 19(1) 25(1) 2(1) 2(1) 1(1)  
C(4) 30(1) 25(1) 27(1) 1(1) 2(1) 6(1)  
C(5) 20(1) 23(1) 29(1) 4(1) 1(1) 0(1)  
C(6) 21(1) 24(1) 27(1) 4(1) -1(1) -1(1)  
C(7) 22(1) 22(1) 29(1) 0(1) 0(1) 3(1)  
C(8) 38(1) 41(1) 30(1) -5(1) 5(1) 4(1)  
C(9) 29(1) 24(1) 50(1) 1(1) -4(1) 1(1)  
C(10) 28(1) 30(1) 30(1) 3(1) -5(1) 4(1)  
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C(11) 23(1) 19(1) 25(1) 1(1) 2(1) 1(1)  
C(12) 30(1) 37(1) 28(1) 5(1) -4(1) 8(1)  
O(6) 45(1) 32(1) 29(1) -2(1) 5(1) 12(1)  
O(7) 21(1) 25(1) 63(1) 2(1) -2(1) -2(1)  
O(8) 19(1) 19(1) 34(1) 1(1) 1(1) 0(1)  
O(9) 37(1) 42(1) 30(1) 0(1) 9(1) 12(1)  
O(10) 28(1) 31(1) 33(1) 4(1) 5(1) 8(1)  
C(13) 31(1) 25(1) 32(1) -1(1) 2(1) 3(1)  
C(14) 24(1) 20(1) 31(1) 2(1) 4(1) 1(1)  
C(15) 25(1) 19(1) 32(1) 2(1) 7(1) 2(1)  
C(16) 35(1) 24(1) 33(1) 1(1) 7(1) 7(1)  
C(17) 22(1) 21(1) 32(1) 2(1) 3(1) 1(1)  
C(18) 23(1) 22(1) 32(1) 2(1) 1(1) -1(1)  
C(19) 24(1) 21(1) 27(1) 1(1) 1(1) 3(1)  
C(20) 35(1) 34(1) 35(1) 1(1) 11(1) 4(1)  
C(21) 30(1) 22(1) 42(1) -1(1) -1(1) -1(1)  
C(22) 36(1) 29(1) 34(1) 1(1) -8(1) 5(1)  
C(23) 25(1) 19(1) 32(1) 2(1) 6(1) 1(1)  
C(24) 33(1) 35(1) 37(1) 3(1) -5(1) 3(1)  
O(11) 40(1) 29(1) 26(1) -3(1) 5(1) 5(1)  
O(12) 19(1) 29(1) 63(1) 0(1) -1(1) -3(1)  
O(13) 20(1) 21(1) 29(1) -1(1) 2(1) 1(1)  
O(14) 39(1) 39(1) 30(1) 4(1) 11(1) 9(1)  
O(15) 27(1) 36(1) 32(1) 6(1) 5(1) 5(1)  
C(25) 29(1) 24(1) 29(1) -2(1) 1(1) -1(1)  
C(26) 25(1) 22(1) 29(1) 2(1) 6(1) 0(1)  
C(27) 25(1) 20(1) 31(1) 1(1) 6(1) 0(1)  
C(28) 32(1) 21(1) 31(1) 0(1) 5(1) 3(1)  
C(29) 21(1) 21(1) 28(1) 1(1) 3(1) 0(1)  
C(30) 23(1) 24(1) 27(1) 2(1) 3(1) -2(1)  
C(31) 24(1) 23(1) 27(1) -1(1) 0(1) 3(1)  
C(32) 30(1) 42(1) 26(1) -1(1) 4(1) 9(1)  
C(33) 31(1) 26(1) 62(1) -9(1) -1(1) 2(1)  
C(34) 39(1) 33(1) 28(1) 4(1) -2(1) 7(1)  
C(35) 27(1) 18(1) 29(1) 2(1) 5(1) -1(1)  
C(36) 32(1) 34(1) 34(1) 6(1) -2(1) 0(1)  
 
Table 5. Hydrogen coordinates (x 104) and isotropic displacement parameters (A2 x 
103) for 118. 
Atom                         x      y     z    U(eq)  
H(1) -7822 2489 6210 33 
H(2) -7761 2454 7105 28 
H(4) -1455 1872 6588 33 
H(5) -4054 3205 6651 29 
H(8A) -10663 4889 7079 44 
H(8B) -8686 4504 7333 44 
E. Appendix 
163 
H(8C) -11009 4226 7091 44 
H(9A) -5519 4947 6802 41 
H(9B) -7528 5308 6533 41 
H(9C) -5798 4902 6237 41 
H(10A) -11386 4161 6232 35 
H(10B) -10930 4808 6124 35 
H(10C) -9225 4345 5889 35 
H(12A) -283 1861 8170 38 
H(12B) -1144 1245 8028 38 
H(12C) 1521 1450 7896 38 
H(13) -3127 3428 7830 35 
H(14) -3002 3429 8723 30 
H(16) 3229 2805 8206 37 
H(17) 712 4151 8235 30 
H(20A) -5875 5788 8779 42 
H(20B) -4108 5328 9001 42 
H(20C) -6387 5139 8691 42 
H(21A) -754 5861 8593 37 
H(21B) -2610 6271 8332 37 
H(21C) -747 5909 8025 37 
H(22A) -6303 5193 7824 40 
H(22B) -5905 5855 7825 40 
H(22C) -4039 5458 7552 40 
H(24A) 4639 2928 9777 42 
H(24B) 3875 2293 9683 42 
H(24C) 6472 2511 9518 42 
H(25) 1753 4431 9451 33 
H(26) 1791 4363 10343 30 
H(28) 8171 3837 9819 34 
H(29) 5438 5151 9913 28 
H(32A) -1575 6688 10494 39 
H(32B) 169 6220 10711 39 
H(32C) -1953 6046 10354 39 
H(33A) 3582 6818 10390 48 
H(33B) 1783 7235 10121 48 
H(33C) 3817 6909 9827 48 
H(34A) -1537 6176 9500 40 
H(34B) -1286 6839 9553 40 
H(34C) 756 6490 9281 40 
H(36A) 9480 3875 11400 40 
H(36B) 8706 3246 11283 40 
H(36C) 11319 3468 11131 40 
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Table 6: Torsion angles [deg] for 118. 
C(4)-O(1)-C(1)-C(2) -2.75(12)  C(2)-C(5)-C(6)-O(3) 149.92(10)  
C(4)-O(1)-C(1)-C(5) 63.78(12)  C(2)-C(5)-C(6)-O(2) -31.37(17)  
C(1)-O(1)-C(4)-C(3) 3.55(14)  C(1)-C(5)-C(6)-O(2) 34.66(16)  
C(7)-O(3)-C(6)-C(5) 179.41(9)  C(14)-C(13)-C(17)-C(18) -106.65(11)  
C(7)-O(3)-C(6)-O(2) 0.75(18)  O(6)-C(13)-C(14)-C(15) 1.66(12)  
C(6)-O(3)-C(7)-C(10) -57.27(13)  O(6)-C(13)-C(17)-C(18) 155.64(10)  
C(6)-O(3)-C(7)-C(9) -175.08(10)  C(17)-C(13)-C(14)-C(15) -109.13(10)  
C(6)-O(3)-C(7)-C(8) 66.86(13)  O(6)-C(13)-C(14)-C(17) 110.79(10)  
C(12)-O(5)-C(11)-O(4) 2.87(16)  O(6)-C(13)-C(17)-C(14) -97.71(11)  
C(12)-O(5)-C(11)-C(3) -175.61(10)  C(13)-C(14)-C(15)-C(23) 179.89(11)  
C(16)-O(6)-C(13)-C(17) 63.83(12)  C(17)-C(14)-C(15)-C(16) -61.32(13)  
C(13)-O(6)-C(16)-C(15) 3.53(14)  C(15)-C(14)-C(17)-C(13) 91.07(10)  
C(16)-O(6)-C(13)-C(14) -3.09(12)  C(13)-C(14)-C(15)-C(16) 0.38(13)  
C(18)-O(8)-C(19)-C(22) -62.85(13)  C(13)-C(14)-C(17)-C(18) 104.77(11)  
C(18)-O(8)-C(19)-C(20) 62.17(13)  C(17)-C(14)-C(15)-C(23) 118.19(12)  
C(18)-O(8)-C(19)-C(21) 179.44(10)  C(15)-C(14)-C(17)-C(18) -164.16(10)  
C(19)-O(8)-C(18)-C(17) -176.72(9)  C(23)-C(15)-C(16)-O(6) 178.03(11)  
C(19)-O(8)-C(18)-O(7) 2.95(18)  C(16)-C(15)-C(23)-O(10) 3.57(17)  
C(24)-O(10)-C(23)-C(15) -177.54(10)  C(14)-C(15)-C(23)-O(10) -175.85(11)  
C(24)-O(10)-C(23)-O(9) 2.13(17)  C(16)-C(15)-C(23)-O(9) -176.10(12)  
C(28)-O(11)-C(25)-C(26) -2.84(12)  C(14)-C(15)-C(16)-O(6) -2.48(14)  
C(25)-O(11)-C(28)-C(27) 3.53(14)  C(14)-C(15)-C(23)-O(9) 4.5(2)  
C(28)-O(11)-C(25)-C(29) 64.07(12)  C(13)-C(17)-C(18)-O(7) 28.09(17)  
C(30)-O(13)-C(31)-C(33) 178.15(11)  C(14)-C(17)-C(18)-O(8) 141.70(10)  
C(30)-O(13)-C(31)-C(32) 59.99(13)  C(14)-C(17)-C(18)-O(7) -37.98(17)  
C(31)-O(13)-C(30)-O(12) 2.18(18)  C(13)-C(17)-C(18)-O(8) -152.23(10)  
C(30)-O(13)-C(31)-C(34) -64.38(13)  O(11)-C(25)-C(26)-C(29) 110.47(10)  
C(31)-O(13)-C(30)-C(29) -177.35(9)  C(29)-C(25)-C(26)-C(27) -109.18(10)  
C(36)-O(15)-C(35)-O(14) 1.94(17)  O(11)-C(25)-C(29)-C(26) -97.75(11)  
C(36)-O(15)-C(35)-C(27) -178.13(10)  O(11)-C(25)-C(26)-C(27) 1.30(12)  
O(1)-C(1)-C(2)-C(5) 110.37(10)  C(26)-C(25)-C(29)-C(30) -107.15(11)  
O(1)-C(1)-C(2)-C(3) 1.14(12)  O(11)-C(25)-C(29)-C(30) 155.11(10)  
C(2)-C(1)-C(5)-C(6) -107.12(11)  C(25)-C(26)-C(27)-C(35) -179.61(11)  
C(5)-C(1)-C(2)-C(3) -109.23(10)  C(29)-C(26)-C(27)-C(28) -61.04(13)  
O(1)-C(1)-C(5)-C(2) -97.79(11)  C(25)-C(26)-C(27)-C(28) 0.73(13)  
O(1)-C(1)-C(5)-C(6) 155.09(10)  C(29)-C(26)-C(27)-C(35) 118.62(12)  
C(1)-C(2)-C(3)-C(11) -177.41(11)  C(25)-C(26)-C(29)-C(30) 104.78(11)  
C(5)-C(2)-C(3)-C(4) -60.75(13)  C(27)-C(26)-C(29)-C(30) -164.06(10)  
C(1)-C(2)-C(5)-C(6) 103.55(11)  C(27)-C(26)-C(29)-C(25) 91.16(10)  
C(3)-C(2)-C(5)-C(1) 90.91(10)  C(26)-C(27)-C(35)-O(15) -173.17(11)  
C(1)-C(2)-C(3)-C(4) 0.91(13)  C(26)-C(27)-C(28)-O(11) -2.71(14)  
C(3)-C(2)-C(5)-C(6) -165.54(10)  C(35)-C(27)-C(28)-O(11) 177.64(11)  
C(5)-C(2)-C(3)-C(11) 120.93(12)  C(28)-C(27)-C(35)-O(14) -173.64(12)  
C(2)-C(3)-C(4)-O(1) -2.86(14)  C(28)-C(27)-C(35)-O(15) 6.43(18)  
C(11)-C(3)-C(4)-O(1) 175.44(11)  C(26)-C(27)-C(35)-O(14) 6.8(2)  
C(2)-C(3)-C(11)-O(4) 4.94(19)  C(25)-C(29)-C(30)-O(12) 27.64(17)  
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C(2)-C(3)-C(11)-O(5) -176.58(10)  C(25)-C(29)-C(30)-O(13) -152.82(10)  
C(4)-C(3)-C(11)-O(4) -173.08(12)  C(26)-C(29)-C(30)-O(12) -38.53(17)  
C(4)-C(3)-C(11)-O(5) 5.39(17)  C(26)-C(29)-C(30)-O(13) 141.00(10)  
C(1)-C(5)-C(6)-O(3) -144.05(10)  
   
Table 7: Hydrogen-bonds for 118 [Å and deg.]. 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA)  
 C(5)-H(5)...O(2)#1 10.000 23.500  3.3286(14)  167.00  
 C(8)-H(8C)...O(2)  0.9800 25.600  3.1007(17)  115.00  
 C(9)-H(9B)...O(14)#2  0.9800 25.300  3.3948(15)  148.00  
 C(10)-H(10A)...O(2)  0.9800 24.300  2.9643(15)  114.00  
 C(16)-H(16)...O(4)#1  0.9500 23.600  3.2267(15)  151.00  
 C(17)-H(17)...O(7)#1 10.000 23.800  3.3650(14)  170.00  
 C(20)-H(20C)...O(7)  0.9800 25.000  3.0280(17)  113.00  
 C(22)-H(22A)...O(7)  0.9800 24.600  3.0107(16)  115.00  
 C(26)-H(26)...O(15)#3 10.000 25.000  3.4325(14)  154.00  
 C(28)-H(28)...O(9)#1  0.9500 23.300  3.1870(15)  150.00  
 C(29)-H(29)...O(12)#1 10.000 23.600  3.3379(14)  166.00  
 C(32)-H(32C)...O(12)  0.9800 24.600  2.9941(17)  114.00  
 C(34)-H(34A)...O(12)  0.9800 24.700  3.0273(17)  116.00  
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(1S,4R,5S,6S)-tert-butyl 4-(hydroxymethyl)-2-oxabicyclo[3.1.0]hexane-6-
carboxylate (140) 
 
 
Table 1: Crystal data and structure refinement for 140. 
      Crystal Data    
Empirical formula  C11 H18 O4  
Formula weight  214.25  
Crystal size  0.2203 x 0.0587 x 0.0207 mm  
Crystal description  stick  
Crystal colour  colourless  
Crystal system Triclinic  
Space group  P 1  
Unit cell dimensions               a = 5.6783(3) A   alpha = 91.884(4) deg.  
                                         b = 9.1467(5) A    beta = 92.675(4) deg.  
                                         c = 22.1094(11) A   gamma = 91.532(4) deg.  
Volume  1145.98(10) A^3  
Z, Calculated density  4,  1.242 Mg/m^3  
Absorption coefficient  0.774 mm^-1  
F(000)  464 
   
       Data Collection    
Measurement device type  SuperNova, Single source at offset, Atlas  
Measurement method  \w scans  
Temperature  123 K  
Wavelength  1.54184 A  
Monochromator   graphite  
Theta range for data collection  4.01 to 75.40 deg.  
Index ranges  =-7<=h<=6 -11<=k<=11 -21<=l<=27 
Reflections collected / unique  7732 / 5280 [R(int) = 0.0338]  
Reflections greater I>2\s(I) 4987 
Absorption correction  Analytical  
Max. and min. transmission  0.984 and 0.922  
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      Refinement    
Refinement method  Full-matrix least-squares on F^2  
Hydrogen treatment  :  
Data / restraints / parameters  5280 / 3 / 542  
Goodness-of-fit on F^2  1.030 
Final R indices [I>2sigma(I)]      R1 = 0.0554, wR2 = 0.1472  
R indices (all data)               R1 = 0.0579, wR2 = 0.1518  
Absolute structure parameter  0.2(2)  
Largest diff. peak and hole  0.330 and -0.313 e.A^-3  
 
Table 2: Atomic coordinates (x 104) and equivalent isotropic displacement 
parameters (Å2 x 103) for 140. U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor. 
Atom    x    y     z  U(eq)  
O(1) 9415(5) 3089(3) -2071(1) 43(1)  
O(2) 7308(5) -1462(3) -1910(1) 35(1)  
O(3) 4243(4) -783(3) -2522(1) 32(1)  
O(4) 4678(5) 4803(3) -689(1) 42(1)  
C(1) 7856(7) 3963(4) -1717(2) 38(1)  
C(2) 7304(6) 3065(4) -1161(2) 31(1)  
C(3) 7663(6) 1505(4) -1381(1) 28(1)  
C(4) 8984(6) 1626(4) -1942(2) 33(1)  
C(5) 6419(6) 1049(4) -1993(1) 28(1)  
C(6) 6071(6) -535(4) -2128(2) 29(1)  
C(7) 3507(6) -2285(4) -2742(2) 32(1)  
C(8) 1546(7) -1951(4) -3210(2) 41(1)  
C(9) 5511(7) -3031(4) -3050(2) 39(1)  
C(10) 2590(7) -3147(4) -2233(2) 39(1)  
C(11) 4894(6) 3355(4) -920(2) 34(1)  
O(5) 7819(4) 4535(3) 381(1) 29(1)  
O(6) 13057(4) 1215(3) 336(1) 33(1)  
O(7) 10021(4) -263(2) -36(1) 26(1)  
O(8) 7770(4) 1621(3) 2128(1) 31(1)  
C(12) 6309(6) 4244(4) 871(2) 28(1)  
C(13) 7809(6) 3499(3) 1361(1) 26(1)  
C(14) 9806(5) 2886(3) 1014(1) 24(1)  
C(15) 9714(6) 3575(3) 417(1) 26(1)  
C(16) 9111(5) 1942(3) 444(1) 25(1)  
C(17) 10960(6) 939(3) 247(1) 25(1)  
C(18) 11543(6) -1471(3) -236(2) 27(1)  
C(19) 9739(7) -2591(4) -505(2) 37(1)  
C(20) 12853(8) -2069(4) 311(2) 42(1)  
C(21) 13165(7) -954(4) -714(2) 36(1)  
C(22) 6366(5) 2383(3) 1690(1) 26(1)  
O(9) 3928(4) -4480(3) 2240(1) 31(1)  
O(10) 9350(4) -2677(3) 3455(1) 38(1)  
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O(11) 6498(4) -2516(3) 4136(1) 28(1)  
O(12) 591(5) -562(3) 1731(1) 41(1)  
C(23) 2372(6) -3342(4) 2039(2) 28(1)  
C(24) 3852(6) -1925(4) 2047(2) 30(1)  
C(25) 5915(6) -2210(4) 2488(2) 30(1)  
C(26) 5849(6) -3803(4) 2573(2) 29(1)  
C(27) 5329(5) -2797(3) 3112(1) 26(1)  
C(28) 7297(6) -2635(4) 3581(2) 28(1)  
C(29) 8160(6) -2334(4) 4674(2) 31(1)  
C(30) 9568(8) -3707(4) 4753(2) 41(1)  
C(31) 6472(8) -2134(6) 5184(2) 52(1)  
C(32) 9746(7) -991(4) 4621(2) 40(1)  
C(33) 2401(6) -618(4) 2193(2) 33(1)  
O(13) 6131(5) -8447(3) 4054(1) 41(1)  
O(14) 3798(4) -5847(3) 5575(1) 33(1)  
O(15) 971(4) -7649(3) 5567(1) 28(1)  
O(16) 1053(5) -6605(3) 2724(1) 38(1)  
C(34) 4518(7) -8206(4) 3549(2) 36(1)  
C(35) 3774(6) -6611(4) 3609(2) 30(1)  
C(36) 4141(6) -6276(3) 4284(2) 27(1)  
C(37) 5619(6) -7456(4) 4521(2) 32(1)  
C(38) 3042(6) -7381(3) 4696(2) 28(1)  
C(39) 2676(6) -6848(3) 5323(2) 27(1)  
C(40) 339(6) -7386(4) 6201(1) 28(1)  
C(41) 2434(6) -7614(4) 6632(2) 34(1)  
C(42) -1587(6) -8558(4) 6269(2) 34(1)  
C(43) -639(6) -5873(4) 6279(2) 36(1)  
C(44) 1288(7) -6330(4) 3363(2) 33(1)  
 
Table 3: Bond lengths [Å] and angles [deg] for 140. 
O(1)-C(1) 1.449(5)  H(10B)-C(10)-H(10C) 109.00  
O(1)-C(4) 1.395(5)  H(10A)-C(10)-H(10B) 110.00  
O(2)-C(6) 1.213(4)  H(10A)-C(10)-H(10C) 109.00  
O(3)-C(6) 1.334(4)  C(7)-C(10)-H(10B) 109.00  
O(3)-C(7) 1.485(5)  C(7)-C(10)-H(10C) 109.00  
O(4)-C(11) 1.414(5)  C(7)-C(10)-H(10A) 109.00  
O(4)-H(4O) 0.8400  C(2)-C(11)-H(11B) 109.00  
O(5)-C(15) 1.408(4)  H(11A)-C(11)-H(11B) 108.00  
O(5)-C(12) 1.441(4)  O(4)-C(11)-H(11B) 109.00  
O(6)-C(17) 1.216(4)  O(4)-C(11)-H(11A) 109.00  
O(7)-C(17) 1.333(4)  C(2)-C(11)-H(11A) 109.00  
O(7)-C(18) 1.489(4)  O(5)-C(12)-C(13) 107.1(3)  
O(8)-C(22) 1.435(4)  C(12)-C(13)-C(22) 111.7(3)  
O(8)-H(8O) 0.8400  C(14)-C(13)-C(22) 115.3(2)  
O(9)-C(23) 1.450(4)  C(12)-C(13)-C(14) 103.1(2)  
O(9)-C(26) 1.405(4)  C(13)-C(14)-C(15) 106.7(2)  
O(10)-C(28) 1.213(4)  C(15)-C(14)-C(16) 60.85(19)  
E. Appendix 
169 
O(11)-C(28) 1.330(4)  C(13)-C(14)-C(16) 116.5(2)  
O(11)-C(29) 1.486(4)  O(5)-C(15)-C(16) 117.3(3)  
O(12)-C(33) 1.418(5)  C(14)-C(15)-C(16) 61.33(19)  
O(12)-H(12O) 0.8400  O(5)-C(15)-C(14) 109.9(3)  
O(13)-C(37) 1.397(4)  C(14)-C(16)-C(15) 57.83(19)  
O(13)-C(34) 1.437(5)  C(14)-C(16)-C(17) 114.5(2)  
O(14)-C(39) 1.207(4)  C(15)-C(16)-C(17) 115.9(3)  
O(15)-C(39) 1.343(4)  O(6)-C(17)-C(16) 122.9(3)  
O(15)-C(40) 1.478(4)  O(7)-C(17)-C(16) 111.5(3)  
O(16)-C(44) 1.426(4)  O(6)-C(17)-O(7) 125.7(3)  
O(16)-H(16O) 0.8400  O(7)-C(18)-C(20) 109.4(3)  
C(1)-C(2) 1.540(5)  C(19)-C(18)-C(21) 110.7(3)  
C(2)-C(11) 1.518(5)  C(19)-C(18)-C(20) 110.6(3)  
C(2)-C(3) 1.515(5)  O(7)-C(18)-C(19) 102.0(3)  
C(3)-C(5) 1.537(5)  O(7)-C(18)-C(21) 110.5(2)  
C(3)-C(4) 1.485(5)  C(20)-C(18)-C(21) 113.1(3)  
C(4)-C(5) 1.534(5)  O(8)-C(22)-C(13) 112.3(2)  
C(5)-C(6) 1.476(5)  O(5)-C(12)-H(12B) 110.00  
C(7)-C(9) 1.519(5)  C(13)-C(12)-H(12B) 110.00  
C(7)-C(10) 1.501(6)  O(5)-C(12)-H(12A) 110.00  
C(7)-C(8) 1.528(5)  C(13)-C(12)-H(12A) 110.00  
C(1)-H(1A) 0.9900  H(12A)-C(12)-H(12B) 109.00  
C(1)-H(1B) 0.9900  C(12)-C(13)-H(13) 109.00  
C(2)-H(2) 10.000 C(22)-C(13)-H(13) 109.00  
C(3)-H(3) 10.000 C(14)-C(13)-H(13) 109.00  
C(4)-H(4) 10.000 C(16)-C(14)-H(14) 119.00  
C(5)-H(5) 10.000 C(13)-C(14)-H(14) 119.00  
C(8)-H(8B) 0.9800  C(15)-C(14)-H(14) 119.00  
C(8)-H(8A) 0.9800  C(16)-C(15)-H(15) 118.00  
C(8)-H(8C) 0.9800  O(5)-C(15)-H(15) 118.00  
C(9)-H(9C) 0.9800  C(14)-C(15)-H(15) 118.00  
C(9)-H(9B) 0.9800  C(17)-C(16)-H(16) 118.00  
C(9)-H(9A) 0.9800  C(14)-C(16)-H(16) 118.00  
C(10)-H(10A) 0.9800  C(15)-C(16)-H(16) 118.00  
C(10)-H(10B) 0.9800  C(18)-C(19)-H(19A) 109.00  
C(10)-H(10C) 0.9800  C(18)-C(19)-H(19C) 109.00  
C(11)-H(11A) 0.9900  C(18)-C(19)-H(19B) 109.00  
C(11)-H(11B) 0.9900  H(19A)-C(19)-H(19B) 109.00  
C(12)-C(13) 1.536(5)  H(19A)-C(19)-H(19C) 109.00  
C(13)-C(22) 1.517(4)  H(19B)-C(19)-H(19C) 109.00  
C(13)-C(14) 1.509(4)  C(18)-C(20)-H(20B) 109.00  
C(14)-C(16) 1.534(4)  C(18)-C(20)-H(20A) 109.00  
C(14)-C(15) 1.480(4)  H(20A)-C(20)-H(20C) 110.00  
C(15)-C(16) 1.527(4)  H(20A)-C(20)-H(20B) 109.00  
C(16)-C(17) 1.484(4)  C(18)-C(20)-H(20C) 109.00  
C(18)-C(19) 1.517(5)  H(20B)-C(20)-H(20C) 109.00  
C(18)-C(21) 1.514(5)  C(18)-C(21)-H(21C) 109.00  
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C(18)-C(20) 1.515(5)  H(21A)-C(21)-H(21B) 110.00  
C(12)-H(12A) 0.9900  C(18)-C(21)-H(21B) 110.00  
C(12)-H(12B) 0.9900  H(21B)-C(21)-H(21C) 109.00  
C(13)-H(13) 10.000 H(21A)-C(21)-H(21C) 109.00  
C(14)-H(14) 10.000 C(18)-C(21)-H(21A) 109.00  
C(15)-H(15) 10.000 H(22A)-C(22)-H(22B) 108.00  
C(16)-H(16) 10.000 O(8)-C(22)-H(22B) 109.00  
C(19)-H(19C) 0.9800  C(13)-C(22)-H(22B) 109.00  
C(19)-H(19B) 0.9800  C(13)-C(22)-H(22A) 109.00  
C(19)-H(19A) 0.9800  O(8)-C(22)-H(22A) 109.00  
C(20)-H(20C) 0.9800  O(9)-C(23)-C(24) 106.9(3)  
C(20)-H(20B) 0.9800  C(25)-C(24)-C(33) 116.5(3)  
C(20)-H(20A) 0.9800  C(23)-C(24)-C(25) 103.6(3)  
C(21)-H(21B) 0.9800  C(23)-C(24)-C(33) 111.4(3)  
C(21)-H(21A) 0.9800  C(26)-C(25)-C(27) 60.7(2)  
C(21)-H(21C) 0.9800  C(24)-C(25)-C(27) 117.3(3)  
C(22)-H(22A) 0.9900  C(24)-C(25)-C(26) 105.6(3)  
C(22)-H(22B) 0.9900  O(9)-C(26)-C(25) 110.9(3)  
C(23)-C(24) 1.525(5)  O(9)-C(26)-C(27) 118.0(3)  
C(24)-C(33) 1.505(5)  C(25)-C(26)-C(27) 61.9(2)  
C(24)-C(25) 1.523(5)  C(25)-C(27)-C(26) 57.4(2)  
C(25)-C(27) 1.544(5)  C(25)-C(27)-C(28) 114.5(3)  
C(25)-C(26) 1.475(5)  C(26)-C(27)-C(28) 114.2(3)  
C(26)-C(27) 1.526(5)  O(10)-C(28)-C(27) 122.3(3)  
C(27)-C(28) 1.491(4)  O(11)-C(28)-C(27) 111.6(3)  
C(29)-C(31) 1.522(6)  O(10)-C(28)-O(11) 126.1(3)  
C(29)-C(30) 1.517(5)  O(11)-C(29)-C(31) 101.6(3)  
C(29)-C(32) 1.515(5)  C(31)-C(29)-C(32) 111.4(3)  
C(23)-H(23B) 0.9900  C(30)-C(29)-C(32) 111.8(3)  
C(23)-H(23A) 0.9900  C(30)-C(29)-C(31) 111.0(3)  
C(24)-H(24) 10.000 O(11)-C(29)-C(30) 110.1(3)  
C(25)-H(25) 10.000 O(11)-C(29)-C(32) 110.5(3)  
C(26)-H(26) 10.000 O(12)-C(33)-C(24) 107.1(3)  
C(27)-H(27) 10.000 O(9)-C(23)-H(23B) 110.00  
C(30)-H(30C) 0.9800  H(23A)-C(23)-H(23B) 109.00  
C(30)-H(30B) 0.9800  C(24)-C(23)-H(23A) 110.00  
C(30)-H(30A) 0.9800  O(9)-C(23)-H(23A) 110.00  
C(31)-H(31A) 0.9800  C(24)-C(23)-H(23B) 110.00  
C(31)-H(31B) 0.9800  C(25)-C(24)-H(24) 108.00  
C(31)-H(31C) 0.9800  C(33)-C(24)-H(24) 108.00  
C(32)-H(32B) 0.9800  C(23)-C(24)-H(24) 108.00  
C(32)-H(32C) 0.9800  C(24)-C(25)-H(25) 119.00  
C(32)-H(32A) 0.9800  C(27)-C(25)-H(25) 119.00  
C(33)-H(33B) 0.9900  C(26)-C(25)-H(25) 119.00  
C(33)-H(33A) 0.9900  C(27)-C(26)-H(26) 118.00  
C(34)-C(35) 1.533(5)  O(9)-C(26)-H(26) 118.00  
C(35)-C(36) 1.517(5)  C(25)-C(26)-H(26) 118.00  
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C(35)-C(44) 1.521(5)  C(25)-C(27)-H(27) 119.00  
C(36)-C(38) 1.524(4)  C(26)-C(27)-H(27) 119.00  
C(36)-C(37) 1.479(5)  C(28)-C(27)-H(27) 119.00  
C(37)-C(38) 1.534(5)  C(29)-C(30)-H(30A) 109.00  
C(38)-C(39) 1.479(5)  H(30A)-C(30)-H(30C) 110.00  
C(40)-C(42) 1.527(5)  H(30B)-C(30)-H(30C) 109.00  
C(40)-C(43) 1.512(5)  H(30A)-C(30)-H(30B) 109.00  
C(40)-C(41) 1.512(5)  C(29)-C(30)-H(30C) 109.00  
C(34)-H(34A) 0.9900  C(29)-C(30)-H(30B) 109.00  
C(34)-H(34B) 0.9900  C(29)-C(31)-H(31A) 109.00  
C(35)-H(35) 10.000 C(29)-C(31)-H(31B) 110.00  
C(36)-H(36) 10.000 H(31B)-C(31)-H(31C) 109.00  
C(37)-H(37) 10.000 H(31A)-C(31)-H(31B) 110.00  
C(38)-H(38) 10.000 C(29)-C(31)-H(31C) 109.00  
C(41)-H(41A) 0.9800  H(31A)-C(31)-H(31C) 109.00  
C(41)-H(41B) 0.9800  C(29)-C(32)-H(32A) 109.00  
C(41)-H(41C) 0.9800  C(29)-C(32)-H(32B) 109.00  
C(42)-H(42A) 0.9800  C(29)-C(32)-H(32C) 110.00  
C(42)-H(42B) 0.9800  H(32A)-C(32)-H(32B) 109.00  
C(42)-H(42C) 0.9800  H(32A)-C(32)-H(32C) 109.00  
C(43)-H(43A) 0.9800  H(32B)-C(32)-H(32C) 110.00  
C(43)-H(43B) 0.9800  O(12)-C(33)-H(33B) 110.00  
C(43)-H(43C) 0.9800  H(33A)-C(33)-H(33B) 109.00  
C(44)-H(44A) 0.9900  C(24)-C(33)-H(33A) 110.00  
C(44)-H(44B) 0.9900  C(24)-C(33)-H(33B) 110.00  
C(1)-O(1)-C(4) 107.5(3)  O(12)-C(33)-H(33A) 110.00  
C(6)-O(3)-C(7) 121.9(3)  O(13)-C(34)-C(35) 106.7(3)  
C(11)-O(4)-H(4O) 109.00  C(34)-C(35)-C(44) 114.9(3)  
C(12)-O(5)-C(15) 108.2(3)  C(36)-C(35)-C(44) 113.5(3)  
C(17)-O(7)-C(18) 120.8(2)  C(34)-C(35)-C(36) 102.6(3)  
C(22)-O(8)-H(8O) 109.00  C(35)-C(36)-C(37) 105.7(3)  
C(23)-O(9)-C(26) 107.8(3)  C(37)-C(36)-C(38) 61.4(2)  
C(28)-O(11)-C(29) 120.7(3)  C(35)-C(36)-C(38) 115.8(3)  
C(33)-O(12)-H(12O) 109.00  O(13)-C(37)-C(36) 110.5(3)  
C(34)-O(13)-C(37) 107.6(3)  C(36)-C(37)-C(38) 60.7(2)  
C(39)-O(15)-C(40) 121.3(3)  O(13)-C(37)-C(38) 117.4(3)  
C(44)-O(16)-H(16O) 110.00  C(36)-C(38)-C(39) 115.9(2)  
O(1)-C(1)-C(2) 106.2(3)  C(37)-C(38)-C(39) 115.7(3)  
C(3)-C(2)-C(11) 115.2(3)  C(36)-C(38)-C(37) 57.9(2)  
C(1)-C(2)-C(11) 113.4(3)  O(14)-C(39)-C(38) 124.0(3)  
C(1)-C(2)-C(3) 103.1(3)  O(15)-C(39)-C(38) 110.4(3)  
C(4)-C(3)-C(5) 61.0(2)  O(14)-C(39)-O(15) 125.6(3)  
C(2)-C(3)-C(5) 115.8(3)  O(15)-C(40)-C(42) 101.9(3)  
C(2)-C(3)-C(4) 105.5(3)  O(15)-C(40)-C(43) 109.9(3)  
O(1)-C(4)-C(3) 110.9(3)  C(41)-C(40)-C(42) 111.1(3)  
O(1)-C(4)-C(5) 117.7(3)  C(41)-C(40)-C(43) 112.1(3)  
C(3)-C(4)-C(5) 61.2(2)  C(42)-C(40)-C(43) 110.7(3)  
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C(4)-C(5)-C(6) 116.1(3)  O(15)-C(40)-C(41) 110.7(3)  
C(3)-C(5)-C(4) 57.8(2)  O(16)-C(44)-C(35) 111.5(3)  
C(3)-C(5)-C(6) 116.9(3)  O(13)-C(34)-H(34A) 110.00  
O(3)-C(6)-C(5) 110.4(3)  O(13)-C(34)-H(34B) 110.00  
O(2)-C(6)-C(5) 123.9(3)  C(35)-C(34)-H(34A) 110.00  
O(2)-C(6)-O(3) 125.7(3)  C(35)-C(34)-H(34B) 110.00  
C(8)-C(7)-C(10) 111.8(3)  H(34A)-C(34)-H(34B) 109.00  
C(8)-C(7)-C(9) 110.1(3)  C(34)-C(35)-H(35) 108.00  
O(3)-C(7)-C(9) 110.7(3)  C(36)-C(35)-H(35) 109.00  
C(9)-C(7)-C(10) 112.6(3)  C(44)-C(35)-H(35) 109.00  
O(3)-C(7)-C(10) 110.3(3)  C(35)-C(36)-H(36) 120.00  
O(3)-C(7)-C(8) 100.8(3)  C(37)-C(36)-H(36) 120.00  
O(4)-C(11)-C(2) 113.3(3)  C(38)-C(36)-H(36) 120.00  
O(1)-C(1)-H(1B) 111.00  O(13)-C(37)-H(37) 118.00  
C(2)-C(1)-H(1B) 110.00  C(36)-C(37)-H(37) 118.00  
O(1)-C(1)-H(1A) 110.00  C(38)-C(37)-H(37) 118.00  
H(1A)-C(1)-H(1B) 109.00  C(36)-C(38)-H(38) 118.00  
C(2)-C(1)-H(1A) 111.00  C(37)-C(38)-H(38) 118.00  
C(11)-C(2)-H(2) 108.00  C(39)-C(38)-H(38) 118.00  
C(3)-C(2)-H(2) 108.00  C(40)-C(41)-H(41A) 109.00  
C(1)-C(2)-H(2) 108.00  C(40)-C(41)-H(41B) 109.00  
C(5)-C(3)-H(3) 120.00  C(40)-C(41)-H(41C) 109.00  
C(2)-C(3)-H(3) 120.00  H(41A)-C(41)-H(41B) 110.00  
C(4)-C(3)-H(3) 120.00  H(41A)-C(41)-H(41C) 109.00  
O(1)-C(4)-H(4) 118.00  H(41B)-C(41)-H(41C) 109.00  
C(3)-C(4)-H(4) 118.00  C(40)-C(42)-H(42A) 109.00  
C(5)-C(4)-H(4) 118.00  C(40)-C(42)-H(42B) 109.00  
C(6)-C(5)-H(5) 117.00  C(40)-C(42)-H(42C) 109.00  
C(4)-C(5)-H(5) 118.00  H(42A)-C(42)-H(42B) 110.00  
C(3)-C(5)-H(5) 118.00  H(42A)-C(42)-H(42C) 109.00  
C(7)-C(8)-H(8B) 109.00  H(42B)-C(42)-H(42C) 109.00  
C(7)-C(8)-H(8C) 109.00  C(40)-C(43)-H(43A) 109.00  
H(8A)-C(8)-H(8C) 110.00  C(40)-C(43)-H(43B) 109.00  
H(8A)-C(8)-H(8B) 109.00  C(40)-C(43)-H(43C) 109.00  
H(8B)-C(8)-H(8C) 109.00  H(43A)-C(43)-H(43B) 109.00  
C(7)-C(8)-H(8A) 109.00  H(43A)-C(43)-H(43C) 109.00  
C(7)-C(9)-H(9B) 109.00  H(43B)-C(43)-H(43C) 110.00  
C(7)-C(9)-H(9C) 109.00  O(16)-C(44)-H(44A) 109.00  
H(9A)-C(9)-H(9C) 109.00  O(16)-C(44)-H(44B) 109.00  
H(9A)-C(9)-H(9B) 110.00  C(35)-C(44)-H(44A) 109.00  
H(9B)-C(9)-H(9C) 109.00  C(35)-C(44)-H(44B) 109.00  
C(7)-C(9)-H(9A) 110.00  H(44A)-C(44)-H(44B) 108.00  
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Table 4: Anisotropic displacement parameters (A2 x 103) for 140. The anisotropic 
displacement factor exponent takes the form: -2 pi2 [ h2 a*2 U11 + .. + 2 h k a*b*U12]. 
Atom             U11   U22   U33    U23    U13  U12  
O(1) 50(2) 43(1) 35(1) -5(1) 19(1) -16(1)  
O(2) 33(1) 38(1) 36(1) 1(1) 1(1) 9(1)  
O(3) 27(1) 29(1) 39(1) -2(1) -3(1) 0(1)  
O(4) 45(2) 39(1) 43(2) -6(1) -1(1) 8(1)  
C(1) 46(2) 35(2) 34(2) -3(1) 8(2) -9(2)  
C(2) 31(2) 34(2) 27(2) -3(1) 3(1) -2(1)  
C(3) 25(2) 35(2) 24(2) -1(1) 2(1) -3(1)  
C(4) 28(2) 41(2) 29(2) -5(1) 7(1) -6(1)  
C(5) 28(2) 31(2) 25(1) 2(1) 0(1) -2(1)  
C(6) 24(2) 35(2) 27(2) 0(1) 7(1) 2(1)  
C(7) 26(2) 28(2) 41(2) -5(1) 3(1) 0(1)  
C(8) 36(2) 31(2) 55(2) -9(2) -7(2) -4(1)  
C(9) 34(2) 43(2) 39(2) -12(2) 7(1) 3(1)  
C(10) 33(2) 32(2) 53(2) -3(2) 11(2) -1(1)  
C(11) 31(2) 38(2) 34(2) -3(1) 4(1) 2(1)  
O(5) 30(1) 31(1) 27(1) 5(1) 4(1) 3(1)  
O(6) 20(1) 39(1) 40(1) -8(1) 5(1) -1(1)  
O(7) 23(1) 27(1) 28(1) -3(1) 3(1) 1(1)  
O(8) 31(1) 33(1) 30(1) 5(1) -1(1) 1(1)  
C(12) 26(2) 28(1) 31(2) 2(1) 5(1) 6(1)  
C(13) 24(2) 28(1) 25(1) -4(1) 1(1) 3(1)  
C(14) 21(1) 28(1) 23(1) 0(1) 1(1) 1(1)  
C(15) 24(2) 30(2) 25(2) 3(1) 2(1) 1(1)  
C(16) 17(1) 30(2) 29(1) -4(1) 2(1) 0(1)  
C(17) 23(2) 30(1) 24(1) 0(1) 7(1) 2(1)  
C(18) 30(2) 25(1) 27(1) -2(1) 6(1) 5(1)  
C(19) 41(2) 31(2) 39(2) -3(1) 3(1) 1(1)  
C(20) 53(2) 38(2) 35(2) 1(1) -3(2) 12(2)  
C(21) 35(2) 38(2) 37(2) -5(1) 15(1) 3(1)  
C(22) 22(2) 30(2) 27(1) 0(1) 2(1) 3(1)  
O(9) 30(1) 31(1) 30(1) 1(1) 3(1) 1(1)  
O(10) 24(1) 58(2) 33(1) 7(1) 3(1) 5(1)  
O(11) 25(1) 35(1) 26(1) 2(1) 3(1) 2(1)  
O(12) 39(2) 42(1) 43(1) 2(1) -6(1) 7(1)  
C(23) 27(2) 30(2) 28(2) 3(1) 1(1) 2(1)  
C(24) 28(2) 34(2) 28(2) 6(1) 6(1) 2(1)  
C(25) 25(2) 34(2) 33(2) 5(1) 5(1) -1(1)  
C(26) 22(2) 38(2) 28(2) 3(1) 6(1) 2(1)  
C(27) 20(1) 29(1) 29(2) 3(1) 3(1) -1(1)  
C(28) 20(2) 32(2) 30(2) 6(1) 2(1) 2(1)  
C(29) 30(2) 34(2) 29(2) -1(1) 3(1) 0(1)  
C(30) 47(2) 37(2) 39(2) 8(2) -14(2) -2(2)  
C(31) 42(2) 83(3) 31(2) -11(2) 6(2) -11(2)  
C(32) 37(2) 33(2) 48(2) 0(2) -6(2) 2(1)  
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C(33) 30(2) 32(2) 38(2) 4(1) 4(1) -1(1)  
O(13) 43(2) 48(1) 32(1) 5(1) 7(1) 16(1)  
O(14) 33(1) 36(1) 28(1) 0(1) 0(1) -6(1)  
O(15) 28(1) 33(1) 25(1) 0(1) 5(1) -1(1)  
O(16) 43(2) 46(1) 24(1) 5(1) -3(1) -10(1)  
C(34) 41(2) 40(2) 29(2) 0(1) 8(1) 1(2)  
C(35) 31(2) 34(2) 24(1) 4(1) 3(1) -1(1)  
C(36) 25(2) 29(1) 27(2) 3(1) 2(1) -3(1)  
C(37) 30(2) 38(2) 28(2) 3(1) 3(1) 6(1)  
C(38) 30(2) 27(1) 27(2) 3(1) 2(1) -3(1)  
C(39) 24(2) 29(2) 28(2) 4(1) 1(1) 2(1)  
C(40) 21(2) 40(2) 24(1) 1(1) 6(1) 1(1)  
C(41) 26(2) 48(2) 28(2) 6(1) 7(1) 3(1)  
C(42) 27(2) 45(2) 32(2) 4(1) 7(1) -1(1)  
C(43) 30(2) 43(2) 36(2) -6(1) 1(1) 8(1)  
C(44) 37(2) 36(2) 25(2) 2(1) -1(1) -1(1)  
 
Table 5: Hydrogen coordinates (x 104) and isotropic displacement parameters (A2 x 
103) for 140. 
Atom                       x      y     z    U(eq)  
H(1A) 6388 4156 -1957 46 
H(1B) 8634 4912 -1588 46 
H(2) 8526 3321 -831 37 
H(3) 8088 744 -1084 33 
H(4) 10259 916 -2013 39 
H(4O) 5509 5375 -885 51 
H(5) 5201 1713 -2162 33 
H(8A) 2171 -1300 -3511 50 
H(8B) 260 -1474 -3007 50 
H(8C) 949 -2866 -3412 50 
H(9A) 4920 -3947 -3252 46 
H(9B) 6757 -3242 -2746 46 
H(9C) 6150 -2384 -3351 46 
H(10A) 1395 -2587 -2029 47 
H(10B) 3893 -3342 -1943 47 
H(10C) 1884 -4077 -2395 47 
H(11A) 3677 3159 -1250 41 
H(11B) 4588 2667 -595 41 
H(8O) 8631 2226 2337 37 
H(12A) 4961 3595 727 34 
H(12B) 5686 5168 1036 34 
H(13) 8463 4263 1662 31 
H(14) 11369 2750 1229 29 
H(15) 11234 3879 241 31 
H(16) 7423 1613 376 30 
H(19A) 10543 -3473 -637 45 
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H(19B) 8891 -2180 -854 45 
H(19C) 8616 -2844 -199 45 
H(20A) 11725 -2327 615 50 
H(20B) 13985 -1324 484 50 
H(20C) 13696 -2942 187 50 
H(21A) 14012 -1788 -877 43 
H(21B) 14301 -221 -533 43 
H(21C) 12231 -518 -1042 43 
H(22A) 5093 2886 1898 31 
H(22B) 5619 1665 1391 31 
H(12O) -70 -1392 1678 49 
H(23A) 1057 -3241 2315 34 
H(23B) 1704 -3582 1625 34 
H(24) 4476 -1809 1635 36 
H(25) 7465 -1693 2440 36 
H(26) 7381 -4317 2585 35 
H(27) 3670 -2747 3242 31 
H(30A) 10493 -3631 5138 50 
H(30B) 10633 -3815 4419 50 
H(30C) 8489 -4561 4751 50 
H(31A) 5384 -2984 5185 63 
H(31B) 5574 -1247 5122 63 
H(31C) 7373 -2043 5573 63 
H(32A) 10768 -854 4989 47 
H(32B) 8777 -129 4570 47 
H(32C) 10720 -1120 4270 47 
H(33A) 1709 -718 2593 40 
H(33B) 3396 289 2204 40 
H(16O) 1705 -5916 2546 46 
H(34A) 3125 -8878 3557 44 
H(34B) 5295 -8380 3162 44 
H(35) 4907 -5986 3391 36 
H(36) 4454 -5243 4435 32 
H(37) 6887 -7192 4837 38 
H(38) 1888 -8128 4508 34 
H(41A) 1926 -7577 7050 41 
H(41B) 3634 -6843 6583 41 
H(41C) 3099 -8571 6543 41 
H(42A) -961 -9525 6180 41 
H(42B) -2924 -8383 5987 41 
H(42C) -2113 -8517 6685 41 
H(43A) -1154 -5732 6693 43 
H(43B) -1985 -5771 5991 43 
H(43C) 588 -5137 6202 43 
H(44A) 153 -6969 3565 39 
H(44B) 902 -5301 3457 39 
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Table 6: Torsion angles [deg] for 140. 
C(4)-O(1)-C(1)-C(2) 25.9(4)  C(12)-C(13)-C(14)-C(15) 13.3(3)  
C(1)-O(1)-C(4)-C(5) 51.3(4)  C(12)-C(13)-C(14)-C(16) -51.9(3)  
C(1)-O(1)-C(4)-C(3) -16.2(4)  C(12)-C(13)-C(22)-O(8) 176.9(2)  
C(7)-O(3)-C(6)-C(5) 179.5(3)  C(13)-C(14)-C(15)-O(5) -0.5(3)  
C(6)-O(3)-C(7)-C(8) -175.3(3)  C(13)-C(14)-C(16)-C(15) 95.1(3)  
C(7)-O(3)-C(6)-O(2) 0.2(5)  C(13)-C(14)-C(16)-C(17) -158.6(2)  
C(6)-O(3)-C(7)-C(10) 66.5(4)  C(16)-C(14)-C(15)-O(5) 111.0(3)  
C(6)-O(3)-C(7)-C(9) -58.8(4)  C(15)-C(14)-C(16)-C(17) 106.3(3)  
C(12)-O(5)-C(15)-C(16) 53.4(3)  C(13)-C(14)-C(15)-C(16) -111.5(3)  
C(15)-O(5)-C(12)-C(13) 22.3(3)  O(5)-C(15)-C(16)-C(17) 157.3(3)  
C(12)-O(5)-C(15)-C(14) -13.8(3)  O(5)-C(15)-C(16)-C(14) -98.8(3)  
C(17)-O(7)-C(18)-C(21) -64.3(4)  C(14)-C(15)-C(16)-C(17) -103.8(3)  
C(17)-O(7)-C(18)-C(20) 60.9(4)  C(15)-C(16)-C(17)-O(7) -144.9(3)  
C(18)-O(7)-C(17)-C(16) -175.8(2)  C(14)-C(16)-C(17)-O(6) -30.0(4)  
C(17)-O(7)-C(18)-C(19) 178.1(3)  C(14)-C(16)-C(17)-O(7) 150.5(2)  
C(18)-O(7)-C(17)-O(6) 4.7(5)  C(15)-C(16)-C(17)-O(6) 34.6(4)  
C(23)-O(9)-C(26)-C(25) -12.9(4)  O(9)-C(23)-C(24)-C(25) -22.2(3)  
C(23)-O(9)-C(26)-C(27) 55.4(4)  O(9)-C(23)-C(24)-C(33) -148.2(3)  
C(26)-O(9)-C(23)-C(24) 22.1(3)  C(33)-C(24)-C(25)-C(27) 72.3(4)  
C(28)-O(11)-C(29)-C(31) 175.9(3)  C(23)-C(24)-C(25)-C(26) 14.3(3)  
C(28)-O(11)-C(29)-C(32) 57.6(4)  C(25)-C(24)-C(33)-O(12) -179.7(3)  
C(29)-O(11)-C(28)-O(10) 3.5(6)  C(23)-C(24)-C(25)-C(27) -50.4(4)  
C(29)-O(11)-C(28)-C(27) -179.6(3)  C(33)-C(24)-C(25)-C(26) 137.0(3)  
C(28)-O(11)-C(29)-C(30) -66.4(4)  C(23)-C(24)-C(33)-O(12) -61.2(4)  
C(34)-O(13)-C(37)-C(38) 50.8(4)  C(27)-C(25)-C(26)-O(9) 111.5(3)  
C(37)-O(13)-C(34)-C(35) 25.8(4)  C(24)-C(25)-C(27)-C(26) 93.3(3)  
C(34)-O(13)-C(37)-C(36) -16.0(4)  C(24)-C(25)-C(26)-O(9) -1.5(4)  
C(40)-O(15)-C(39)-C(38) 177.1(3)  C(26)-C(25)-C(27)-C(28) 104.1(3)  
C(40)-O(15)-C(39)-O(14) -1.8(5)  C(24)-C(25)-C(27)-C(28) -162.6(3)  
C(39)-O(15)-C(40)-C(42) -178.7(3)  C(24)-C(25)-C(26)-C(27) -112.9(3)  
C(39)-O(15)-C(40)-C(43) 63.9(4)  O(9)-C(26)-C(27)-C(25) -100.0(3)  
C(39)-O(15)-C(40)-C(41) -60.5(4)  O(9)-C(26)-C(27)-C(28) 155.4(3)  
O(1)-C(1)-C(2)-C(3) -25.2(4)  C(25)-C(26)-C(27)-C(28) -104.6(3)  
O(1)-C(1)-C(2)-C(11) -150.3(3)  C(26)-C(27)-C(28)-O(11) -144.6(3)  
C(1)-C(2)-C(11)-O(4) -64.8(4)  C(26)-C(27)-C(28)-O(10) 32.5(5)  
C(1)-C(2)-C(3)-C(4) 15.4(3)  C(25)-C(27)-C(28)-O(11) 151.8(3)  
C(1)-C(2)-C(3)-C(5) -49.5(4)  C(25)-C(27)-C(28)-O(10) -31.2(5)  
C(3)-C(2)-C(11)-O(4) 176.8(3)  O(13)-C(34)-C(35)-C(36) -25.1(4)  
C(11)-C(2)-C(3)-C(4) 139.4(3)  O(13)-C(34)-C(35)-C(44) -148.8(3)  
C(11)-C(2)-C(3)-C(5) 74.5(4)  C(34)-C(35)-C(44)-O(16) -64.6(4)  
C(2)-C(3)-C(4)-O(1) -0.3(4)  C(34)-C(35)-C(36)-C(38) -50.1(4)  
C(2)-C(3)-C(5)-C(6) -160.7(3)  C(44)-C(35)-C(36)-C(37) 139.9(3)  
C(5)-C(3)-C(4)-O(1) 110.9(3)  C(34)-C(35)-C(36)-C(37) 15.3(3)  
C(4)-C(3)-C(5)-C(6) 105.3(3)  C(36)-C(35)-C(44)-O(16) 177.7(3)  
C(2)-C(3)-C(5)-C(4) 94.1(3)  C(44)-C(35)-C(36)-C(38) 74.5(4)  
C(2)-C(3)-C(4)-C(5) -111.3(3)  C(37)-C(36)-C(38)-C(39) 105.4(3)  
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O(1)-C(4)-C(5)-C(6) 153.5(3)  C(35)-C(36)-C(37)-O(13) -0.5(4)  
C(3)-C(4)-C(5)-C(6) -106.7(3)  C(35)-C(36)-C(37)-C(38) -111.2(3)  
O(1)-C(4)-C(5)-C(3) -99.8(3)  C(38)-C(36)-C(37)-O(13) 110.7(3)  
C(3)-C(5)-C(6)-O(2) -25.8(5)  C(35)-C(36)-C(38)-C(37) 94.6(3)  
C(4)-C(5)-C(6)-O(3) -139.6(3)  C(35)-C(36)-C(38)-C(39) -160.1(3)  
C(3)-C(5)-C(6)-O(3) 155.0(3)  O(13)-C(37)-C(38)-C(39) 155.1(3)  
C(4)-C(5)-C(6)-O(2) 39.6(5)  C(36)-C(37)-C(38)-C(39) -105.6(3)  
O(5)-C(12)-C(13)-C(22) -146.0(3)  O(13)-C(37)-C(38)-C(36) -99.3(3)  
O(5)-C(12)-C(13)-C(14) -21.7(3)  C(37)-C(38)-C(39)-O(14) 40.5(4)  
C(22)-C(13)-C(14)-C(16) 70.0(3)  C(37)-C(38)-C(39)-O(15) -138.4(3)  
C(14)-C(13)-C(22)-O(8) 59.7(3)  C(36)-C(38)-C(39)-O(14) -24.5(5)  
C(22)-C(13)-C(14)-C(15) 135.2(3)  C(36)-C(38)-C(39)-O(15) 156.7(3)  
 
Table 7: Hydrogen-bonds for 140 [Å and deg.]. 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA)  
 O(8)-H(8O)...O(16)#1  0.8400 18.800  2.704(4)  168.00  
 O(16)-H(16O)...O(9)  0.8400 19.600  2.779(4)  166.00  
 C(9)-H(9B)...O(2)  0.9800 24.300  2.982(5)  116.00  
 C(10)-H(10A)...O(2)#2  0.9800 25.800  3.501(5)  156.00  
 C(10)-H(10B)...O(2)  0.9800 25.500  3.097(5)  115.00  
 C(12)-H(12A)...O(6)#2  0.9900 25.100  3.434(4)  155.00  
 C(16)-H(16)...O(6)#2 10.000 24.900  3.480(4)  169.00  
 C(19)-H(19B)...O(2)  0.9800 25.800  3.537(5)  167.00  
 C(20)-H(20B)...O(6)  0.9800 24.200  3.002(5)  117.00  
 C(21)-H(21B)...O(6)  0.9800 24.300  3.007(5)  117.00  
 C(27)-H(27)...O(10)#2 10.000 25.200  3.517(4)  174.00  
 C(30)-H(30B)...O(10)  0.9800 24.900  3.047(5)  116.00  
 C(32)-H(32B)...O(13)#3  0.9800 24.500  3.378(5)  158.00  
 C(32)-H(32C)...O(10)  0.9800 23.500  2.956(5)  119.00  
 C(41)-H(41A)...O(1)#4  0.9800 25.300  3.459(5)  158.00  
 C(41)-H(41B)...O(14)  0.9800 24.400  3.004(4)  116.00  
 C(43)-H(43B)...O(14)#2  0.9800 25.200  3.456(4)  159.00  
 C(43)-H(43C)...O(14)  0.9800 24.300  3.022(4)  118.00  
 C(44)-H(44B)...O(10)#2  0.9900 25.800  3.548(5)  166.00  
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(3S,3aR,6aR)-5-oxohexahydrofuro[2,3-b]furan-3-carboxylic acid (145) 
 
 
 
Table 1: Crystal data and structure refinement for 145. 
      Crystal Data    
Empirical formula  C7 H8 O5  
Formula weight  172.13  
Crystal size  0.1337 x 0.0766 x 0.0487 mm  
Crystal description  prism  
Crystal colour  colourless  
Crystal system Monoclinic  
Space group  P 21/n  
Unit cell dimensions               a = 5.39904(17) A   alpha = 90 deg.  
                                         b = 14.8577(4) A    beta = 103.704(3) deg.  
                                         c = 8.6593(3) A   gamma = 90 deg.  
Volume  674.85(4) A^3  
Z, Calculated density  4,  1.694 Mg/m^3  
Absorption coefficient  1.277 mm^-1  
F(000)  360 
   
       Data Collection    
Measurement device type  SuperNova, Single source at offset, Atlas  
Measurement method  \w scans  
Temperature  123 K  
Wavelength  1.54184 A  
Monochromator   graphite  
Theta range for data collection  5.96 to 75.77 deg.  
Index ranges  =-5<=h<=6 -18<=k<=18 -9<=l<=10 
Reflections collected / unique  2478 / 1379 [R(int) = 0.0260]  
Reflections greater I>2\s(I) 1247 
Absorption correction  Analytical  
Max. and min. transmission  0.946 and 0.910  
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      Refinement    
Refinement method  Full-matrix least-squares on F^2  
Hydrogen treatment  :  
Data / restraints / parameters  1379 / 0 / 112  
Goodness-of-fit on F^2  1.045 
Final R indices [I>2sigma(I)]      R1 = 0.0444, wR2 = 0.1187  
R indices (all data)               R1 = 0.0487, wR2 = 0.1250  
Absolute structure parameter  .  
Largest diff. peak and hole  0.313 and -0.282 e.A^-3  
 
Table 2: Atomic coordinates (x 104) and equivalent isotropic displacement 
parameters (Å2 x 103) for 145. U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor. 
Atom x y z U(eq) 
O(1) 4366(2) 2897(1) 3804(1) 19(1)  
O(2) 4524(2) 2787(1) 1131(1) 17(1)  
O(3) 4550(2) 3613(1) -1004(1) 21(1)  
O(4) 968(2) 5427(1) 3470(1) 24(1)  
O(5) -2719(2) 4782(1) 2260(1) 21(1)  
C(1) 681(3) 3805(1) 3370(2) 16(1)  
C(2) 3466(3) 3746(1) 4281(2) 20(1)  
C(3) 2972(3) 2663(1) 2292(2) 16(1)  
C(4) 683(3) 3304(1) 1807(2) 15(1)  
C(5) 1324(3) 3883(1) 493(2) 16(1)  
C(6) 3587(3) 3436(1) 91(2) 16(1)  
C(7) -291(3) 4758(1) 3073(2) 16(1)  
 
Table 3: Bond lengths [Å] and angles [deg] for 145. 
O(1)-C(2) 1.448(2)  O(1)-C(3)-O(2) 110.16(13)  
O(1)-C(3) 1.3909(19)  C(1)-C(4)-C(5) 115.37(13)  
O(2)-C(3) 1.4649(19)  C(3)-C(4)-C(5) 104.04(13)  
O(2)-C(6) 1.3343(19)  C(1)-C(4)-C(3) 103.09(12)  
O(3)-C(6) 1.214(2)  C(4)-C(5)-C(6) 105.29(13)  
O(4)-C(7) 1.2079(19)  O(2)-C(6)-C(5) 111.23(13)  
O(5)-C(7) 1.333(2)  O(3)-C(6)-C(5) 127.41(14)  
O(5)-H(5O) 0.91(3)  O(2)-C(6)-O(3) 121.36(15)  
C(1)-C(4) 1.545(2)  O(4)-C(7)-C(1) 125.01(15)  
C(1)-C(7) 1.510(2)  O(5)-C(7)-C(1) 111.95(13)  
C(1)-C(2) 1.526(2)  O(4)-C(7)-O(5) 123.01(14)  
C(3)-C(4) 1.538(2)  C(2)-C(1)-H(1) 109.00  
C(4)-C(5) 1.529(2)  C(4)-C(1)-H(1) 109.00  
C(5)-C(6) 1.502(2)  C(7)-C(1)-H(1) 109.00  
C(1)-H(1) 10.000 O(1)-C(2)-H(2A) 111.00  
C(2)-H(2A) 0.9900  O(1)-C(2)-H(2B) 111.00  
C(2)-H(2B) 0.9900  C(1)-C(2)-H(2A) 111.00  
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C(3)-H(3) 10.000 C(1)-C(2)-H(2B) 111.00  
C(4)-H(4) 10.000 H(2A)-C(2)-H(2B) 109.00  
C(5)-H(5A) 0.9900  O(1)-C(3)-H(3) 110.00  
C(5)-H(5B) 0.9900  O(2)-C(3)-H(3) 110.00  
C(2)-O(1)-C(3) 110.09(12)  C(4)-C(3)-H(3) 110.00  
C(3)-O(2)-C(6) 111.54(12)  C(1)-C(4)-H(4) 111.00  
C(7)-O(5)-H(5O) 108.2(17)  C(3)-C(4)-H(4) 111.00  
C(2)-C(1)-C(4) 102.72(13)  C(5)-C(4)-H(4) 111.00  
C(2)-C(1)-C(7) 113.71(13)  C(4)-C(5)-H(5A) 111.00  
C(4)-C(1)-C(7) 111.97(12)  C(4)-C(5)-H(5B) 111.00  
O(1)-C(2)-C(1) 104.99(12)  C(6)-C(5)-H(5A) 111.00  
O(1)-C(3)-C(4) 108.83(12)  C(6)-C(5)-H(5B) 111.00  
O(2)-C(3)-C(4) 106.72(12)  H(5A)-C(5)-H(5B) 109.00  
 
Table 4: Anisotropic displacement parameters (A2 x 103) for 145. The anisotropic 
displacement factor exponent takes the form: -2 pi2 [ h2 a*2 U11 + .. + 2 h k a*b*U12]. 
Atom            U11   U22   U33    U23    U13  U12  
O(1) 21(1) 20(1) 16(1) 1(1) 2(1) 5(1)  
O(2) 16(1) 18(1) 18(1) 2(1) 7(1) 3(1)  
O(3) 23(1) 24(1) 19(1) 4(1) 11(1) 5(1)  
O(4) 27(1) 18(1) 25(1) -1(1) 4(1) -2(1)  
O(5) 20(1) 19(1) 24(1) 1(1) 5(1) 2(1)  
C(1) 19(1) 17(1) 15(1) 1(1) 7(1) 0(1)  
C(2) 22(1) 20(1) 16(1) -2(1) 3(1) 1(1)  
C(3) 16(1) 17(1) 15(1) 1(1) 5(1) 0(1)  
C(4) 15(1) 14(1) 17(1) -1(1) 5(1) 1(1)  
C(5) 18(1) 16(1) 16(1) 0(1) 6(1) 3(1)  
C(6) 17(1) 16(1) 15(1) -2(1) 3(1) 1(1)  
C(7) 21(1) 18(1) 12(1) 0(1) 9(1) 1(1)  
 
Table 5: Hydrogen coordinates (x 104) and isotropic displacement parameters (A2 x 
103) for 145. 
Atom x y z U(eq) 
H(1) -406 3470 3963 19 
H(2A) 4462 4254 3997 23 
H(2B) 3609 3758 5442 23 
H(3) 2375 2025 2280 19 
H(4) -941 2964 1409 18 
H(5A) -133 3902 -448 20 
H(5B) 1748 4505 873 20 
H(5O) -3150(50) 5365(18) 2020(30) 25 
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Table 6: Torsion angles [deg] for 145. 
C(3)-O(1)-C(2)-C(1) 27.00(16)  C(2)-C(1)-C(7)-O(4) 1.4(2)  
C(2)-O(1)-C(3)-O(2) 106.70(13)  C(2)-C(1)-C(7)-O(5) 179.30(12)  
C(2)-O(1)-C(3)-C(4) -9.98(16)  C(4)-C(1)-C(7)-O(4) -114.45(17)  
C(6)-O(2)-C(3)-C(4) 3.47(16)  C(4)-C(1)-C(7)-O(5) 63.42(17)  
C(3)-O(2)-C(6)-O(3) -176.95(14)  O(1)-C(3)-C(4)-C(1) -10.77(16)  
C(3)-O(2)-C(6)-C(5) 3.76(17)  O(2)-C(3)-C(4)-C(5) -8.85(15)  
C(6)-O(2)-C(3)-O(1) -114.52(14)  O(1)-C(3)-C(4)-C(5) 110.00(13)  
C(4)-C(1)-C(2)-O(1) -32.22(15)  O(2)-C(3)-C(4)-C(1) -129.62(12)  
C(7)-C(1)-C(2)-O(1) -153.42(12)  C(1)-C(4)-C(5)-C(6) 122.83(14)  
C(2)-C(1)-C(4)-C(3) 25.72(15)  C(3)-C(4)-C(5)-C(6) 10.69(15)  
C(2)-C(1)-C(4)-C(5) -86.98(16)  C(4)-C(5)-C(6)-O(3) 171.37(16)  
C(7)-C(1)-C(4)-C(3) 148.10(13)  C(4)-C(5)-C(6)-O(2) -9.39(17)  
C(7)-C(1)-C(4)-C(5) 35.40(19)  
   
Table 7: Hydrogen-bonds for 145 [Å and deg.]. 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA)  
 O(5)-H(5O)...O(3)#1  0.91(3)  1.83(3)  2.7086(18)  163(2)  
 C(2)-H(2A)...O(5)#2  0.9900 25.100  3.374(2)  146.00  
 C(3)-H(3)...O(3)#3 10.000 25.500  3.237(2)  126.00  
 C(4)-H(4)...O(2)#4 10.000 24.200  3.327(2)  151.00  
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(R)-1-(4-chlorophenyl)ethanaminium (3S,3aS,6aS)-5-oxohexahydrofuro[2,3-
b]furan-3-carboxylate (57) 
 
 
Table 1: Crystal data and structure refinement for 57. 
      Crystal Data    
Empirical formula  C8 H11 Cl N, C7 H7 O5  
Formula weight  327.75  
Crystal size  0.5084 x 0.0431 x 0.0264 mm  
Crystal description  stick  
Crystal colour  colourless  
Crystal system Orthorhombic  
Space group  P 21 21 21  
Unit cell dimensions               a = 6.6331(4) A   alpha = 90 deg.  
                                         b = 15.380(1) A    beta = 90 deg.  
                                         c = 15.6364(10) A   gamma = 90 deg.  
Volume  1595.18(17) A^3  
Z, Calculated density  4,  1.365 Mg/m^3  
Absorption coefficient  2.330 mm^-1  
F(000)  688 
   
       Data Collection    
Measurement device type  SuperNova, Single source at offset, Atlas  
Measurement method  \w scans  
Temperature  123 K  
Wavelength  1.54184 A  
Monochromator   graphite  
Theta range for data collection  4.03 to 75.50 deg.  
Index ranges  =-8<=h<=8 -19<=k<=19 -19<=l<=19 
Reflections collected / unique  11839 / 3283 [R(int) = 0.0618]  
Reflections greater I>2\s(I) 2637 
Absorption correction  Analytical  
Max. and min. transmission  0.943 and 0.589  
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      Refinement    
Refinement method  Full-matrix least-squares on F^2  
Hydrogen treatment  :  
Data / restraints / parameters  3283 / 0 / 201  
Goodness-of-fit on F^2  1.089 
Final R indices [I>2sigma(I)]      R1 = 0.0738, wR2 = 0.2097  
R indices (all data)               R1 = 0.0868, wR2 = 0.2274  
Absolute structure parameter  -0.04(4)  
Largest diff. peak and hole  0.507 and -0.305 e.A^-3  
 
Table 2: Atomic coordinates (x 104) and equivalent isotropic displacement 
parameters (Å2 x 103) for 57. U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor. 
Atom x y z U(eq) 
Cl(1) 5443(2) 1615(1) 2341(1) 71(1)  
N(1) 8548(5) -1868(2) 4550(3) 49(1)  
C(1) 6248(7) 609(3) 2725(3) 50(1)  
C(2) 4995(7) -91(3) 2635(3) 54(1)  
C(3) 5650(8) -887(3) 2933(3) 53(1)  
C(4) 7539(7) -968(3) 3310(3) 45(1)  
C(5) 8742(6) -256(3) 3389(3) 46(1)  
C(6) 8114(7) 556(3) 3098(3) 48(1)  
C(7) 8192(8) -1865(3) 3612(3) 55(2)  
C(8) 10098(14) -2183(4) 3182(5) 96(3)  
O(1) 4274(8) 3086(3) 5187(4) 97(2)  
O(2) 3213(6) 1989(3) 5980(2) 66(1)  
O(3) 3863(6) 575(3) 6426(2) 66(1)  
O(4) 1760(5) -854(2) 5021(3) 75(2)  
O(5) 4752(5) -1465(2) 5129(3) 67(1)  
C(9) 3916(9) 2323(3) 5254(4) 70(2)  
C(10) 4045(11) 1629(3) 4568(4) 69(2)  
C(11) 3177(8) 823(3) 4968(3) 53(1)  
C(12) 2720(8) 1082(3) 5889(3) 57(2)  
C(13) 5566(8) 262(4) 5927(4) 64(2)  
C(14) 4637(7) 62(3) 5067(3) 50(1)  
C(15) 3618(6) -829(3) 5067(3) 45(1)  
 
Table 3: Bond lengths [Å] and angles [deg] for 57. 
Cl(1)-C(1) 1.743(5)  C(1)-C(6)-C(5) 117.5(4)  
O(1)-C(9) 1.202(7)  N(1)-C(7)-C(4) 110.8(4)  
O(2)-C(12) 1.440(7)  C(4)-C(7)-C(8) 113.2(4)  
O(2)-C(9) 1.330(7)  N(1)-C(7)-C(8) 107.8(5)  
O(3)-C(12) 1.374(6)  C(3)-C(2)-H(2) 121.00  
O(3)-C(13) 1.455(7)  C(1)-C(2)-H(2) 121.00  
O(4)-C(15) 1.235(5)  C(4)-C(3)-H(3) 120.00  
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O(5)-C(15) 1.238(5)  C(2)-C(3)-H(3) 120.00  
N(1)-C(7) 1.486(7)  C(6)-C(5)-H(5) 119.00  
N(1)-H(1O) 0.9100  C(4)-C(5)-H(5) 119.00  
N(1)-H(1P) 0.9100  C(1)-C(6)-H(6) 121.00  
N(1)-H(1N) 0.9100  C(5)-C(6)-H(6) 121.00  
C(1)-C(2) 1.367(7)  C(4)-C(7)-H(7) 108.00  
C(1)-C(6) 1.371(7)  N(1)-C(7)-H(7) 108.00  
C(2)-C(3) 1.380(7)  C(8)-C(7)-H(7) 108.00  
C(3)-C(4) 1.390(7)  C(7)-C(8)-H(8B) 109.00  
C(4)-C(5) 1.361(6)  C(7)-C(8)-H(8C) 109.00  
C(4)-C(7) 1.521(7)  H(8A)-C(8)-H(8C) 110.00  
C(5)-C(6) 1.393(7)  H(8B)-C(8)-H(8C) 110.00  
C(7)-C(8) 1.513(10)  H(8A)-C(8)-H(8B) 109.00  
C(2)-H(2) 0.9500  C(7)-C(8)-H(8A) 109.00  
C(3)-H(3) 0.9500  O(1)-C(9)-O(2) 121.4(6)  
C(5)-H(5) 0.9500  O(1)-C(9)-C(10) 127.9(6)  
C(6)-H(6) 0.9500  O(2)-C(9)-C(10) 110.6(4)  
C(7)-H(7) 10.000 C(9)-C(10)-C(11) 105.4(5)  
C(8)-H(8A) 0.9800  C(10)-C(11)-C(12) 104.7(4)  
C(8)-H(8B) 0.9800  C(10)-C(11)-C(14) 115.6(5)  
C(8)-H(8C) 0.9800  C(12)-C(11)-C(14) 103.3(4)  
C(9)-C(10) 1.516(8)  O(2)-C(12)-O(3) 111.4(4)  
C(10)-C(11) 1.503(7)  O(2)-C(12)-C(11) 107.5(4)  
C(11)-C(12) 1.525(7)  O(3)-C(12)-C(11) 108.6(4)  
C(11)-C(14) 1.527(7)  O(3)-C(13)-C(14) 103.2(4)  
C(13)-C(14) 1.511(8)  C(11)-C(14)-C(13) 101.1(4)  
C(14)-C(15) 1.528(6)  C(11)-C(14)-C(15) 114.0(4)  
C(10)-H(10A) 0.9900  C(13)-C(14)-C(15) 111.3(4)  
C(10)-H(10B) 0.9900  O(4)-C(15)-O(5) 125.9(4)  
C(11)-H(11) 10.000 O(4)-C(15)-C(14) 118.0(4)  
C(12)-H(12) 10.000 O(5)-C(15)-C(14) 116.1(4)  
C(13)-H(13A) 0.9900  C(9)-C(10)-H(10A) 111.00  
C(13)-H(13B) 0.9900  C(9)-C(10)-H(10B) 111.00  
C(14)-H(14) 10.000 C(11)-C(10)-H(10A) 111.00  
C(9)-O(2)-C(12) 111.7(4)  C(11)-C(10)-H(10B) 111.00  
C(12)-O(3)-C(13) 106.8(4)  H(10A)-C(10)-H(10B) 109.00  
H(1N)-N(1)-H(1O) 110.00  C(10)-C(11)-H(11) 111.00  
C(7)-N(1)-H(1P) 109.00  C(12)-C(11)-H(11) 111.00  
C(7)-N(1)-H(1O) 109.00  C(14)-C(11)-H(11) 111.00  
H(1N)-N(1)-H(1P) 110.00  O(2)-C(12)-H(12) 110.00  
H(1O)-N(1)-H(1P) 109.00  O(3)-C(12)-H(12) 110.00  
C(7)-N(1)-H(1N) 109.00  C(11)-C(12)-H(12) 110.00  
Cl(1)-C(1)-C(2) 118.5(4)  O(3)-C(13)-H(13A) 111.00  
Cl(1)-C(1)-C(6) 118.4(4)  O(3)-C(13)-H(13B) 111.00  
C(2)-C(1)-C(6) 123.1(4)  C(14)-C(13)-H(13A) 111.00  
C(1)-C(2)-C(3) 118.2(4)  C(14)-C(13)-H(13B) 111.00  
C(2)-C(3)-C(4) 120.4(4)  H(13A)-C(13)-H(13B) 109.00  
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C(3)-C(4)-C(7) 118.0(4)  C(11)-C(14)-H(14) 110.00  
C(5)-C(4)-C(7) 122.3(4)  C(13)-C(14)-H(14) 110.00  
C(3)-C(4)-C(5) 119.7(4)  C(15)-C(14)-H(14) 110.00  
C(4)-C(5)-C(6) 121.1(4)  
   
Table 4: Anisotropic displacement parameters (A2 x 103) for 57. The anisotropic 
displacement factor exponent takes the form: -2 pi2 [ h2 a*2 U11 + .. + 2 h k a*b*U12]. 
Atom U11 U22 U33 U23 U13 U12 
Cl(1) 80(1) 58(1) 75(1) 17(1) -11(1) 15(1)  
N(1) 35(2) 35(2) 76(2) 14(2) 0(2) -1(1)  
C(1) 55(2) 51(2) 45(2) 4(2) -5(2) 9(2)  
C(2) 49(2) 56(2) 56(2) -3(2) -12(2) 5(2)  
C(3) 52(2) 48(2) 60(3) -8(2) -10(2) -6(2)  
C(4) 50(2) 38(2) 48(2) -3(2) -3(2) 0(2)  
C(5) 36(2) 45(2) 56(2) 4(2) -5(2) 1(2)  
C(6) 46(2) 45(2) 52(2) 1(2) 0(2) -3(2)  
C(7) 63(3) 34(2) 68(3) -3(2) -1(2) 2(2)  
C(8) 136(7) 63(4) 89(4) 8(3) 37(5) 40(4)  
O(1) 92(3) 48(2) 152(5) -24(2) 53(3) -17(2)  
O(2) 67(2) 65(2) 67(2) -15(2) 2(2) -4(2)  
O(3) 67(2) 83(3) 49(2) 5(2) 3(2) 9(2)  
O(4) 40(2) 52(2) 134(4) 7(2) -22(2) -2(1)  
O(5) 44(2) 50(2) 106(3) 25(2) 14(2) 7(1)  
C(9) 68(3) 49(3) 93(4) -12(3) 17(3) -9(2)  
C(10) 96(4) 45(2) 66(3) -3(2) 20(3) 1(3)  
C(11) 59(2) 43(2) 57(2) -1(2) -2(2) -4(2)  
C(12) 51(2) 59(3) 62(3) 1(2) 2(2) -2(2)  
C(13) 42(2) 77(3) 74(3) 0(3) -8(2) -6(2)  
C(14) 45(2) 53(2) 53(2) 1(2) 4(2) -5(2)  
C(15) 39(2) 41(2) 56(2) 8(2) -3(2) -2(2)  
 
Table 5: Hydrogen coordinates (x 104) and isotropic displacement parameters (A2 x 
103) for 57. 
Atom                     x      y     z    U(eq)  
H(1N) 8728 -2425 4732 73 
H(1O) 7466 -1631 4821 73 
H(1P) 9670 -1550 4670 73 
H(2) 3708 -31 2375 65 
H(3) 4804 -1382 2881 64 
H(5) 10032 -314 3647 55 
H(6) 8948 1054 3157 57 
H(7) 7084 -2286 3482 66 
H(8A) 9868 -2234 2565 144 
H(8B) 11191 -1767 3287 144 
H(8C) 10470 -2752 3416 144 
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H(10A) 3257 1800 4058 83 
H(10B) 5463 1531 4396 83 
H(11) 1922 637 4665 64 
H(12) 1256 990 6012 69 
H(13A) 6158 -266 6188 77 
H(13B) 6623 713 5877 77 
H(14) 5691 86 4610 60 
 
Table 6: Torsion angles [deg] for 57. 
C(12)-O(2)-C(9)-C(10) -2.1(6)  C(4)-C(5)-C(6)-C(1) -0.4(7)  
C(9)-O(2)-C(12)-C(11) -0.4(6)  O(2)-C(9)-C(10)-C(11) 3.7(7)  
C(9)-O(2)-C(12)-O(3) 118.5(5)  O(1)-C(9)-C(10)-C(11) -172.7(6)  
C(12)-O(2)-C(9)-O(1) 174.6(6)  C(9)-C(10)-C(11)-C(14) -116.6(5)  
C(13)-O(3)-C(12)-O(2) -95.9(5)  C(9)-C(10)-C(11)-C(12) -3.7(6)  
C(12)-O(3)-C(13)-C(14) -39.5(5)  C(10)-C(11)-C(12)-O(2) 2.7(6)  
C(13)-O(3)-C(12)-C(11) 22.3(5)  C(12)-C(11)-C(14)-C(13) -26.1(5)  
C(6)-C(1)-C(2)-C(3) -0.2(7)  C(12)-C(11)-C(14)-C(15) 93.4(5)  
C(2)-C(1)-C(6)-C(5) 0.5(7)  C(10)-C(11)-C(12)-O(3) -118.0(5)  
Cl(1)-C(1)-C(2)-C(3) 179.4(4)  C(14)-C(11)-C(12)-O(2) 124.0(4)  
Cl(1)-C(1)-C(6)-C(5) -179.1(4)  C(14)-C(11)-C(12)-O(3) 3.4(5)  
C(1)-C(2)-C(3)-C(4) -0.3(7)  C(10)-C(11)-C(14)-C(13) 87.6(5)  
C(2)-C(3)-C(4)-C(5) 0.4(7)  C(10)-C(11)-C(14)-C(15) -152.9(4)  
C(2)-C(3)-C(4)-C(7) -179.0(4)  O(3)-C(13)-C(14)-C(11) 39.6(5)  
C(5)-C(4)-C(7)-N(1) 62.1(6)  O(3)-C(13)-C(14)-C(15) -81.8(5)  
C(3)-C(4)-C(5)-C(6) 0.0(7)  C(11)-C(14)-C(15)-O(4) -2.6(6)  
C(5)-C(4)-C(7)-C(8) -59.0(7)  C(11)-C(14)-C(15)-O(5) 178.6(4)  
C(3)-C(4)-C(7)-C(8) 120.3(6)  C(13)-C(14)-C(15)-O(4) 111.0(5)  
C(7)-C(4)-C(5)-C(6) 179.3(4)  C(13)-C(14)-C(15)-O(5) -67.8(6)  
C(3)-C(4)-C(7)-N(1) -118.6(5)  
   
Table 7: Hydrogen-bonds for 57 [Å and deg.]. 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA)  
 N(1)-H(1N)...O(5)#1  0.9100 18.500  2.732(4)  162.00  
 N(1)-H(1O)...O(5)  0.9100 18.800  2.747(5)  158.00  
 N(1)-H(1P)...O(4)#2  0.9100 18.400  2.741(5)  173.00  
 C(2)-H(2)...O(3)#3  0.9500 24.100  3.268(6)  150.00  
 C(5)-H(5)...O(4)#2  0.9500 25.700  3.371(6)  142.00  
 C(7)-H(7)...Cl(1)#4 10.000 27.100  3.674(5)  163.00  
 C(11)-H(11)...O(4) 10.000 23.600  2.746(6)  102.00  
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 ((3S,3aS,6aS)-5-oxohexahydrofuro[2,3-b]furan-3-yl)methyl benzoate (153) 
 
 
Table 1: Crystal data and structure refinement for 153. 
      Crystal Data    
Empirical formula  C14 H14 O5  
Formula weight  262.25  
Crystal size  0.2101 x 0.0992 x 0.0510 mm  
Crystal description  plate  
Crystal colour  colourless  
Crystal system Orthorhombic  
Space group  P 21 21 21  
Unit cell dimensions               a = 6.55267(18) A   alpha = 90 deg.  
                                         b = 8.8207(3) A    beta = 90 deg.  
                                         c = 21.7464(7) A   gamma = 90 deg.  
Volume  1256.92(7) A^3  
Z, Calculated density  4,  1.386 Mg/m^3  
Absorption coefficient  0.887 mm^-1  
F(000)  552 
   
       Data Collection    
Measurement device type  SuperNova, Single source at offset, Atlas  
Measurement method  \w scans  
Temperature  123 K  
Wavelength  1.54184 A  
Monochromator   graphite  
Theta range for data collection  4.07 to 76.33 deg.  
Index ranges  =-7<=h<=7 -10<=k<=10 -26<=l<=27 
Reflections collected / unique  4694 / 2540 [R(int) = 0.0322]  
Reflections greater I>2\s(I) 2394 
Absorption correction  Analytical  
Max. and min. transmission  0.959 and 0.907  
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      Refinement    
Refinement method  Full-matrix least-squares on F^2  
Hydrogen treatment  :  
Data / restraints / parameters  2540 / 0 / 172  
Goodness-of-fit on F^2  1.042 
Final R indices [I>2sigma(I)]      R1 = 0.0459, wR2 = 0.1243  
R indices (all data)               R1 = 0.0481, wR2 = 0.1275  
Absolute structure parameter  0.2(2)  
Largest diff. peak and hole  0.211 and -0.233 e.A^-3  
 
Table 2: Atomic coordinates (x 104) and equivalent isotropic displacement 
parameters (Å2 x 103) for 153. U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor. 
Atom    x    y     z  U(eq)  
O(1) -7618(2) -3000(2) -8373(1) 38(1)  
O(2) -4434(2) -2337(2) -8634(1) 30(1)  
O(3) -1673(3) -3483(2) -10081(1) 38(1)  
O(4) 707(2) -5381(2) -10253(1) 35(1)  
O(5) 3597(2) -6343(2) -9900(1) 48(1)  
C(1) -6515(3) -452(2) -8214(1) 30(1)  
C(2) -4925(3) 596(2) -8254(1) 32(1)  
C(3) -5239(4) 2078(3) -8059(1) 37(1)  
C(4) -7111(4) 2515(3) -7824(1) 41(1)  
C(5) -8687(4) 1490(3) -7785(1) 43(1)  
C(6) -8409(4) 2(3) -7982(1) 38(1)  
C(7) -6285(3) -2056(2) -8413(1) 30(1)  
C(8) -4150(3) -3837(2) -8892(1) 31(1)  
C(9) -1888(3) -4001(2) -9026(1) 30(1)  
C(10) -1145(3) -2840(2) -9491(1) 34(1)  
C(11) -1351(3) -5032(2) -10046(1) 32(1)  
C(12) -1468(3) -5508(2) -9364(1) 29(1)  
C(13) 631(4) -6187(2) -9228(1) 36(1)  
C(14) 1845(3) -6011(2) -9810(1) 33(1)  
 
Table 3: Bond lengths [Å] and angles [deg] for 153. 
O(1)-C(7) 1.210(2)  O(2)-C(8)-C(9) 106.67(15)  
O(2)-C(7) 1.329(2)  C(8)-C(9)-C(10) 112.13(16)  
O(2)-C(8) 1.448(2)  C(8)-C(9)-C(12) 110.35(15)  
O(3)-C(10) 1.444(3)  C(10)-C(9)-C(12) 101.89(16)  
O(3)-C(11) 1.385(2)  O(3)-C(10)-C(9) 104.48(15)  
O(4)-C(11) 1.455(2)  O(3)-C(11)-O(4) 109.44(16)  
O(4)-C(14) 1.339(3)  O(3)-C(11)-C(12) 108.30(15)  
O(5)-C(14) 1.201(2)  O(4)-C(11)-C(12) 106.62(15)  
C(1)-C(2) 1.396(3)  C(9)-C(12)-C(11) 103.42(15)  
C(1)-C(6) 1.398(3)  C(9)-C(12)-C(13) 113.97(16)  
C(1)-C(7) 1.487(3)  C(11)-C(12)-C(13) 104.29(16)  
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C(2)-C(3) 1.390(3)  C(12)-C(13)-C(14) 105.90(17)  
C(3)-C(4) 1.384(4)  O(4)-C(14)-O(5) 121.1(2)  
C(4)-C(5) 1.375(4)  O(4)-C(14)-C(13) 110.70(17)  
C(5)-C(6) 1.393(4)  O(5)-C(14)-C(13) 128.2(2)  
C(8)-C(9) 1.518(3)  C(1)-C(2)-H(2) 120.00  
C(9)-C(10) 1.520(3)  C(3)-C(2)-H(2) 120.00  
C(9)-C(12) 1.544(3)  C(2)-C(3)-H(3) 120.00  
C(11)-C(12) 1.543(3)  C(4)-C(3)-H(3) 120.00  
C(12)-C(13) 1.529(3)  C(3)-C(4)-H(4) 120.00  
C(13)-C(14) 1.502(3)  C(5)-C(4)-H(4) 120.00  
C(2)-H(2) 0.9500  C(4)-C(5)-H(5) 120.00  
C(3)-H(3) 0.9500  C(6)-C(5)-H(5) 120.00  
C(4)-H(4) 0.9500  C(1)-C(6)-H(6) 120.00  
C(5)-H(5) 0.9500  C(5)-C(6)-H(6) 120.00  
C(6)-H(6) 0.9500  O(2)-C(8)-H(8A) 110.00  
C(8)-H(8A) 0.9900  O(2)-C(8)-H(8B) 110.00  
C(8)-H(8B) 0.9900  C(9)-C(8)-H(8A) 110.00  
C(9)-H(9) 10.000 C(9)-C(8)-H(8B) 110.00  
C(10)-H(10A) 0.9900  H(8A)-C(8)-H(8B) 109.00  
C(10)-H(10B) 0.9900  C(8)-C(9)-H(9) 111.00  
C(11)-H(11) 10.000 C(10)-C(9)-H(9) 111.00  
C(12)-H(12) 10.000 C(12)-C(9)-H(9) 111.00  
C(13)-H(13A) 0.9900  O(3)-C(10)-H(10A) 111.00  
C(13)-H(13B) 0.9900  O(3)-C(10)-H(10B) 111.00  
C(7)-O(2)-C(8) 115.34(15)  C(9)-C(10)-H(10A) 111.00  
C(10)-O(3)-C(11) 107.57(15)  C(9)-C(10)-H(10B) 111.00  
C(11)-O(4)-C(14) 112.42(15)  H(10A)-C(10)-H(10B) 109.00  
C(2)-C(1)-C(6) 119.70(18)  O(3)-C(11)-H(11) 111.00  
C(2)-C(1)-C(7) 122.44(17)  O(4)-C(11)-H(11) 111.00  
C(6)-C(1)-C(7) 117.86(18)  C(12)-C(11)-H(11) 111.00  
C(1)-C(2)-C(3) 119.58(19)  C(9)-C(12)-H(12) 112.00  
C(2)-C(3)-C(4) 120.4(2)  C(11)-C(12)-H(12) 112.00  
C(3)-C(4)-C(5) 120.4(2)  C(13)-C(12)-H(12) 112.00  
C(4)-C(5)-C(6) 120.1(2)  C(12)-C(13)-H(13A) 111.00  
C(1)-C(6)-C(5) 119.8(2)  C(12)-C(13)-H(13B) 111.00  
O(1)-C(7)-O(2) 123.80(17)  C(14)-C(13)-H(13A) 111.00  
O(1)-C(7)-C(1) 124.13(18)  C(14)-C(13)-H(13B) 111.00  
O(2)-C(7)-C(1) 112.06(16)  H(13A)-C(13)-H(13B) 109.00  
 
Table 4: Anisotropic displacement parameters (A2 x 103) for 153. The anisotropic 
displacement factor exponent takes the form: -2 pi2 [ h2 a*2 U11 + .. + 2 h k a*b*U12]. 
Atom              U11   U22   U33    U23    U13  U12  
O(1) 29(1) 40(1) 45(1) -5(1) 5(1) -8(1)  
O(2) 25(1) 29(1) 38(1) -3(1) 5(1) -2(1)  
O(3) 34(1) 39(1) 40(1) 11(1) 0(1) 6(1)  
O(4) 31(1) 40(1) 34(1) -2(1) 4(1) -1(1)  
O(5) 26(1) 42(1) 74(1) -18(1) 2(1) 6(1)  
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C(1) 29(1) 32(1) 28(1) 1(1) 0(1) 2(1)  
C(2) 31(1) 34(1) 29(1) 0(1) 1(1) 1(1)  
C(3) 42(1) 33(1) 35(1) -1(1) -4(1) -1(1)  
C(4) 50(1) 39(1) 35(1) -5(1) -2(1) 12(1)  
C(5) 41(1) 45(1) 42(1) -3(1) 8(1) 13(1)  
C(6) 33(1) 38(1) 42(1) 0(1) 8(1) 3(1)  
C(7) 27(1) 33(1) 31(1) 1(1) 2(1) -2(1)  
C(8) 30(1) 26(1) 37(1) -2(1) 4(1) -4(1)  
C(9) 26(1) 29(1) 36(1) -2(1) 2(1) -4(1)  
C(10) 27(1) 27(1) 48(1) 2(1) 8(1) 0(1)  
C(11) 25(1) 37(1) 34(1) 0(1) -2(1) -2(1)  
C(12) 24(1) 28(1) 35(1) -1(1) 1(1) -1(1)  
C(13) 37(1) 35(1) 36(1) -3(1) -5(1) 7(1)  
C(14) 27(1) 28(1) 44(1) -9(1) -2(1) -1(1)  
 
Table 5: Hydrogen coordinates (x 104) and isotropic displacement parameters (A2 x 
103) for 153. 
Atom                    x      y     z    U(eq)  
H(2) -3636 298 -8413 38 
H(3) -4163 2796 -8088 44 
H(4) -7309 3529 -7689 50 
H(5) -9968 1797 -7623 51 
H(6) -9503 -702 -7960 45 
H(8A) -4954 -3950 -9274 37 
H(8B) -4598 -4621 -8595 37 
H(9) -1073 -3939 -8638 36 
H(10A) -1835 -1853 -9429 41 
H(10B) 348 -2691 -9457 41 
H(11) -2385 -5593 -10296 38 
H(12) -2584 -6262 -9292 35 
H(13A) 1296 -5641 -8885 43 
H(13B) 505 -7271 -9116 43 
 
Table 6: Torsion angles [deg] for 153. 
C(7)-O(2)-C(8)-C(9) -171.59(16)  C(2)-C(3)-C(4)-C(5) -0.5(3)  
C(8)-O(2)-C(7)-O(1) 6.2(3)  C(3)-C(4)-C(5)-C(6) -0.1(4)  
C(8)-O(2)-C(7)-C(1) -174.38(16)  C(4)-C(5)-C(6)-C(1) 0.8(3)  
C(11)-O(3)-C(10)-C(9) -37.9(2)  O(2)-C(8)-C(9)-C(10) -61.4(2)  
C(10)-O(3)-C(11)-O(4) -92.25(18)  O(2)-C(8)-C(9)-C(12) -174.21(16)  
C(10)-O(3)-C(11)-C(12) 23.6(2)  C(8)-C(9)-C(10)-O(3) -82.31(19)  
C(14)-O(4)-C(11)-O(3) 117.86(17)  C(12)-C(9)-C(10)-O(3) 35.68(19)  
C(11)-O(4)-C(14)-C(13) 0.7(2)  C(8)-C(9)-C(12)-C(11) 97.99(18)  
C(14)-O(4)-C(11)-C(12) 0.9(2)  C(8)-C(9)-C(12)-C(13) -149.45(17)  
C(11)-O(4)-C(14)-O(5) -178.55(18)  C(10)-C(9)-C(12)-C(11) -21.27(19)  
C(6)-C(1)-C(2)-C(3) 0.4(3)  C(10)-C(9)-C(12)-C(13) 91.30(19)  
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C(7)-C(1)-C(2)-C(3) -179.88(19)  O(3)-C(11)-C(12)-C(9) -0.3(2)  
C(2)-C(1)-C(6)-C(5) -0.9(3)  O(4)-C(11)-C(12)-C(13) -2.08(18)  
C(7)-C(1)-C(6)-C(5) 179.4(2)  O(3)-C(11)-C(12)-C(13) -119.77(17)  
C(2)-C(1)-C(7)-O(1) 178.5(2)  O(4)-C(11)-C(12)-C(9) 117.37(16)  
C(6)-C(1)-C(7)-O(1) -1.8(3)  C(9)-C(12)-C(13)-C(14) -109.61(18)  
C(6)-C(1)-C(7)-O(2) 178.79(17)  C(11)-C(12)-C(13)-C(14) 2.43(19)  
C(2)-C(1)-C(7)-O(2) -0.9(3)  C(12)-C(13)-C(14)-O(5) 177.2(2)  
C(1)-C(2)-C(3)-C(4) 0.3(3)  C(12)-C(13)-C(14)-O(4) -2.0(2)  
 
Table 7: Hydrogen-bonds for 153 [Å and deg.]. 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA)  
 C(9)-H(9)...O(1)#1 10.000 24.800  3.259(2)  135.00  
 C(10)-H(10A)...O(2)  0.9900 24.600  2.883(2)  105.00  
 C(10)-H(10B)...O(3)#2  0.9900 24.300  3.289(3)  145.00  
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 ((3S,3aS,6aS)-5-oxo-6a-(2-oxopropyl)hexahydrofuro[2,3-b]furan-3-yl)methyl 
benzoate (5) 
 
 
 
Table 1: Crystal data and structure refinement for 5.  
      Crystal Data    
Empirical formula  C17 H18 O6  
Formula weight  318.31  
Crystal size  0.2041 x 0.0467 x 0.0293 mm  
Crystal description  stick  
Crystal colour  colourless  
Crystal system Monoclinic  
Space group  P 21  
Unit cell dimensions               a = 9.9890(2) A   alpha = 90 deg.  
                                         b = 6.47394(13) A    beta = 99.014(2) deg.  
                                         c = 12.1110(3) A   gamma = 90 deg.  
Volume  773.52(3) A^3  
Z, Calculated density  2,  1.367 Mg/m^3  
Absorption coefficient  0.870 mm^-1  
F(000)  336 
   
       Data Collection    
Measurement device type  SuperNova, Single source at offset, Atlas  
Measurement method  \w scans  
Temperature  123 K  
Wavelength  1.54184 A  
Monochromator   graphite  
Theta range for data collection  3.70 to 72.89 deg.  
Index ranges  =-12<=h<=8 -7<=k<=7 -14<=l<=14 
Reflections collected / unique  5084 / 2940 [R(int) = 0.0335]  
Reflections greater I>2\s(I) 2830 
Absorption correction  Analytical  
Max. and min. transmission  0.975 and 0.884  
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      Refinement    
Refinement method  Full-matrix least-squares on F^2  
Hydrogen treatment  :  
Data / restraints / parameters  2940 / 1 / 208  
Goodness-of-fit on F^2  1.036 
Final R indices [I>2sigma(I)]      R1 = 0.0438, wR2 = 0.1160  
R indices (all data)               R1 = 0.0452, wR2 = 0.1190  
Absolute structure parameter  0.13(18)  
Largest diff. peak and hole  0.346 and -0.297 e.A^-3  
 
Table 2: Atomic coordinates (x 104) and equivalent isotropic displacement 
parameters (Å2 x 103) for 5. U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor. 
Atom    x    y     z  U(eq)  
O(1) 3884(2) 4619(2) 4672(1) 35(1)  
O(2) 2911(1) 1556(2) 4191(1) 31(1)  
O(3) 357(1) -1675(2) 5619(1) 31(1)  
O(4) 855(1) -4031(2) 7068(1) 31(1)  
O(5) 2166(2) -6608(2) 7829(1) 39(1)  
O(6) 1779(2) -1494(2) 9061(1) 35(1)  
C(1) 3479(2) 3351(3) 3973(2) 28(1)  
C(2) 3562(2) 3603(3) 2758(2) 29(1)  
C(3) 3242(2) 2012(4) 1990(2) 35(1)  
C(4) 3362(2) 2339(5) 872(2) 42(1)  
C(5) 3779(2) 4236(5) 533(2) 47(1)  
C(6) 4082(3) 5826(5) 1287(2) 47(1)  
C(7) 3980(2) 5518(4) 2409(2) 37(1)  
C(8) 2750(2) 1233(3) 5345(2) 28(1)  
C(9) 2657(2) -1073(3) 5533(2) 26(1)  
C(10) 1368(2) -2015(3) 4902(2) 30(1)  
C(11) 981(2) -1885(3) 6720(2) 28(1)  
C(12) 2067(2) -4895(3) 7434(2) 29(1)  
C(13) 3200(2) -3483(3) 7248(2) 28(1)  
C(14) 2525(2) -1498(3) 6764(2) 25(1)  
C(15) 221(2) -563(3) 7441(2) 32(1)  
C(16) 793(2) -503(3) 8663(2) 32(1)  
C(17) 58(3) 891(4) 9352(2) 43(1)  
 
Table 3: Bond lengths [Å] and angles [deg] for 5. 
O(1)-C(1) 1.204(2)  O(3)-C(10)-C(9) 104.67(15)  
O(2)-C(1) 1.338(2)  O(3)-C(11)-O(4) 108.93(15)  
O(2)-C(8) 1.447(2)  O(3)-C(11)-C(14) 108.08(15)  
O(3)-C(10) 1.448(2)  O(3)-C(11)-C(15) 108.05(16)  
O(3)-C(11) 1.387(2)  O(4)-C(11)-C(14) 105.82(15)  
O(4)-C(11) 1.463(2)  O(4)-C(11)-C(15) 107.35(15)  
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O(4)-C(12) 1.344(2)  C(14)-C(11)-C(15) 118.33(16)  
O(5)-C(12) 1.206(2)  O(4)-C(12)-O(5) 121.79(19)  
O(6)-C(16) 1.211(2)  O(4)-C(12)-C(13) 111.05(16)  
C(1)-C(2) 1.496(3)  O(5)-C(12)-C(13) 127.14(19)  
C(2)-C(3) 1.390(3)  C(12)-C(13)-C(14) 105.80(15)  
C(2)-C(7) 1.394(3)  C(9)-C(14)-C(11) 103.33(15)  
C(3)-C(4) 1.395(3)  C(9)-C(14)-C(13) 114.99(16)  
C(4)-C(5) 1.380(4)  C(11)-C(14)-C(13) 104.72(15)  
C(5)-C(6) 1.378(4)  C(11)-C(15)-C(16) 115.91(17)  
C(6)-C(7) 1.393(3)  O(6)-C(16)-C(15) 122.59(18)  
C(8)-C(9) 1.515(3)  O(6)-C(16)-C(17) 122.5(2)  
C(9)-C(10) 1.518(3)  C(15)-C(16)-C(17) 114.89(18)  
C(9)-C(14) 1.542(3)  C(2)-C(3)-H(3) 120.00  
C(11)-C(14) 1.555(3)  C(4)-C(3)-H(3) 120.00  
C(11)-C(15) 1.509(3)  C(3)-C(4)-H(4) 120.00  
C(12)-C(13) 1.499(3)  C(5)-C(4)-H(4) 120.00  
C(13)-C(14) 1.526(3)  C(4)-C(5)-H(5) 120.00  
C(15)-C(16) 1.502(3)  C(6)-C(5)-H(5) 120.00  
C(16)-C(17) 1.497(3)  C(5)-C(6)-H(6) 120.00  
C(3)-H(3) 0.9500  C(7)-C(6)-H(6) 120.00  
C(4)-H(4) 0.9500  C(2)-C(7)-H(7) 120.00  
C(5)-H(5) 0.9500  C(6)-C(7)-H(7) 120.00  
C(6)-H(6) 0.9500  O(2)-C(8)-H(8A) 110.00  
C(7)-H(7) 0.9500  O(2)-C(8)-H(8B) 110.00  
C(8)-H(8A) 0.9900  C(9)-C(8)-H(8A) 110.00  
C(8)-H(8B) 0.9900  C(9)-C(8)-H(8B) 110.00  
C(9)-H(9) 10.000 H(8A)-C(8)-H(8B) 108.00  
C(10)-H(10A) 0.9900  C(8)-C(9)-H(9) 110.00  
C(10)-H(10B) 0.9900  C(10)-C(9)-H(9) 110.00  
C(13)-H(13A) 0.9900  C(14)-C(9)-H(9) 110.00  
C(13)-H(13B) 0.9900  O(3)-C(10)-H(10A) 111.00  
C(14)-H(14) 10.000 O(3)-C(10)-H(10B) 111.00  
C(15)-H(15A) 0.9900  C(9)-C(10)-H(10A) 111.00  
C(15)-H(15B) 0.9900  C(9)-C(10)-H(10B) 111.00  
C(17)-H(17A) 0.9800  H(10A)-C(10)-H(10B) 109.00  
C(17)-H(17B) 0.9800  C(12)-C(13)-H(13A) 111.00  
C(17)-H(17C) 0.9800  C(12)-C(13)-H(13B) 111.00  
C(1)-O(2)-C(8) 115.54(15)  C(14)-C(13)-H(13A) 111.00  
C(10)-O(3)-C(11) 108.14(14)  C(14)-C(13)-H(13B) 111.00  
C(11)-O(4)-C(12) 112.12(15)  H(13A)-C(13)-H(13B) 109.00  
O(1)-C(1)-O(2) 124.03(19)  C(9)-C(14)-H(14) 111.00  
O(1)-C(1)-C(2) 123.66(18)  C(11)-C(14)-H(14) 111.00  
O(2)-C(1)-C(2) 112.31(17)  C(13)-C(14)-H(14) 111.00  
C(1)-C(2)-C(3) 122.29(18)  C(11)-C(15)-H(15A) 108.00  
C(1)-C(2)-C(7) 117.38(18)  C(11)-C(15)-H(15B) 108.00  
C(3)-C(2)-C(7) 120.3(2)  C(16)-C(15)-H(15A) 108.00  
C(2)-C(3)-C(4) 119.4(2)  C(16)-C(15)-H(15B) 108.00  
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C(3)-C(4)-C(5) 120.0(3)  H(15A)-C(15)-H(15B) 107.00  
C(4)-C(5)-C(6) 120.9(2)  C(16)-C(17)-H(17A) 109.00  
C(5)-C(6)-C(7) 119.8(3)  C(16)-C(17)-H(17B) 109.00  
C(2)-C(7)-C(6) 119.6(2)  C(16)-C(17)-H(17C) 109.00  
O(2)-C(8)-C(9) 107.83(15)  H(17A)-C(17)-H(17B) 110.00  
C(8)-C(9)-C(10) 112.80(16)  H(17A)-C(17)-H(17C) 110.00  
C(8)-C(9)-C(14) 109.73(15)  H(17B)-C(17)-H(17C) 109.00  
C(10)-C(9)-C(14) 102.74(15)  
   
Table 4: Anisotropic displacement parameters (A2 x 103) for 5. The anisotropic 
displacement factor exponent takes the form: -2 pi2 [ h2 a*2 U11 + .. + 2 h k a*b*U12]. 
Atom              U11   U22   U33    U23    U13  U12  
O(1) 44(1) 29(1) 36(1) -4(1) 13(1) -4(1)  
O(2) 35(1) 30(1) 28(1) 2(1) 5(1) -6(1)  
O(3) 22(1) 37(1) 32(1) 0(1) 0(1) -2(1)  
O(4) 28(1) 27(1) 38(1) 1(1) 5(1) -6(1)  
O(5) 51(1) 25(1) 43(1) 5(1) 10(1) -2(1)  
O(6) 36(1) 38(1) 31(1) 1(1) 8(1) 2(1)  
C(1) 23(1) 28(1) 34(1) 2(1) 8(1) 3(1)  
C(2) 21(1) 37(1) 31(1) 4(1) 6(1) 4(1)  
C(3) 27(1) 44(1) 33(1) -1(1) 6(1) 4(1)  
C(4) 30(1) 64(2) 32(1) -3(1) 4(1) 5(1)  
C(5) 36(1) 73(2) 32(1) 14(1) 10(1) 8(1)  
C(6) 41(1) 60(2) 43(1) 18(1) 15(1) 0(1)  
C(7) 33(1) 39(1) 40(1) 9(1) 8(1) 0(1)  
C(8) 32(1) 26(1) 26(1) 1(1) 4(1) -3(1)  
C(9) 24(1) 26(1) 28(1) 2(1) 4(1) -1(1)  
C(10) 29(1) 32(1) 28(1) -1(1) 2(1) -4(1)  
C(11) 24(1) 27(1) 31(1) 2(1) 2(1) -4(1)  
C(12) 34(1) 25(1) 28(1) -1(1) 7(1) -1(1)  
C(13) 26(1) 27(1) 30(1) 4(1) 5(1) 2(1)  
C(14) 22(1) 24(1) 27(1) 0(1) 3(1) -2(1)  
C(15) 21(1) 33(1) 42(1) 2(1) 8(1) 0(1)  
C(16) 30(1) 28(1) 40(1) 0(1) 13(1) -5(1)  
C(17) 43(1) 41(1) 47(1) -5(1) 19(1) 2(1)  
 
Table 5: Hydrogen coordinates (x 104) and isotropic displacement parameters (A2 x 
103) for 5. 
Atom                         x      y     z    U(eq)  
H(3) 2944 714 2226 41 
H(4) 3156 1256 344 50 
H(5) 3859 4448 -230 56 
H(6) 4359 7129 1042 56 
H(7) 4195 6605 2934 44 
H(8A) 1916 1925 5502 34 
H(8B) 3534 1816 5850 34 
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H(9) 3472 -1790 5331 31 
H(10A) 1104 -1326 4170 36 
H(10B) 1490 -3509 4775 36 
H(13A) 3745 -4109 6719 33 
H(13B) 3802 -3199 7962 33 
H(14) 2833 -283 7247 29 
H(15A) 190 868 7149 38 
H(15B) -724 -1069 7361 38 
H(17A) 680 1958 9702 64 
H(17B) -282 81 9933 64 
H(17C) -705 1545 8871 64 
 
Table 6: Torsion angles [deg] for 5. 
C(8)-O(2)-C(1)-O(1) 2.5(3)  O(2)-C(8)-C(9)-C(10) -67.7(2)  
C(8)-O(2)-C(1)-C(2) -177.82(15)  O(2)-C(8)-C(9)-C(14) 178.40(15)  
C(1)-O(2)-C(8)-C(9) -157.17(16)  C(8)-C(9)-C(10)-O(3) -84.02(18)  
C(11)-O(3)-C(10)-C(9) -36.31(18)  C(14)-C(9)-C(10)-O(3) 34.04(18)  
C(10)-O(3)-C(11)-O(4) -91.71(17)  C(8)-C(9)-C(14)-C(11) 100.04(17)  
C(10)-O(3)-C(11)-C(14) 22.81(19)  C(8)-C(9)-C(14)-C(13) -146.47(16)  
C(10)-O(3)-C(11)-C(15) 151.97(15)  C(10)-C(9)-C(14)-C(11) -20.16(18)  
C(12)-O(4)-C(11)-O(3) 123.27(16)  C(10)-C(9)-C(14)-C(13) 93.33(18)  
C(12)-O(4)-C(11)-C(14) 7.3(2)  O(3)-C(11)-C(14)-C(9) -0.62(19)  
C(12)-O(4)-C(11)-C(15) -119.96(17)  O(3)-C(11)-C(14)-C(13) -121.35(16)  
C(11)-O(4)-C(12)-O(5) 174.76(18)  O(4)-C(11)-C(14)-C(9) 115.95(16)  
C(11)-O(4)-C(12)-C(13) -6.8(2)  O(4)-C(11)-C(14)-C(13) -4.79(18)  
O(1)-C(1)-C(2)-C(3) 171.9(2)  C(15)-C(11)-C(14)-C(9) -123.74(18)  
O(1)-C(1)-C(2)-C(7) -8.1(3)  C(15)-C(11)-C(14)-C(13) 115.53(18)  
O(2)-C(1)-C(2)-C(3) -7.8(3)  O(3)-C(11)-C(15)-C(16) -176.97(16)  
O(2)-C(1)-C(2)-C(7) 172.24(17)  O(4)-C(11)-C(15)-C(16) 65.7(2)  
C(1)-C(2)-C(3)-C(4) -178.97(19)  C(14)-C(11)-C(15)-C(16) -53.8(2)  
C(7)-C(2)-C(3)-C(4) 1.0(3)  O(4)-C(12)-C(13)-C(14) 3.3(2)  
C(1)-C(2)-C(7)-C(6) 179.6(2)  O(5)-C(12)-C(13)-C(14) -178.35(19)  
C(3)-C(2)-C(7)-C(6) -0.3(3)  C(12)-C(13)-C(14)-C(9) -111.52(17)  
C(2)-C(3)-C(4)-C(5) -0.8(3)  C(12)-C(13)-C(14)-C(11) 1.15(19)  
C(3)-C(4)-C(5)-C(6) 0.0(3)  C(11)-C(15)-C(16)-O(6) -2.0(3)  
C(4)-C(5)-C(6)-C(7) 0.6(4)  C(11)-C(15)-C(16)-C(17) 177.43(18)  
C(5)-C(6)-C(7)-C(2) -0.5(4)  
   
Table 7: Hydrogen-bonds for 5 [Å and deg.]. 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA)  
 C(9)-H(9)...O(1)#1 10.000 25.100  3.281(2)  133.00  
 C(10)-H(10A)...O(2)  0.9900 25.900  2.980(2)  103.00  
 C(14)-H(14)...O(5)#2 10.000 26.000  3.458(2)  144.00  
 C(15)-H(15A)...O(5)#2  0.9900 25.900  3.204(2)  120.00  
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